- id: 3
  properties:
    _type: Code
    code: C98388
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Interventional Study
    id: Code_1
    instanceType: Code
    label: Code_1
- id: 5
  properties:
    _type: Code
    code: C15601
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Phase II Trial
    id: Code_2
    instanceType: Code
    label: Code_2
- id: 4
  properties:
    _type: AliasCode
    id: AliasCode_1
    instanceType: AliasCode
    label: AliasCode_1
    standardCodeAliases: []
- id: 7
  properties:
    _type: Code
    code: C132352
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sponsor Approval Date
    id: Code_9
    instanceType: Code
    label: Code_9
- id: 9
  properties:
    _type: Code
    code: C68846
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Global
    id: Code_10
    instanceType: Code
    label: Code_10
- id: 8
  properties:
    _type: GeographicScope
    code: null
    id: GeographicScope_1
    instanceType: GeographicScope
    label: GeographicScope_1
- id: 6
  properties:
    _type: GovernanceDate
    dateValue: '2006-06-01'
    description: Design approval date
    id: GovernanceDate_1
    instanceType: GovernanceDate
    label: GovernanceDate_1
    name: D_APPROVE
- id: 12
  properties:
    _type: Code
    code: C99904x3
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: IRB/IEC Feedback
    id: Code_72
    instanceType: Code
    label: Code_72
- id: 11
  properties:
    _type: StudyAmendmentReason
    id: StudyAmendmentReason_1
    instanceType: StudyAmendmentReason
    label: StudyAmendmentReason_1
    otherReason: null
- id: 14
  properties:
    _type: Code
    code: C17649
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Other
    id: Code_73
    instanceType: Code
    label: Code_73
- id: 13
  properties:
    _type: StudyAmendmentReason
    id: StudyAmendmentReason_2
    instanceType: StudyAmendmentReason
    label: StudyAmendmentReason_2
    otherReason: Fix typographical errors
- id: 16
  properties:
    _type: Code
    code: C41129
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Region
    id: Code_75
    instanceType: Code
    label: Code_75
- id: 18
  properties:
    _type: Code
    code: '150'
    codeSystem: ISO 3166 1 alpha3
    codeSystemVersion: 2020-08
    decode: Europe
    id: Code_74
    instanceType: Code
    label: Code_74
- id: 17
  properties:
    _type: AliasCode
    id: AliasCode_3
    instanceType: AliasCode
    label: AliasCode_3
    standardCodeAliases: []
- id: 19
  properties:
    _type: Quantity
    id: Quantity_1
    instanceType: Quantity
    label: Quantity_1
    unit: null
    value: 15.0
- id: 15
  properties:
    _type: SubjectEnrollment
    id: SubjectEnrollment_1
    instanceType: SubjectEnrollment
    label: SubjectEnrollment_1
- id: 10
  properties:
    _type: StudyAmendment
    id: StudyAmendment_1
    instanceType: StudyAmendment
    label: StudyAmendment_1
    number: '1'
    substantialImpact: true
    summary: Updated inclusion criteria
- id: 20
  properties:
    _type: Code
    code: PHARMA
    codeSystem: SPONSOR
    codeSystemVersion: '12'
    decode: Eli Lilly
    id: Code_4
    instanceType: Code
    label: Code_4
- id: 23
  properties:
    _type: Code
    code: C70793
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Study Sponsor
    id: Code_76
    instanceType: Code
    label: Code_76
- id: 25
  properties:
    _type: Code
    code: USA
    codeSystem: ISO 3166 1 alpha3
    codeSystemVersion: 2020-08
    decode: United States of America
    id: Code_77
    instanceType: Code
    label: Code_77
- id: 24
  properties:
    _type: Address
    city: Indianapolis
    district: ''
    id: Address_1
    instanceType: Address
    label: Address_1
    line: Lilly Corporate Ctr
    postalCode: '4628'
    state: IN
    text: Lilly Corporate Ctr, Indianapolis, IN, 4628, United States of America
- id: 22
  properties:
    _type: Organization
    id: Organization_1
    identifier: 00-642-1325
    identifierScheme: DUNS
    instanceType: Organization
    label: Organization_1
    name: Eli Lilly
- id: 21
  properties:
    _type: StudyIdentifier
    id: StudyIdentifier_1
    instanceType: StudyIdentifier
    label: StudyIdentifier_1
    studyIdentifier: H2Q-MC-LZZT
- id: 28
  properties:
    _type: Code
    code: C93453
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Study Registry
    id: Code_78
    instanceType: Code
    label: Code_78
- id: 30
  properties:
    _type: Code
    code: USA
    codeSystem: ISO 3166 1 alpha3
    codeSystemVersion: 2020-08
    decode: United States of America
    id: Code_79
    instanceType: Code
    label: Code_79
- id: 29
  properties:
    _type: Address
    city: Bethesda
    district: 8600 Rockville Pike
    id: Address_2
    instanceType: Address
    label: Address_2
    line: National Library of Medicine
    postalCode: '20894'
    state: MD
    text: National Library of Medicine, Bethesda, 8600 Rockville Pike, MD, 20894,
      United States of America
- id: 27
  properties:
    _type: Organization
    id: Organization_2
    identifier: CT-GOV
    identifierScheme: USGOV
    instanceType: Organization
    label: Organization_2
    name: ClinicalTrials.gov
- id: 26
  properties:
    _type: StudyIdentifier
    id: StudyIdentifier_2
    instanceType: StudyIdentifier
    label: StudyIdentifier_2
    studyIdentifier: NCT12345678
- id: 32
  properties:
    _type: Code
    code: C49656
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Treatment Study
    id: Code_137
    instanceType: Code
    label: Code_137
- id: 33
  properties:
    _type: Code
    code: C49666
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Efficacy Study
    id: Code_138
    instanceType: Code
    label: Code_138
- id: 34
  properties:
    _type: Code
    code: C49667
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Safety Study
    id: Code_139
    instanceType: Code
    label: Code_139
- id: 35
  properties:
    _type: Code
    code: C49663
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Pharmacokinetic Study
    id: Code_140
    instanceType: Code
    label: Code_140
- id: 36
  properties:
    _type: Code
    code: MILD_MOD_ALZ
    codeSystem: SPONSOR
    codeSystemVersion: '12'
    decode: Mild to Moderate Alzheimer's Disease
    id: Code_134
    instanceType: Code
    label: Code_134
- id: 37
  properties:
    _type: Code
    code: '26929004'
    codeSystem: SNOMED
    codeSystemVersion: January 31, 2018
    decode: Alzheimer's disease
    id: Code_135
    instanceType: Code
    label: Code_135
- id: 38
  properties:
    _type: Code
    code: C99907x1
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: EXTENSION
    id: Code_143
    instanceType: Code
    label: Code_143
- id: 39
  properties:
    _type: Code
    code: C98704
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ADAPTIVE
    id: Code_144
    instanceType: Code
    label: Code_144
- id: 40
  properties:
    _type: Code
    code: C82639
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Parallel Study
    id: Code_141
    instanceType: Code
    label: Code_141
- id: 42
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_83
    instanceType: Code
    label: Code_83
- id: 43
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_84
    instanceType: Code
    label: Code_84
- id: 44
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_85
    instanceType: Code
    label: Code_85
- id: 45
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_1
    instanceType: TransitionRule
    label: TransitionRule_1
    name: ENCOUNTER_START_RULE_1
    text: Subject identifier
- id: 46
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_2
    instanceType: TransitionRule
    label: TransitionRule_2
    name: ENCOUNTER_START_RULE_1
    text: completion of screening activities
- id: 41
  properties:
    _type: Encounter
    description: Screening encounter
    id: Encounter_1
    instanceType: Encounter
    label: Encounter_1
    name: E1
- id: 48
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_86
    instanceType: Code
    label: Code_86
- id: 49
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_87
    instanceType: Code
    label: Code_87
- id: 50
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_88
    instanceType: Code
    label: Code_88
- id: 51
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_3
    instanceType: TransitionRule
    label: TransitionRule_3
    name: ENCOUNTER_START_RULE_2
    text: subject leaves clinic after connection of ambulatory ECG machine
- id: 47
  properties:
    _type: Encounter
    description: Screening encounter - Ambulatory ECG Placement
    id: Encounter_2
    instanceType: Encounter
    label: Encounter_2
    name: E2
    transitionStartRule: null
- id: 53
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_89
    instanceType: Code
    label: Code_89
- id: 54
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_90
    instanceType: Code
    label: Code_90
- id: 55
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_91
    instanceType: Code
    label: Code_91
- id: 56
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_4
    instanceType: TransitionRule
    label: TransitionRule_4
    name: ENCOUNTER_START_RULE_3
    text: subject has connection of ambulatory ECG machine removed
- id: 57
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_5
    instanceType: TransitionRule
    label: TransitionRule_5
    name: ENCOUNTER_START_RULE_3
    text: Radomized
- id: 52
  properties:
    _type: Encounter
    description: Baseline encounter - Ambulatory ECG Removal
    id: Encounter_3
    instanceType: Encounter
    label: Encounter_3
    name: E3
- id: 59
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_92
    instanceType: Code
    label: Code_92
- id: 60
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_93
    instanceType: Code
    label: Code_93
- id: 61
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_94
    instanceType: Code
    label: Code_94
- id: 58
  properties:
    _type: Encounter
    description: Day 14
    id: Encounter_4
    instanceType: Encounter
    label: Encounter_4
    name: E4
    transitionEndRule: null
    transitionStartRule: null
- id: 63
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_95
    instanceType: Code
    label: Code_95
- id: 64
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_96
    instanceType: Code
    label: Code_96
- id: 65
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_97
    instanceType: Code
    label: Code_97
- id: 62
  properties:
    _type: Encounter
    description: Day 28
    id: Encounter_5
    instanceType: Encounter
    label: Encounter_5
    name: E5
    transitionEndRule: null
    transitionStartRule: null
- id: 67
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_98
    instanceType: Code
    label: Code_98
- id: 68
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_99
    instanceType: Code
    label: Code_99
- id: 69
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_100
    instanceType: Code
    label: Code_100
- id: 66
  properties:
    _type: Encounter
    description: Day 42
    id: Encounter_6
    instanceType: Encounter
    label: Encounter_6
    name: E7
    transitionEndRule: null
    transitionStartRule: null
- id: 71
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_101
    instanceType: Code
    label: Code_101
- id: 72
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_102
    instanceType: Code
    label: Code_102
- id: 73
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_103
    instanceType: Code
    label: Code_103
- id: 74
  properties:
    _type: Code
    code: C171537
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Telephone Call
    id: Code_104
    instanceType: Code
    label: Code_104
- id: 70
  properties:
    _type: Encounter
    description: Day 56
    id: Encounter_7
    instanceType: Encounter
    label: Encounter_7
    name: E8
    transitionEndRule: null
    transitionStartRule: null
- id: 76
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_105
    instanceType: Code
    label: Code_105
- id: 77
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_106
    instanceType: Code
    label: Code_106
- id: 78
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_107
    instanceType: Code
    label: Code_107
- id: 79
  properties:
    _type: Code
    code: C171537
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Telephone Call
    id: Code_108
    instanceType: Code
    label: Code_108
- id: 75
  properties:
    _type: Encounter
    description: Day 84
    id: Encounter_8
    instanceType: Encounter
    label: Encounter_8
    name: E9
    transitionEndRule: null
    transitionStartRule: null
- id: 81
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_109
    instanceType: Code
    label: Code_109
- id: 82
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_110
    instanceType: Code
    label: Code_110
- id: 83
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_111
    instanceType: Code
    label: Code_111
- id: 84
  properties:
    _type: Code
    code: C171537
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Telephone Call
    id: Code_112
    instanceType: Code
    label: Code_112
- id: 80
  properties:
    _type: Encounter
    description: Day 112
    id: Encounter_9
    instanceType: Encounter
    label: Encounter_9
    name: E10
    transitionEndRule: null
    transitionStartRule: null
- id: 86
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_113
    instanceType: Code
    label: Code_113
- id: 87
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_114
    instanceType: Code
    label: Code_114
- id: 88
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_115
    instanceType: Code
    label: Code_115
- id: 89
  properties:
    _type: Code
    code: C171537
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Telephone Call
    id: Code_116
    instanceType: Code
    label: Code_116
- id: 85
  properties:
    _type: Encounter
    description: Day 140
    id: Encounter_10
    instanceType: Encounter
    label: Encounter_10
    name: E11
    transitionEndRule: null
    transitionStartRule: null
- id: 91
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_117
    instanceType: Code
    label: Code_117
- id: 92
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_118
    instanceType: Code
    label: Code_118
- id: 93
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_119
    instanceType: Code
    label: Code_119
- id: 90
  properties:
    _type: Encounter
    description: Day 168
    id: Encounter_11
    instanceType: Encounter
    label: Encounter_11
    name: E12
    transitionEndRule: null
    transitionStartRule: null
- id: 95
  properties:
    _type: Code
    code: C25716
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Visit
    id: Code_120
    instanceType: Code
    label: Code_120
- id: 96
  properties:
    _type: Code
    code: C51282
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinic
    id: Code_121
    instanceType: Code
    label: Code_121
- id: 97
  properties:
    _type: Code
    code: C175574
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: In Person
    id: Code_122
    instanceType: Code
    label: Code_122
- id: 98
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_6
    instanceType: TransitionRule
    label: TransitionRule_6
    name: ENCOUNTER_START_RULE_12
    text: End of treatment
- id: 94
  properties:
    _type: Encounter
    description: Day 182
    id: Encounter_12
    instanceType: Encounter
    label: Encounter_12
    name: E13
    transitionStartRule: null
- id: 99
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_1
    instanceType: Activity
    label: Activity_1
    name: Informed consent
- id: 100
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_2
    instanceType: Activity
    label: Activity_2
    name: Inclusion/exclusion criteria
- id: 101
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_3
    instanceType: Activity
    label: Activity_3
    name: Patient number assigned
- id: 102
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_4
    instanceType: Activity
    label: Activity_4
    name: Demographics
- id: 103
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_5
    instanceType: Activity
    label: Activity_5
    name: Hachinski
- id: 104
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_6
    instanceType: Activity
    label: Activity_6
    name: MMSE
- id: 105
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_7
    instanceType: Activity
    label: Activity_7
    name: Physical examination
- id: 106
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_8
    instanceType: Activity
    label: Activity_8
    name: Medical history
- id: 107
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_9
    instanceType: Activity
    label: Activity_9
    name: Habits
- id: 108
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_10
    instanceType: Activity
    label: Activity_10
    name: Chest X-ray
- id: 109
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_11
    instanceType: Activity
    label: Activity_11
    name: Apo E genotyping
- id: 110
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_12
    instanceType: Activity
    label: Activity_12
    name: Patient randomised
- id: 111
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_13
    instanceType: Activity
    label: Activity_13
    name: Vital signs / Temperature
- id: 112
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_14
    instanceType: Activity
    label: Activity_14
    name: Ambulatory ECG placed
- id: 113
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_15
    instanceType: Activity
    label: Activity_15
    name: Ambulatory ECG removed
- id: 114
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_16
    instanceType: Activity
    label: Activity_16
    name: ECG
- id: 115
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_17
    instanceType: Activity
    label: Activity_17
    name: Placebo TTS test
- id: 118
  properties:
    _type: Code
    code: '383371000119108'
    codeSystem: SNOMED
    codeSystemVersion: January 31, 2018
    decode: CT of head without contrast
    id: Code_80
    instanceType: Code
    label: Code_80
- id: 117
  properties:
    _type: Procedure
    description: CT Scan
    id: Procedure_1
    instanceType: Procedure
    label: Procedure_1
    name: PR1
    procedureType: CT Scan
- id: 116
  properties:
    _type: Activity
    description: ''
    id: Activity_18
    instanceType: Activity
    label: Activity_18
    name: CT scan
- id: 119
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_19
    instanceType: Activity
    label: Activity_19
    name: Concomitant medications
- id: 120
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_20
    instanceType: Activity
    label: Activity_20
    name: Hematology
- id: 121
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_21
    instanceType: Activity
    label: Activity_21
    name: Chemistry
- id: 122
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_22
    instanceType: Activity
    label: Activity_22
    name: Uninalysis
- id: 123
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_23
    instanceType: Activity
    label: Activity_23
    name: Plasma Specimen (Xanomeline)
- id: 124
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_24
    instanceType: Activity
    label: Activity_24
    name: Hemoglobin A1C
- id: 125
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_25
    instanceType: Activity
    label: Activity_25
    name: Study drug
- id: 126
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_26
    instanceType: Activity
    label: Activity_26
    name: TTS Acceptability Survey
- id: 127
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_27
    instanceType: Activity
    label: Activity_27
    name: ADAS-Cog
- id: 128
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_28
    instanceType: Activity
    label: Activity_28
    name: CIBIC+
- id: 129
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_29
    instanceType: Activity
    label: Activity_29
    name: DAD
- id: 130
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_30
    instanceType: Activity
    label: Activity_30
    name: NPI-X
- id: 131
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_31
    instanceType: Activity
    label: Activity_31
    name: Adverse events
- id: 132
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_32
    instanceType: Activity
    label: Activity_32
    name: Check adverse events
- id: 135
  properties:
    _type: Code
    code: '123'
    codeSystem: SPONSOR
    codeSystemVersion: '12'
    decode: Subject Supine
    id: Code_81
    instanceType: Code
    label: Code_81
- id: 134
  properties:
    _type: Procedure
    description: Subject Supine
    id: Procedure_2
    instanceType: Procedure
    label: Procedure_2
    name: PR_SUPINE
    procedureType: ''
- id: 133
  properties:
    _type: Activity
    description: ''
    id: Activity_33
    instanceType: Activity
    label: Activity_33
    name: Supine
- id: 136
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_34
    instanceType: Activity
    label: Activity_34
    name: Vital Signs Supine
- id: 139
  properties:
    _type: Code
    code: '124'
    codeSystem: SPONSOR
    codeSystemVersion: '12'
    decode: Subject Standing
    id: Code_82
    instanceType: Code
    label: Code_82
- id: 138
  properties:
    _type: Procedure
    description: Subject Standing
    id: Procedure_3
    instanceType: Procedure
    label: Procedure_3
    name: PR_STAND
    procedureType: ''
- id: 137
  properties:
    _type: Activity
    description: ''
    id: Activity_35
    instanceType: Activity
    label: Activity_35
    name: Stand
- id: 140
  properties:
    _type: Activity
    definedProcedures: []
    description: ''
    id: Activity_36
    instanceType: Activity
    label: Activity_36
    name: Vital Signs Standing
- id: 144
  properties:
    _type: Code
    code: C20197
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Male
    id: Code_429
    instanceType: Code
    label: Code_429
- id: 143
  properties:
    _type: ResponseCode
    id: ResponseCode_151
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_151
- id: 146
  properties:
    _type: Code
    code: C16576
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Female
    id: Code_430
    instanceType: Code
    label: Code_430
- id: 145
  properties:
    _type: ResponseCode
    id: ResponseCode_152
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_152
- id: 148
  properties:
    _type: Code
    code: C28421
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sex
    id: Code_431
    instanceType: Code
    label: Code_431
- id: 147
  properties:
    _type: AliasCode
    id: AliasCode_139
    instanceType: AliasCode
    label: AliasCode_139
    standardCodeAliases: []
- id: 142
  properties:
    _type: BiomedicalConceptProperty
    datatype: string
    id: BiomedicalConceptProperty_116
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_116
    name: Sex
- id: 150
  properties:
    _type: Code
    code: C28421
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sex
    id: Code_432
    instanceType: Code
    label: Code_432
- id: 149
  properties:
    _type: AliasCode
    id: AliasCode_140
    instanceType: AliasCode
    label: AliasCode_140
    standardCodeAliases: []
- id: 141
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_20
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_20
    name: Sex
    reference: /mdr/bc/packages/2023-03-31/biomedicalconcepts/C28421
    synonyms: []
- id: 154
  properties:
    _type: Code
    code: C17049
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Race
    id: Code_433
    instanceType: Code
    label: Code_433
- id: 153
  properties:
    _type: AliasCode
    id: AliasCode_141
    instanceType: AliasCode
    label: AliasCode_141
    standardCodeAliases: []
- id: 152
  properties:
    _type: BiomedicalConceptProperty
    datatype: string
    id: BiomedicalConceptProperty_117
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_117
    name: Race
    responseCodes: []
- id: 156
  properties:
    _type: Code
    code: C17049
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Race
    id: Code_434
    instanceType: Code
    label: Code_434
- id: 155
  properties:
    _type: AliasCode
    id: AliasCode_142
    instanceType: AliasCode
    label: AliasCode_142
    standardCodeAliases: []
- id: 151
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_21
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_21
    name: Race
    reference: /mdr/bc/packages/2023-03-31/biomedicalconcepts/C17049
    synonyms:
    - Racial Group
- id: 160
  properties:
    _type: Code
    code: C174446
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: TEMP
    id: Code_435
    instanceType: Code
    label: Code_435
- id: 159
  properties:
    _type: AliasCode
    id: AliasCode_143
    instanceType: AliasCode
    label: AliasCode_143
    standardCodeAliases: []
- id: 158
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_118
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_118
    name: VSTESTCD
    responseCodes: []
- id: 163
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_436
    instanceType: Code
    label: Code_436
- id: 162
  properties:
    _type: AliasCode
    id: AliasCode_144
    instanceType: AliasCode
    label: AliasCode_144
    standardCodeAliases: []
- id: 161
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_119
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_119
    name: VSORRES
    responseCodes: []
- id: 166
  properties:
    _type: Code
    code: C42559
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Degree Celsius
    id: Code_437
    instanceType: Code
    label: Code_437
- id: 165
  properties:
    _type: ResponseCode
    id: ResponseCode_153
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_153
- id: 168
  properties:
    _type: Code
    code: C44277
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Degree Fahrenheit
    id: Code_438
    instanceType: Code
    label: Code_438
- id: 167
  properties:
    _type: ResponseCode
    id: ResponseCode_154
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_154
- id: 170
  properties:
    _type: Code
    code: C42537
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Kelvin
    id: Code_439
    instanceType: Code
    label: Code_439
- id: 169
  properties:
    _type: ResponseCode
    id: ResponseCode_155
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_155
- id: 172
  properties:
    _type: Code
    code: C44276
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Temperature
    id: Code_440
    instanceType: Code
    label: Code_440
- id: 171
  properties:
    _type: AliasCode
    id: AliasCode_145
    instanceType: AliasCode
    label: AliasCode_145
    standardCodeAliases: []
- id: 164
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_120
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_120
    name: VSORRESU
- id: 175
  properties:
    _type: Code
    code: C12674
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Axilla
    id: Code_441
    instanceType: Code
    label: Code_441
- id: 174
  properties:
    _type: ResponseCode
    id: ResponseCode_156
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_156
- id: 177
  properties:
    _type: Code
    code: C12394
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Ear
    id: Code_442
    instanceType: Code
    label: Code_442
- id: 176
  properties:
    _type: ResponseCode
    id: ResponseCode_157
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_157
- id: 179
  properties:
    _type: Code
    code: C89803
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Forehead
    id: Code_443
    instanceType: Code
    label: Code_443
- id: 178
  properties:
    _type: ResponseCode
    id: ResponseCode_158
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_158
- id: 181
  properties:
    _type: Code
    code: C12421
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Oral Cavity
    id: Code_444
    instanceType: Code
    label: Code_444
- id: 180
  properties:
    _type: ResponseCode
    id: ResponseCode_159
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_159
- id: 183
  properties:
    _type: Code
    code: C12390
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Rectum
    id: Code_445
    instanceType: Code
    label: Code_445
- id: 182
  properties:
    _type: ResponseCode
    id: ResponseCode_160
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_160
- id: 185
  properties:
    _type: Code
    code: C13717
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Anatomic Site
    id: Code_446
    instanceType: Code
    label: Code_446
- id: 184
  properties:
    _type: AliasCode
    id: AliasCode_146
    instanceType: AliasCode
    label: AliasCode_146
    standardCodeAliases: []
- id: 173
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_121
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_121
    name: VSLOC
- id: 187
  properties:
    _type: Code
    code: C174446
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: TEMP
    id: Code_447
    instanceType: Code
    label: Code_447
- id: 186
  properties:
    _type: AliasCode
    id: AliasCode_147
    instanceType: AliasCode
    label: AliasCode_147
    standardCodeAliases: []
- id: 157
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_22
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_22
    name: Temperature
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/TEMP
    synonyms:
    - Temperature
    - Body Temperature
- id: 191
  properties:
    _type: Code
    code: C25208
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: WEIGHT
    id: Code_448
    instanceType: Code
    label: Code_448
- id: 190
  properties:
    _type: AliasCode
    id: AliasCode_148
    instanceType: AliasCode
    label: AliasCode_148
    standardCodeAliases: []
- id: 189
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_122
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_122
    name: VSTESTCD
    responseCodes: []
- id: 194
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_449
    instanceType: Code
    label: Code_449
- id: 193
  properties:
    _type: AliasCode
    id: AliasCode_149
    instanceType: AliasCode
    label: AliasCode_149
    standardCodeAliases: []
- id: 192
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_123
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_123
    name: VSORRES
    responseCodes: []
- id: 197
  properties:
    _type: Code
    code: C48531
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Pound
    id: Code_450
    instanceType: Code
    label: Code_450
- id: 196
  properties:
    _type: ResponseCode
    id: ResponseCode_161
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_161
- id: 199
  properties:
    _type: Code
    code: C48155
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Gram
    id: Code_451
    instanceType: Code
    label: Code_451
- id: 198
  properties:
    _type: ResponseCode
    id: ResponseCode_162
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_162
- id: 201
  properties:
    _type: Code
    code: C28252
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Kilogram
    id: Code_452
    instanceType: Code
    label: Code_452
- id: 200
  properties:
    _type: ResponseCode
    id: ResponseCode_163
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_163
- id: 203
  properties:
    _type: Code
    code: C48208
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Weight
    id: Code_453
    instanceType: Code
    label: Code_453
- id: 202
  properties:
    _type: AliasCode
    id: AliasCode_150
    instanceType: AliasCode
    label: AliasCode_150
    standardCodeAliases: []
- id: 195
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_124
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_124
    name: VSORRESU
- id: 205
  properties:
    _type: Code
    code: C25208
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: WEIGHT
    id: Code_454
    instanceType: Code
    label: Code_454
- id: 204
  properties:
    _type: AliasCode
    id: AliasCode_151
    instanceType: AliasCode
    label: AliasCode_151
    standardCodeAliases: []
- id: 188
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_23
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_23
    name: Weight
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/WEIGHT
    synonyms:
    - Weight
    - Body Weight
- id: 209
  properties:
    _type: Code
    code: C25347
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: HEIGHT
    id: Code_455
    instanceType: Code
    label: Code_455
- id: 208
  properties:
    _type: AliasCode
    id: AliasCode_152
    instanceType: AliasCode
    label: AliasCode_152
    standardCodeAliases: []
- id: 207
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_125
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_125
    name: VSTESTCD
    responseCodes: []
- id: 212
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_456
    instanceType: Code
    label: Code_456
- id: 211
  properties:
    _type: AliasCode
    id: AliasCode_153
    instanceType: AliasCode
    label: AliasCode_153
    standardCodeAliases: []
- id: 210
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_126
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_126
    name: VSORRES
    responseCodes: []
- id: 215
  properties:
    _type: Code
    code: C49668
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Centimeter
    id: Code_457
    instanceType: Code
    label: Code_457
- id: 214
  properties:
    _type: ResponseCode
    id: ResponseCode_164
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_164
- id: 217
  properties:
    _type: Code
    code: C48500
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Inch
    id: Code_458
    instanceType: Code
    label: Code_458
- id: 216
  properties:
    _type: ResponseCode
    id: ResponseCode_165
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_165
- id: 219
  properties:
    _type: Code
    code: C41139
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Meter
    id: Code_459
    instanceType: Code
    label: Code_459
- id: 218
  properties:
    _type: ResponseCode
    id: ResponseCode_166
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_166
- id: 221
  properties:
    _type: Code
    code: C168688
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Height
    id: Code_460
    instanceType: Code
    label: Code_460
- id: 220
  properties:
    _type: AliasCode
    id: AliasCode_154
    instanceType: AliasCode
    label: AliasCode_154
    standardCodeAliases: []
- id: 213
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_127
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_127
    name: VSORRESU
- id: 223
  properties:
    _type: Code
    code: C25347
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: HEIGHT
    id: Code_461
    instanceType: Code
    label: Code_461
- id: 222
  properties:
    _type: AliasCode
    id: AliasCode_155
    instanceType: AliasCode
    label: AliasCode_155
    standardCodeAliases: []
- id: 206
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_24
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_24
    name: Height
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/HEIGHT
    synonyms:
    - Height
    - Body Height
- id: 227
  properties:
    _type: Code
    code: C64433
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALT
    id: Code_462
    instanceType: Code
    label: Code_462
- id: 226
  properties:
    _type: AliasCode
    id: AliasCode_156
    instanceType: AliasCode
    label: AliasCode_156
    standardCodeAliases: []
- id: 225
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_128
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_128
    name: LBTESTCD
    responseCodes: []
- id: 230
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_463
    instanceType: Code
    label: Code_463
- id: 229
  properties:
    _type: AliasCode
    id: AliasCode_157
    instanceType: AliasCode
    label: AliasCode_157
    standardCodeAliases: []
- id: 228
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_129
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_129
    name: LBORRES
    responseCodes: []
- id: 233
  properties:
    _type: Code
    code: C67456
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit per Liter
    id: Code_464
    instanceType: Code
    label: Code_464
- id: 232
  properties:
    _type: ResponseCode
    id: ResponseCode_167
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_167
- id: 235
  properties:
    _type: Code
    code: C67397
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Microkatal per Liter
    id: Code_465
    instanceType: Code
    label: Code_465
- id: 234
  properties:
    _type: ResponseCode
    id: ResponseCode_168
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_168
- id: 237
  properties:
    _type: Code
    code: C67376
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: International Unit per Liter
    id: Code_466
    instanceType: Code
    label: Code_466
- id: 236
  properties:
    _type: ResponseCode
    id: ResponseCode_169
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_169
- id: 239
  properties:
    _type: Code
    code: C70510
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Nanokatal per Liter
    id: Code_467
    instanceType: Code
    label: Code_467
- id: 238
  properties:
    _type: ResponseCode
    id: ResponseCode_170
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_170
- id: 241
  properties:
    _type: Code
    code: C67365
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Catalytic Activity Concentration
    id: Code_468
    instanceType: Code
    label: Code_468
- id: 240
  properties:
    _type: AliasCode
    id: AliasCode_158
    instanceType: AliasCode
    label: AliasCode_158
    standardCodeAliases: []
- id: 231
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_130
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_130
    name: LBORRESU
- id: 244
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_469
    instanceType: Code
    label: Code_469
- id: 243
  properties:
    _type: AliasCode
    id: AliasCode_159
    instanceType: AliasCode
    label: AliasCode_159
    standardCodeAliases: []
- id: 242
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_131
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_131
    name: LBSPEC
    responseCodes: []
- id: 247
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_470
    instanceType: Code
    label: Code_470
- id: 246
  properties:
    _type: ResponseCode
    id: ResponseCode_171
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_171
- id: 249
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_471
    instanceType: Code
    label: Code_471
- id: 248
  properties:
    _type: ResponseCode
    id: ResponseCode_172
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_172
- id: 251
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_472
    instanceType: Code
    label: Code_472
- id: 250
  properties:
    _type: AliasCode
    id: AliasCode_160
    instanceType: AliasCode
    label: AliasCode_160
    standardCodeAliases: []
- id: 245
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_132
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_132
    name: LBFAST
- id: 253
  properties:
    _type: Code
    code: C64433
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALT
    id: Code_473
    instanceType: Code
    label: Code_473
- id: 252
  properties:
    _type: AliasCode
    id: AliasCode_161
    instanceType: AliasCode
    label: AliasCode_161
    standardCodeAliases: []
- id: 224
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_25
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_25
    name: Alanine Aminotransferase Concentration in Serum/Plasma
    reference: /mdr/specializations/sdtm/packages/2023-07-06/datasetspecializations/ALTSERPL
    synonyms:
    - ALT
    - SGPT
    - Alanine Aminotransferase Measurement
- id: 257
  properties:
    _type: Code
    code: C64431
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALB
    id: Code_474
    instanceType: Code
    label: Code_474
- id: 256
  properties:
    _type: AliasCode
    id: AliasCode_162
    instanceType: AliasCode
    label: AliasCode_162
    standardCodeAliases: []
- id: 255
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_133
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_133
    name: LBTESTCD
    responseCodes: []
- id: 260
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_475
    instanceType: Code
    label: Code_475
- id: 259
  properties:
    _type: AliasCode
    id: AliasCode_163
    instanceType: AliasCode
    label: AliasCode_163
    standardCodeAliases: []
- id: 258
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_134
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_134
    name: LBORRES
    responseCodes: []
- id: 263
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_476
    instanceType: Code
    label: Code_476
- id: 262
  properties:
    _type: AliasCode
    id: AliasCode_164
    instanceType: AliasCode
    label: AliasCode_164
    standardCodeAliases: []
- id: 261
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_135
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_135
    name: LBSPEC
    responseCodes: []
- id: 266
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_477
    instanceType: Code
    label: Code_477
- id: 265
  properties:
    _type: ResponseCode
    id: ResponseCode_173
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_173
- id: 268
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_478
    instanceType: Code
    label: Code_478
- id: 267
  properties:
    _type: ResponseCode
    id: ResponseCode_174
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_174
- id: 270
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_479
    instanceType: Code
    label: Code_479
- id: 269
  properties:
    _type: AliasCode
    id: AliasCode_165
    instanceType: AliasCode
    label: AliasCode_165
    standardCodeAliases: []
- id: 264
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_136
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_136
    name: LBFAST
- id: 272
  properties:
    _type: Code
    code: C64431
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALB
    id: Code_480
    instanceType: Code
    label: Code_480
- id: 271
  properties:
    _type: AliasCode
    id: AliasCode_166
    instanceType: AliasCode
    label: AliasCode_166
    standardCodeAliases: []
- id: 254
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_26
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_26
    name: Albumin Presence in Urine
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/ALBURINPRES
    synonyms:
    - Albumin
    - Albumin Measurement
- id: 276
  properties:
    _type: Code
    code: C64432
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALP
    id: Code_481
    instanceType: Code
    label: Code_481
- id: 275
  properties:
    _type: AliasCode
    id: AliasCode_167
    instanceType: AliasCode
    label: AliasCode_167
    standardCodeAliases: []
- id: 274
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_137
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_137
    name: LBTESTCD
    responseCodes: []
- id: 279
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_482
    instanceType: Code
    label: Code_482
- id: 278
  properties:
    _type: AliasCode
    id: AliasCode_168
    instanceType: AliasCode
    label: AliasCode_168
    standardCodeAliases: []
- id: 277
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_138
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_138
    name: LBORRES
    responseCodes: []
- id: 282
  properties:
    _type: Code
    code: C67456
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit per Liter
    id: Code_483
    instanceType: Code
    label: Code_483
- id: 281
  properties:
    _type: ResponseCode
    id: ResponseCode_175
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_175
- id: 284
  properties:
    _type: Code
    code: C67397
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Microkatal per Liter
    id: Code_484
    instanceType: Code
    label: Code_484
- id: 283
  properties:
    _type: ResponseCode
    id: ResponseCode_176
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_176
- id: 286
  properties:
    _type: Code
    code: C67376
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: International Unit per Liter
    id: Code_485
    instanceType: Code
    label: Code_485
- id: 285
  properties:
    _type: ResponseCode
    id: ResponseCode_177
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_177
- id: 288
  properties:
    _type: Code
    code: C67365
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Catalytic Activity Concentration
    id: Code_486
    instanceType: Code
    label: Code_486
- id: 287
  properties:
    _type: AliasCode
    id: AliasCode_169
    instanceType: AliasCode
    label: AliasCode_169
    standardCodeAliases: []
- id: 280
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_139
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_139
    name: LBORRESU
- id: 291
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_487
    instanceType: Code
    label: Code_487
- id: 290
  properties:
    _type: AliasCode
    id: AliasCode_170
    instanceType: AliasCode
    label: AliasCode_170
    standardCodeAliases: []
- id: 289
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_140
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_140
    name: LBSPEC
    responseCodes: []
- id: 294
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_488
    instanceType: Code
    label: Code_488
- id: 293
  properties:
    _type: ResponseCode
    id: ResponseCode_178
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_178
- id: 296
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_489
    instanceType: Code
    label: Code_489
- id: 295
  properties:
    _type: ResponseCode
    id: ResponseCode_179
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_179
- id: 298
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_490
    instanceType: Code
    label: Code_490
- id: 297
  properties:
    _type: AliasCode
    id: AliasCode_171
    instanceType: AliasCode
    label: AliasCode_171
    standardCodeAliases: []
- id: 292
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_141
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_141
    name: LBFAST
- id: 300
  properties:
    _type: Code
    code: C64432
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALP
    id: Code_491
    instanceType: Code
    label: Code_491
- id: 299
  properties:
    _type: AliasCode
    id: AliasCode_172
    instanceType: AliasCode
    label: AliasCode_172
    standardCodeAliases: []
- id: 273
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_27
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_27
    name: Alkaline Phosphatase Concentration in Serum/Plasma
    reference: /mdr/specializations/sdtm/packages/2023-07-06/datasetspecializations/ALPSERPL
    synonyms:
    - Alkaline Phosphatase
    - Alkaline Phosphatase Measurement
- id: 304
  properties:
    _type: Code
    code: C64467
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: AST
    id: Code_492
    instanceType: Code
    label: Code_492
- id: 303
  properties:
    _type: AliasCode
    id: AliasCode_173
    instanceType: AliasCode
    label: AliasCode_173
    standardCodeAliases: []
- id: 302
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_142
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_142
    name: LBTESTCD
    responseCodes: []
- id: 307
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_493
    instanceType: Code
    label: Code_493
- id: 306
  properties:
    _type: AliasCode
    id: AliasCode_174
    instanceType: AliasCode
    label: AliasCode_174
    standardCodeAliases: []
- id: 305
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_143
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_143
    name: LBORRES
    responseCodes: []
- id: 310
  properties:
    _type: Code
    code: C67456
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit per Liter
    id: Code_494
    instanceType: Code
    label: Code_494
- id: 309
  properties:
    _type: ResponseCode
    id: ResponseCode_180
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_180
- id: 312
  properties:
    _type: Code
    code: C67397
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Microkatal per Liter
    id: Code_495
    instanceType: Code
    label: Code_495
- id: 311
  properties:
    _type: ResponseCode
    id: ResponseCode_181
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_181
- id: 314
  properties:
    _type: Code
    code: C67376
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: International Unit per Liter
    id: Code_496
    instanceType: Code
    label: Code_496
- id: 313
  properties:
    _type: ResponseCode
    id: ResponseCode_182
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_182
- id: 316
  properties:
    _type: Code
    code: C67365
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Catalytic Activity Concentration
    id: Code_497
    instanceType: Code
    label: Code_497
- id: 315
  properties:
    _type: AliasCode
    id: AliasCode_175
    instanceType: AliasCode
    label: AliasCode_175
    standardCodeAliases: []
- id: 308
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_144
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_144
    name: LBORRESU
- id: 319
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_498
    instanceType: Code
    label: Code_498
- id: 318
  properties:
    _type: AliasCode
    id: AliasCode_176
    instanceType: AliasCode
    label: AliasCode_176
    standardCodeAliases: []
- id: 317
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_145
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_145
    name: LBSPEC
    responseCodes: []
- id: 322
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_499
    instanceType: Code
    label: Code_499
- id: 321
  properties:
    _type: ResponseCode
    id: ResponseCode_183
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_183
- id: 324
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_500
    instanceType: Code
    label: Code_500
- id: 323
  properties:
    _type: ResponseCode
    id: ResponseCode_184
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_184
- id: 326
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_501
    instanceType: Code
    label: Code_501
- id: 325
  properties:
    _type: AliasCode
    id: AliasCode_177
    instanceType: AliasCode
    label: AliasCode_177
    standardCodeAliases: []
- id: 320
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_146
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_146
    name: LBFAST
- id: 328
  properties:
    _type: Code
    code: C64467
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: AST
    id: Code_502
    instanceType: Code
    label: Code_502
- id: 327
  properties:
    _type: AliasCode
    id: AliasCode_178
    instanceType: AliasCode
    label: AliasCode_178
    standardCodeAliases: []
- id: 301
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_28
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_28
    name: Aspartate Aminotransferase in Serum/Plasma
    reference: /mdr/specializations/sdtm/packages/2023-07-06/datasetspecializations/ASTSERPL
    synonyms:
    - AST
    - SGOT
    - Aspartate Aminotransferase Measurement
- id: 332
  properties:
    _type: Code
    code: C64547
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: CREAT
    id: Code_503
    instanceType: Code
    label: Code_503
- id: 331
  properties:
    _type: AliasCode
    id: AliasCode_179
    instanceType: AliasCode
    label: AliasCode_179
    standardCodeAliases: []
- id: 330
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_147
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_147
    name: LBTESTCD
    responseCodes: []
- id: 335
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_504
    instanceType: Code
    label: Code_504
- id: 334
  properties:
    _type: AliasCode
    id: AliasCode_180
    instanceType: AliasCode
    label: AliasCode_180
    standardCodeAliases: []
- id: 333
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_148
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_148
    name: LBORRES
    responseCodes: []
- id: 338
  properties:
    _type: Code
    code: C67015
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Milligram per Deciliter
    id: Code_505
    instanceType: Code
    label: Code_505
- id: 337
  properties:
    _type: ResponseCode
    id: ResponseCode_185
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_185
- id: 340
  properties:
    _type: Code
    code: C64572
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Microgram per Milliliter
    id: Code_506
    instanceType: Code
    label: Code_506
- id: 339
  properties:
    _type: ResponseCode
    id: ResponseCode_186
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_186
- id: 342
  properties:
    _type: Code
    code: C64387
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Millimole per Liter
    id: Code_507
    instanceType: Code
    label: Code_507
- id: 341
  properties:
    _type: ResponseCode
    id: ResponseCode_187
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_187
- id: 344
  properties:
    _type: Code
    code: C48508
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Micromole per Liter
    id: Code_508
    instanceType: Code
    label: Code_508
- id: 343
  properties:
    _type: ResponseCode
    id: ResponseCode_188
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_188
- id: 346
  properties:
    _type: Code
    code: C48207
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Concentration
    id: Code_509
    instanceType: Code
    label: Code_509
- id: 345
  properties:
    _type: AliasCode
    id: AliasCode_181
    instanceType: AliasCode
    label: AliasCode_181
    standardCodeAliases: []
- id: 336
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_149
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_149
    name: LBORRESU
- id: 349
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_510
    instanceType: Code
    label: Code_510
- id: 348
  properties:
    _type: AliasCode
    id: AliasCode_182
    instanceType: AliasCode
    label: AliasCode_182
    standardCodeAliases: []
- id: 347
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_150
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_150
    name: LBSPEC
    responseCodes: []
- id: 352
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_511
    instanceType: Code
    label: Code_511
- id: 351
  properties:
    _type: ResponseCode
    id: ResponseCode_189
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_189
- id: 354
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_512
    instanceType: Code
    label: Code_512
- id: 353
  properties:
    _type: ResponseCode
    id: ResponseCode_190
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_190
- id: 356
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_513
    instanceType: Code
    label: Code_513
- id: 355
  properties:
    _type: AliasCode
    id: AliasCode_183
    instanceType: AliasCode
    label: AliasCode_183
    standardCodeAliases: []
- id: 350
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_151
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_151
    name: LBFAST
- id: 358
  properties:
    _type: Code
    code: C64547
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: CREAT
    id: Code_514
    instanceType: Code
    label: Code_514
- id: 357
  properties:
    _type: AliasCode
    id: AliasCode_184
    instanceType: AliasCode
    label: AliasCode_184
    standardCodeAliases: []
- id: 329
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_29
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_29
    name: Creatinine Concentration in Urine
    reference: /mdr/specializations/sdtm/packages/2023-10-03/datasetspecializations/CREATURIN
    synonyms:
    - Creatinine
    - Creatinine Measurement
- id: 362
  properties:
    _type: Code
    code: C64853
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: K
    id: Code_515
    instanceType: Code
    label: Code_515
- id: 361
  properties:
    _type: AliasCode
    id: AliasCode_185
    instanceType: AliasCode
    label: AliasCode_185
    standardCodeAliases: []
- id: 360
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_152
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_152
    name: LBTESTCD
    responseCodes: []
- id: 365
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_516
    instanceType: Code
    label: Code_516
- id: 364
  properties:
    _type: AliasCode
    id: AliasCode_186
    instanceType: AliasCode
    label: AliasCode_186
    standardCodeAliases: []
- id: 363
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_153
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_153
    name: LBORRES
    responseCodes: []
- id: 368
  properties:
    _type: Code
    code: C67474
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Milliequivalent per Liter
    id: Code_517
    instanceType: Code
    label: Code_517
- id: 367
  properties:
    _type: ResponseCode
    id: ResponseCode_191
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_191
- id: 370
  properties:
    _type: Code
    code: C67473
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Milliequivalent per Deciliter
    id: Code_518
    instanceType: Code
    label: Code_518
- id: 369
  properties:
    _type: ResponseCode
    id: ResponseCode_192
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_192
- id: 372
  properties:
    _type: Code
    code: C64387
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Millimole per Liter
    id: Code_519
    instanceType: Code
    label: Code_519
- id: 371
  properties:
    _type: ResponseCode
    id: ResponseCode_193
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_193
- id: 374
  properties:
    _type: Code
    code: C64567
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Molarity Unit
    id: Code_520
    instanceType: Code
    label: Code_520
- id: 373
  properties:
    _type: AliasCode
    id: AliasCode_187
    instanceType: AliasCode
    label: AliasCode_187
    standardCodeAliases: []
- id: 366
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_154
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_154
    name: LBORRESU
- id: 377
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_521
    instanceType: Code
    label: Code_521
- id: 376
  properties:
    _type: AliasCode
    id: AliasCode_188
    instanceType: AliasCode
    label: AliasCode_188
    standardCodeAliases: []
- id: 375
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_155
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_155
    name: LBSPEC
    responseCodes: []
- id: 380
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_522
    instanceType: Code
    label: Code_522
- id: 379
  properties:
    _type: ResponseCode
    id: ResponseCode_194
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_194
- id: 382
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_523
    instanceType: Code
    label: Code_523
- id: 381
  properties:
    _type: ResponseCode
    id: ResponseCode_195
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_195
- id: 384
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_524
    instanceType: Code
    label: Code_524
- id: 383
  properties:
    _type: AliasCode
    id: AliasCode_189
    instanceType: AliasCode
    label: AliasCode_189
    standardCodeAliases: []
- id: 378
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_156
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_156
    name: LBFAST
- id: 386
  properties:
    _type: Code
    code: C64853
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: K
    id: Code_525
    instanceType: Code
    label: Code_525
- id: 385
  properties:
    _type: AliasCode
    id: AliasCode_190
    instanceType: AliasCode
    label: AliasCode_190
    standardCodeAliases: []
- id: 359
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_30
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_30
    name: Potassium Concentration in Urine
    reference: /mdr/specializations/sdtm/packages/2023-07-06/datasetspecializations/KURIN
    synonyms:
    - Potassium
    - K
    - Potassium Measurement
- id: 390
  properties:
    _type: Code
    code: C64809
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: SODIUM
    id: Code_526
    instanceType: Code
    label: Code_526
- id: 389
  properties:
    _type: AliasCode
    id: AliasCode_191
    instanceType: AliasCode
    label: AliasCode_191
    standardCodeAliases: []
- id: 388
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_157
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_157
    name: LBTESTCD
    responseCodes: []
- id: 393
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_527
    instanceType: Code
    label: Code_527
- id: 392
  properties:
    _type: AliasCode
    id: AliasCode_192
    instanceType: AliasCode
    label: AliasCode_192
    standardCodeAliases: []
- id: 391
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_158
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_158
    name: LBORRES
    responseCodes: []
- id: 396
  properties:
    _type: Code
    code: C67474
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Milliequivalent per Liter
    id: Code_528
    instanceType: Code
    label: Code_528
- id: 395
  properties:
    _type: ResponseCode
    id: ResponseCode_196
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_196
- id: 398
  properties:
    _type: Code
    code: C67473
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Milliequivalent per Deciliter
    id: Code_529
    instanceType: Code
    label: Code_529
- id: 397
  properties:
    _type: ResponseCode
    id: ResponseCode_197
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_197
- id: 400
  properties:
    _type: Code
    code: C64387
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Millimole per Liter
    id: Code_530
    instanceType: Code
    label: Code_530
- id: 399
  properties:
    _type: ResponseCode
    id: ResponseCode_198
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_198
- id: 402
  properties:
    _type: Code
    code: C64567
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Molarity Unit
    id: Code_531
    instanceType: Code
    label: Code_531
- id: 401
  properties:
    _type: AliasCode
    id: AliasCode_193
    instanceType: AliasCode
    label: AliasCode_193
    standardCodeAliases: []
- id: 394
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_159
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_159
    name: LBORRESU
- id: 405
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_532
    instanceType: Code
    label: Code_532
- id: 404
  properties:
    _type: AliasCode
    id: AliasCode_194
    instanceType: AliasCode
    label: AliasCode_194
    standardCodeAliases: []
- id: 403
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_160
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_160
    name: LBSPEC
    responseCodes: []
- id: 408
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_533
    instanceType: Code
    label: Code_533
- id: 407
  properties:
    _type: ResponseCode
    id: ResponseCode_199
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_199
- id: 410
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_534
    instanceType: Code
    label: Code_534
- id: 409
  properties:
    _type: ResponseCode
    id: ResponseCode_200
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_200
- id: 412
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_535
    instanceType: Code
    label: Code_535
- id: 411
  properties:
    _type: AliasCode
    id: AliasCode_195
    instanceType: AliasCode
    label: AliasCode_195
    standardCodeAliases: []
- id: 406
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_161
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_161
    name: LBFAST
- id: 414
  properties:
    _type: Code
    code: C64809
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: SODIUM
    id: Code_536
    instanceType: Code
    label: Code_536
- id: 413
  properties:
    _type: AliasCode
    id: AliasCode_196
    instanceType: AliasCode
    label: AliasCode_196
    standardCodeAliases: []
- id: 387
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_31
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_31
    name: Sodium Concentration in Urine
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/SODIUMURIN
    synonyms:
    - Sodium
    - NA
    - Sodium Measurement
- id: 418
  properties:
    _type: Code
    code: C64849
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: HBA1C
    id: Code_537
    instanceType: Code
    label: Code_537
- id: 417
  properties:
    _type: AliasCode
    id: AliasCode_197
    instanceType: AliasCode
    label: AliasCode_197
    standardCodeAliases: []
- id: 416
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_162
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_162
    name: LBTESTCD
    responseCodes: []
- id: 421
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_538
    instanceType: Code
    label: Code_538
- id: 420
  properties:
    _type: AliasCode
    id: AliasCode_198
    instanceType: AliasCode
    label: AliasCode_198
    standardCodeAliases: []
- id: 419
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_163
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_163
    name: LBORRES
    responseCodes: []
- id: 424
  properties:
    _type: Code
    code: C64783
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Gram per Deciliter
    id: Code_539
    instanceType: Code
    label: Code_539
- id: 423
  properties:
    _type: ResponseCode
    id: ResponseCode_201
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_201
- id: 426
  properties:
    _type: Code
    code: No Concept Code
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: LBORRESU
    id: Code_540
    instanceType: Code
    label: Code_540
- id: 425
  properties:
    _type: AliasCode
    id: AliasCode_199
    instanceType: AliasCode
    label: AliasCode_199
    standardCodeAliases: []
- id: 422
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_164
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_164
    name: LBORRESU
- id: 429
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_541
    instanceType: Code
    label: Code_541
- id: 428
  properties:
    _type: AliasCode
    id: AliasCode_200
    instanceType: AliasCode
    label: AliasCode_200
    standardCodeAliases: []
- id: 427
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_165
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_165
    name: LBSPEC
    responseCodes: []
- id: 432
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_542
    instanceType: Code
    label: Code_542
- id: 431
  properties:
    _type: ResponseCode
    id: ResponseCode_202
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_202
- id: 434
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_543
    instanceType: Code
    label: Code_543
- id: 433
  properties:
    _type: ResponseCode
    id: ResponseCode_203
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_203
- id: 436
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_544
    instanceType: Code
    label: Code_544
- id: 435
  properties:
    _type: AliasCode
    id: AliasCode_201
    instanceType: AliasCode
    label: AliasCode_201
    standardCodeAliases: []
- id: 430
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_166
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_166
    name: LBFAST
- id: 438
  properties:
    _type: Code
    code: C64849
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: HBA1C
    id: Code_545
    instanceType: Code
    label: Code_545
- id: 437
  properties:
    _type: AliasCode
    id: AliasCode_202
    instanceType: AliasCode
    label: AliasCode_202
    standardCodeAliases: []
- id: 415
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_32
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_32
    name: Hemoglobin A1C Concentration in Blood
    reference: /mdr/specializations/sdtm/packages/2023-10-03/datasetspecializations/HBA1CBLD
    synonyms:
    - Hemoglobin A1C
    - HBA1C
    - Glycosylated Hemoglobin A1C
    - Glycosylated Hemoglobin Measurement
- id: 442
  properties:
    _type: Code
    code: C78541
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Verbatim Description
    id: Code_145
    instanceType: Code
    label: Code_145
- id: 441
  properties:
    _type: AliasCode
    id: AliasCode_5
    instanceType: AliasCode
    label: AliasCode_5
    standardCodeAliases: []
- id: 440
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_1
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_1
    name: AETERM
    responseCodes: []
- id: 445
  properties:
    _type: Code
    code: C83344
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Dictionary Derived Term
    id: Code_146
    instanceType: Code
    label: Code_146
- id: 444
  properties:
    _type: AliasCode
    id: AliasCode_6
    instanceType: AliasCode
    label: AliasCode_6
    standardCodeAliases: []
- id: 443
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_2
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_2
    name: AEDECOD
    responseCodes: []
- id: 448
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_147
    instanceType: Code
    label: Code_147
- id: 447
  properties:
    _type: ResponseCode
    id: ResponseCode_1
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_1
- id: 450
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_148
    instanceType: Code
    label: Code_148
- id: 449
  properties:
    _type: ResponseCode
    id: ResponseCode_2
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_2
- id: 452
  properties:
    _type: Code
    code: C87840
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Pre-specified
    id: Code_149
    instanceType: Code
    label: Code_149
- id: 451
  properties:
    _type: AliasCode
    id: AliasCode_7
    instanceType: AliasCode
    label: AliasCode_7
    standardCodeAliases: []
- id: 446
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_3
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_3
    name: AEPRESP
- id: 455
  properties:
    _type: Code
    code: C83205
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Location
    id: Code_150
    instanceType: Code
    label: Code_150
- id: 454
  properties:
    _type: AliasCode
    id: AliasCode_8
    instanceType: AliasCode
    label: AliasCode_8
    standardCodeAliases: []
- id: 453
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_4
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_4
    name: AELOC
    responseCodes: []
- id: 458
  properties:
    _type: Code
    code: C53253
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Severity of Adverse Event
    id: Code_151
    instanceType: Code
    label: Code_151
- id: 457
  properties:
    _type: AliasCode
    id: AliasCode_9
    instanceType: AliasCode
    label: AliasCode_9
    standardCodeAliases: []
- id: 456
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_5
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_5
    name: AESEV
    responseCodes: []
- id: 461
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_152
    instanceType: Code
    label: Code_152
- id: 460
  properties:
    _type: ResponseCode
    id: ResponseCode_3
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_3
- id: 463
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_153
    instanceType: Code
    label: Code_153
- id: 462
  properties:
    _type: ResponseCode
    id: ResponseCode_4
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_4
- id: 465
  properties:
    _type: Code
    code: C53252
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Seriousness of Adverse Event
    id: Code_154
    instanceType: Code
    label: Code_154
- id: 464
  properties:
    _type: AliasCode
    id: AliasCode_10
    instanceType: AliasCode
    label: AliasCode_10
    standardCodeAliases: []
- id: 459
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_6
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_6
    name: AESER
- id: 468
  properties:
    _type: Code
    code: C83013
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Action Taken with Study Treatment
    id: Code_155
    instanceType: Code
    label: Code_155
- id: 467
  properties:
    _type: AliasCode
    id: AliasCode_11
    instanceType: AliasCode
    label: AliasCode_11
    standardCodeAliases: []
- id: 466
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_7
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_7
    name: AEACN
    responseCodes: []
- id: 471
  properties:
    _type: Code
    code: C83109
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Other Actions taken in Response to Adverse Event
    id: Code_156
    instanceType: Code
    label: Code_156
- id: 470
  properties:
    _type: AliasCode
    id: AliasCode_12
    instanceType: AliasCode
    label: AliasCode_12
    standardCodeAliases: []
- id: 469
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_8
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_8
    name: AEACNOTH
    responseCodes: []
- id: 474
  properties:
    _type: Code
    code: C41358
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Attribution to Product or Procedure
    id: Code_157
    instanceType: Code
    label: Code_157
- id: 473
  properties:
    _type: AliasCode
    id: AliasCode_13
    instanceType: AliasCode
    label: AliasCode_13
    standardCodeAliases: []
- id: 472
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_9
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_9
    name: AEREL
    responseCodes: []
- id: 477
  properties:
    _type: Code
    code: C83210
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Relationship to Non Study Treatment
    id: Code_158
    instanceType: Code
    label: Code_158
- id: 476
  properties:
    _type: AliasCode
    id: AliasCode_14
    instanceType: AliasCode
    label: AliasCode_14
    standardCodeAliases: []
- id: 475
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_10
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_10
    name: AERELNST
    responseCodes: []
- id: 480
  properties:
    _type: Code
    code: C83208
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Pattern
    id: Code_159
    instanceType: Code
    label: Code_159
- id: 479
  properties:
    _type: AliasCode
    id: AliasCode_15
    instanceType: AliasCode
    label: AliasCode_15
    standardCodeAliases: []
- id: 478
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_11
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_11
    name: AEPATT
    responseCodes: []
- id: 483
  properties:
    _type: Code
    code: C49489
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Outcome
    id: Code_160
    instanceType: Code
    label: Code_160
- id: 482
  properties:
    _type: AliasCode
    id: AliasCode_16
    instanceType: AliasCode
    label: AliasCode_16
    standardCodeAliases: []
- id: 481
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_12
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_12
    name: AEOUT
    responseCodes: []
- id: 486
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_161
    instanceType: Code
    label: Code_161
- id: 485
  properties:
    _type: ResponseCode
    id: ResponseCode_5
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_5
- id: 488
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_162
    instanceType: Code
    label: Code_162
- id: 487
  properties:
    _type: ResponseCode
    id: ResponseCode_6
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_6
- id: 490
  properties:
    _type: Code
    code: C83211
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Involves Cancer
    id: Code_163
    instanceType: Code
    label: Code_163
- id: 489
  properties:
    _type: AliasCode
    id: AliasCode_17
    instanceType: AliasCode
    label: AliasCode_17
    standardCodeAliases: []
- id: 484
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_13
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_13
    name: AESCAN
- id: 493
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_164
    instanceType: Code
    label: Code_164
- id: 492
  properties:
    _type: ResponseCode
    id: ResponseCode_7
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_7
- id: 495
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_165
    instanceType: Code
    label: Code_165
- id: 494
  properties:
    _type: ResponseCode
    id: ResponseCode_8
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_8
- id: 497
  properties:
    _type: Code
    code: C83117
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Seriousness Due to Congenital Anomaly
    id: Code_166
    instanceType: Code
    label: Code_166
- id: 496
  properties:
    _type: AliasCode
    id: AliasCode_18
    instanceType: AliasCode
    label: AliasCode_18
    standardCodeAliases: []
- id: 491
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_14
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_14
    name: AESCONG
- id: 500
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_167
    instanceType: Code
    label: Code_167
- id: 499
  properties:
    _type: ResponseCode
    id: ResponseCode_9
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_9
- id: 502
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_168
    instanceType: Code
    label: Code_168
- id: 501
  properties:
    _type: ResponseCode
    id: ResponseCode_10
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_10
- id: 504
  properties:
    _type: Code
    code: C113380
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Disabling Adverse Event
    id: Code_169
    instanceType: Code
    label: Code_169
- id: 503
  properties:
    _type: AliasCode
    id: AliasCode_19
    instanceType: AliasCode
    label: AliasCode_19
    standardCodeAliases: []
- id: 498
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_15
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_15
    name: AESDISAB
- id: 507
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_170
    instanceType: Code
    label: Code_170
- id: 506
  properties:
    _type: ResponseCode
    id: ResponseCode_11
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_11
- id: 509
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_171
    instanceType: Code
    label: Code_171
- id: 508
  properties:
    _type: ResponseCode
    id: ResponseCode_12
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_12
- id: 511
  properties:
    _type: Code
    code: C48275
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Death Related to Adverse Event
    id: Code_172
    instanceType: Code
    label: Code_172
- id: 510
  properties:
    _type: AliasCode
    id: AliasCode_20
    instanceType: AliasCode
    label: AliasCode_20
    standardCodeAliases: []
- id: 505
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_16
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_16
    name: AESDTH
- id: 514
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_173
    instanceType: Code
    label: Code_173
- id: 513
  properties:
    _type: ResponseCode
    id: ResponseCode_13
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_13
- id: 516
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_174
    instanceType: Code
    label: Code_174
- id: 515
  properties:
    _type: ResponseCode
    id: ResponseCode_14
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_14
- id: 518
  properties:
    _type: Code
    code: C83052
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event associated with Hospitalization
    id: Code_175
    instanceType: Code
    label: Code_175
- id: 517
  properties:
    _type: AliasCode
    id: AliasCode_21
    instanceType: AliasCode
    label: AliasCode_21
    standardCodeAliases: []
- id: 512
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_17
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_17
    name: AESHOSP
- id: 521
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_176
    instanceType: Code
    label: Code_176
- id: 520
  properties:
    _type: ResponseCode
    id: ResponseCode_15
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_15
- id: 523
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_177
    instanceType: Code
    label: Code_177
- id: 522
  properties:
    _type: ResponseCode
    id: ResponseCode_16
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_16
- id: 525
  properties:
    _type: Code
    code: C84266
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Life Threatening Adverse Event
    id: Code_178
    instanceType: Code
    label: Code_178
- id: 524
  properties:
    _type: AliasCode
    id: AliasCode_22
    instanceType: AliasCode
    label: AliasCode_22
    standardCodeAliases: []
- id: 519
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_18
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_18
    name: AESLIFE
- id: 528
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_179
    instanceType: Code
    label: Code_179
- id: 527
  properties:
    _type: ResponseCode
    id: ResponseCode_17
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_17
- id: 530
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_180
    instanceType: Code
    label: Code_180
- id: 529
  properties:
    _type: ResponseCode
    id: ResponseCode_18
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_18
- id: 532
  properties:
    _type: Code
    code: C83214
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Occurred with Overdose
    id: Code_181
    instanceType: Code
    label: Code_181
- id: 531
  properties:
    _type: AliasCode
    id: AliasCode_23
    instanceType: AliasCode
    label: AliasCode_23
    standardCodeAliases: []
- id: 526
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_19
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_19
    name: AESOD
- id: 535
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_182
    instanceType: Code
    label: Code_182
- id: 534
  properties:
    _type: ResponseCode
    id: ResponseCode_19
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_19
- id: 537
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_183
    instanceType: Code
    label: Code_183
- id: 536
  properties:
    _type: ResponseCode
    id: ResponseCode_20
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_20
- id: 539
  properties:
    _type: Code
    code: C83053
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Associated with Serious Medical Event
    id: Code_184
    instanceType: Code
    label: Code_184
- id: 538
  properties:
    _type: AliasCode
    id: AliasCode_24
    instanceType: AliasCode
    label: AliasCode_24
    standardCodeAliases: []
- id: 533
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_20
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_20
    name: AESMIE
- id: 542
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_185
    instanceType: Code
    label: Code_185
- id: 541
  properties:
    _type: ResponseCode
    id: ResponseCode_21
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_21
- id: 544
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_186
    instanceType: Code
    label: Code_186
- id: 543
  properties:
    _type: ResponseCode
    id: ResponseCode_22
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_22
- id: 546
  properties:
    _type: Code
    code: C83199
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Concomitant Treatment
    id: Code_187
    instanceType: Code
    label: Code_187
- id: 545
  properties:
    _type: AliasCode
    id: AliasCode_25
    instanceType: AliasCode
    label: AliasCode_25
    standardCodeAliases: []
- id: 540
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_21
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_21
    name: AECONTRT
- id: 549
  properties:
    _type: Code
    code: C83215
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event Start Date Time
    id: Code_188
    instanceType: Code
    label: Code_188
- id: 548
  properties:
    _type: AliasCode
    id: AliasCode_26
    instanceType: AliasCode
    label: AliasCode_26
    standardCodeAliases: []
- id: 547
  properties:
    _type: BiomedicalConceptProperty
    datatype: datetime
    id: BiomedicalConceptProperty_22
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_22
    name: AESTDTC
    responseCodes: []
- id: 552
  properties:
    _type: Code
    code: C83201
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Adverse Event End Date Time
    id: Code_189
    instanceType: Code
    label: Code_189
- id: 551
  properties:
    _type: AliasCode
    id: AliasCode_27
    instanceType: AliasCode
    label: AliasCode_27
    standardCodeAliases: []
- id: 550
  properties:
    _type: BiomedicalConceptProperty
    datatype: datetime
    id: BiomedicalConceptProperty_23
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_23
    name: AEENDTC
    responseCodes: []
- id: 554
  properties:
    _type: Code
    code: C179175
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Solicited Adverse Event
    id: Code_190
    instanceType: Code
    label: Code_190
- id: 553
  properties:
    _type: AliasCode
    id: AliasCode_28
    instanceType: AliasCode
    label: AliasCode_28
    standardCodeAliases: []
- id: 439
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_1
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_1
    name: Adverse Event Prespecified
    reference: /mdr/specializations/sdtm/packages/2023-10-03/datasetspecializations/AEPRESP
    synonyms:
    - Adverse Event
    - Solicited Adverse Event
- id: 558
  properties:
    _type: Code
    code: C25298
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: SYSBP
    id: Code_191
    instanceType: Code
    label: Code_191
- id: 557
  properties:
    _type: AliasCode
    id: AliasCode_29
    instanceType: AliasCode
    label: AliasCode_29
    standardCodeAliases: []
- id: 556
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_24
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_24
    name: VSTESTCD
    responseCodes: []
- id: 561
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_192
    instanceType: Code
    label: Code_192
- id: 560
  properties:
    _type: AliasCode
    id: AliasCode_30
    instanceType: AliasCode
    label: AliasCode_30
    standardCodeAliases: []
- id: 559
  properties:
    _type: BiomedicalConceptProperty
    datatype: integer
    id: BiomedicalConceptProperty_25
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_25
    name: VSORRES
    responseCodes: []
- id: 564
  properties:
    _type: Code
    code: C49669
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Pressure
    id: Code_193
    instanceType: Code
    label: Code_193
- id: 563
  properties:
    _type: AliasCode
    id: AliasCode_31
    instanceType: AliasCode
    label: AliasCode_31
    standardCodeAliases: []
- id: 562
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_26
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_26
    name: VSORRESU
    responseCodes: []
- id: 567
  properties:
    _type: Code
    code: C62122
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sitting
    id: Code_194
    instanceType: Code
    label: Code_194
- id: 566
  properties:
    _type: ResponseCode
    id: ResponseCode_23
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_23
- id: 569
  properties:
    _type: Code
    code: C62166
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Standing
    id: Code_195
    instanceType: Code
    label: Code_195
- id: 568
  properties:
    _type: ResponseCode
    id: ResponseCode_24
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_24
- id: 571
  properties:
    _type: Code
    code: C62167
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Supine Position
    id: Code_196
    instanceType: Code
    label: Code_196
- id: 570
  properties:
    _type: ResponseCode
    id: ResponseCode_25
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_25
- id: 573
  properties:
    _type: Code
    code: C62164
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Body Position
    id: Code_197
    instanceType: Code
    label: Code_197
- id: 572
  properties:
    _type: AliasCode
    id: AliasCode_32
    instanceType: AliasCode
    label: AliasCode_32
    standardCodeAliases: []
- id: 565
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_27
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_27
    name: VSPOS
- id: 576
  properties:
    _type: Code
    code: C12681
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Brachial Artery
    id: Code_198
    instanceType: Code
    label: Code_198
- id: 575
  properties:
    _type: ResponseCode
    id: ResponseCode_26
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_26
- id: 578
  properties:
    _type: Code
    code: C12687
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Common Carotid Artery
    id: Code_199
    instanceType: Code
    label: Code_199
- id: 577
  properties:
    _type: ResponseCode
    id: ResponseCode_27
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_27
- id: 580
  properties:
    _type: Code
    code: C32478
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Dorsalis Pedis Artery
    id: Code_200
    instanceType: Code
    label: Code_200
- id: 579
  properties:
    _type: ResponseCode
    id: ResponseCode_28
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_28
- id: 582
  properties:
    _type: Code
    code: C12715
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Femoral Artery
    id: Code_201
    instanceType: Code
    label: Code_201
- id: 581
  properties:
    _type: ResponseCode
    id: ResponseCode_29
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_29
- id: 584
  properties:
    _type: Code
    code: C12838
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Radial Artery
    id: Code_202
    instanceType: Code
    label: Code_202
- id: 583
  properties:
    _type: ResponseCode
    id: ResponseCode_30
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_30
- id: 586
  properties:
    _type: Code
    code: C13717
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Anatomic Site
    id: Code_203
    instanceType: Code
    label: Code_203
- id: 585
  properties:
    _type: AliasCode
    id: AliasCode_33
    instanceType: AliasCode
    label: AliasCode_33
    standardCodeAliases: []
- id: 574
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_28
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_28
    name: VSLOC
- id: 589
  properties:
    _type: Code
    code: C25229
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Left
    id: Code_204
    instanceType: Code
    label: Code_204
- id: 588
  properties:
    _type: ResponseCode
    id: ResponseCode_31
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_31
- id: 591
  properties:
    _type: Code
    code: C25228
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Right
    id: Code_205
    instanceType: Code
    label: Code_205
- id: 590
  properties:
    _type: ResponseCode
    id: ResponseCode_32
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_32
- id: 593
  properties:
    _type: Code
    code: C25185
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laterality
    id: Code_206
    instanceType: Code
    label: Code_206
- id: 592
  properties:
    _type: AliasCode
    id: AliasCode_34
    instanceType: AliasCode
    label: AliasCode_34
    standardCodeAliases: []
- id: 587
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_29
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_29
    name: VSLAT
- id: 595
  properties:
    _type: Code
    code: C25298
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: SYSBP
    id: Code_207
    instanceType: Code
    label: Code_207
- id: 594
  properties:
    _type: AliasCode
    id: AliasCode_35
    instanceType: AliasCode
    label: AliasCode_35
    standardCodeAliases: []
- id: 555
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_2
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_2
    name: Systolic Blood Pressure
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/SYSBP
    synonyms:
    - SYSBP
    - Systolic Blood Pressure
- id: 599
  properties:
    _type: Code
    code: C25299
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: DIABP
    id: Code_208
    instanceType: Code
    label: Code_208
- id: 598
  properties:
    _type: AliasCode
    id: AliasCode_36
    instanceType: AliasCode
    label: AliasCode_36
    standardCodeAliases: []
- id: 597
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_30
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_30
    name: VSTESTCD
    responseCodes: []
- id: 602
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_209
    instanceType: Code
    label: Code_209
- id: 601
  properties:
    _type: AliasCode
    id: AliasCode_37
    instanceType: AliasCode
    label: AliasCode_37
    standardCodeAliases: []
- id: 600
  properties:
    _type: BiomedicalConceptProperty
    datatype: integer
    id: BiomedicalConceptProperty_31
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_31
    name: VSORRES
    responseCodes: []
- id: 605
  properties:
    _type: Code
    code: C49669
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Pressure
    id: Code_210
    instanceType: Code
    label: Code_210
- id: 604
  properties:
    _type: AliasCode
    id: AliasCode_38
    instanceType: AliasCode
    label: AliasCode_38
    standardCodeAliases: []
- id: 603
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_32
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_32
    name: VSORRESU
    responseCodes: []
- id: 608
  properties:
    _type: Code
    code: C62122
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sitting
    id: Code_211
    instanceType: Code
    label: Code_211
- id: 607
  properties:
    _type: ResponseCode
    id: ResponseCode_33
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_33
- id: 610
  properties:
    _type: Code
    code: C62166
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Standing
    id: Code_212
    instanceType: Code
    label: Code_212
- id: 609
  properties:
    _type: ResponseCode
    id: ResponseCode_34
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_34
- id: 612
  properties:
    _type: Code
    code: C62167
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Supine Position
    id: Code_213
    instanceType: Code
    label: Code_213
- id: 611
  properties:
    _type: ResponseCode
    id: ResponseCode_35
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_35
- id: 614
  properties:
    _type: Code
    code: C62164
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Body Position
    id: Code_214
    instanceType: Code
    label: Code_214
- id: 613
  properties:
    _type: AliasCode
    id: AliasCode_39
    instanceType: AliasCode
    label: AliasCode_39
    standardCodeAliases: []
- id: 606
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_33
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_33
    name: VSPOS
- id: 617
  properties:
    _type: Code
    code: C12681
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Brachial Artery
    id: Code_215
    instanceType: Code
    label: Code_215
- id: 616
  properties:
    _type: ResponseCode
    id: ResponseCode_36
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_36
- id: 619
  properties:
    _type: Code
    code: C12687
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Common Carotid Artery
    id: Code_216
    instanceType: Code
    label: Code_216
- id: 618
  properties:
    _type: ResponseCode
    id: ResponseCode_37
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_37
- id: 621
  properties:
    _type: Code
    code: C32478
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Dorsalis Pedis Artery
    id: Code_217
    instanceType: Code
    label: Code_217
- id: 620
  properties:
    _type: ResponseCode
    id: ResponseCode_38
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_38
- id: 623
  properties:
    _type: Code
    code: C12715
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Femoral Artery
    id: Code_218
    instanceType: Code
    label: Code_218
- id: 622
  properties:
    _type: ResponseCode
    id: ResponseCode_39
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_39
- id: 625
  properties:
    _type: Code
    code: C12838
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Radial Artery
    id: Code_219
    instanceType: Code
    label: Code_219
- id: 624
  properties:
    _type: ResponseCode
    id: ResponseCode_40
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_40
- id: 627
  properties:
    _type: Code
    code: C13717
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Anatomic Site
    id: Code_220
    instanceType: Code
    label: Code_220
- id: 626
  properties:
    _type: AliasCode
    id: AliasCode_40
    instanceType: AliasCode
    label: AliasCode_40
    standardCodeAliases: []
- id: 615
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_34
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_34
    name: VSLOC
- id: 630
  properties:
    _type: Code
    code: C25229
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Left
    id: Code_221
    instanceType: Code
    label: Code_221
- id: 629
  properties:
    _type: ResponseCode
    id: ResponseCode_41
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_41
- id: 632
  properties:
    _type: Code
    code: C25228
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Right
    id: Code_222
    instanceType: Code
    label: Code_222
- id: 631
  properties:
    _type: ResponseCode
    id: ResponseCode_42
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_42
- id: 634
  properties:
    _type: Code
    code: C25185
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laterality
    id: Code_223
    instanceType: Code
    label: Code_223
- id: 633
  properties:
    _type: AliasCode
    id: AliasCode_41
    instanceType: AliasCode
    label: AliasCode_41
    standardCodeAliases: []
- id: 628
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_35
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_35
    name: VSLAT
- id: 636
  properties:
    _type: Code
    code: C25299
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: DIABP
    id: Code_224
    instanceType: Code
    label: Code_224
- id: 635
  properties:
    _type: AliasCode
    id: AliasCode_42
    instanceType: AliasCode
    label: AliasCode_42
    standardCodeAliases: []
- id: 596
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_3
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_3
    name: Diastolic Blood Pressure
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/DIABP
    synonyms:
    - DIABP
    - Diastolic Blood Pressure
- id: 640
  properties:
    _type: Code
    code: C174446
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: TEMP
    id: Code_225
    instanceType: Code
    label: Code_225
- id: 639
  properties:
    _type: AliasCode
    id: AliasCode_43
    instanceType: AliasCode
    label: AliasCode_43
    standardCodeAliases: []
- id: 638
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_36
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_36
    name: VSTESTCD
    responseCodes: []
- id: 643
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_226
    instanceType: Code
    label: Code_226
- id: 642
  properties:
    _type: AliasCode
    id: AliasCode_44
    instanceType: AliasCode
    label: AliasCode_44
    standardCodeAliases: []
- id: 641
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_37
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_37
    name: VSORRES
    responseCodes: []
- id: 646
  properties:
    _type: Code
    code: C42559
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Degree Celsius
    id: Code_227
    instanceType: Code
    label: Code_227
- id: 645
  properties:
    _type: ResponseCode
    id: ResponseCode_43
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_43
- id: 648
  properties:
    _type: Code
    code: C44277
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Degree Fahrenheit
    id: Code_228
    instanceType: Code
    label: Code_228
- id: 647
  properties:
    _type: ResponseCode
    id: ResponseCode_44
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_44
- id: 650
  properties:
    _type: Code
    code: C42537
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Kelvin
    id: Code_229
    instanceType: Code
    label: Code_229
- id: 649
  properties:
    _type: ResponseCode
    id: ResponseCode_45
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_45
- id: 652
  properties:
    _type: Code
    code: C44276
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Temperature
    id: Code_230
    instanceType: Code
    label: Code_230
- id: 651
  properties:
    _type: AliasCode
    id: AliasCode_45
    instanceType: AliasCode
    label: AliasCode_45
    standardCodeAliases: []
- id: 644
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_38
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_38
    name: VSORRESU
- id: 655
  properties:
    _type: Code
    code: C12674
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Axilla
    id: Code_231
    instanceType: Code
    label: Code_231
- id: 654
  properties:
    _type: ResponseCode
    id: ResponseCode_46
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_46
- id: 657
  properties:
    _type: Code
    code: C12394
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Ear
    id: Code_232
    instanceType: Code
    label: Code_232
- id: 656
  properties:
    _type: ResponseCode
    id: ResponseCode_47
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_47
- id: 659
  properties:
    _type: Code
    code: C89803
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Forehead
    id: Code_233
    instanceType: Code
    label: Code_233
- id: 658
  properties:
    _type: ResponseCode
    id: ResponseCode_48
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_48
- id: 661
  properties:
    _type: Code
    code: C12421
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Oral Cavity
    id: Code_234
    instanceType: Code
    label: Code_234
- id: 660
  properties:
    _type: ResponseCode
    id: ResponseCode_49
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_49
- id: 663
  properties:
    _type: Code
    code: C12390
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Rectum
    id: Code_235
    instanceType: Code
    label: Code_235
- id: 662
  properties:
    _type: ResponseCode
    id: ResponseCode_50
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_50
- id: 665
  properties:
    _type: Code
    code: C13717
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Anatomic Site
    id: Code_236
    instanceType: Code
    label: Code_236
- id: 664
  properties:
    _type: AliasCode
    id: AliasCode_46
    instanceType: AliasCode
    label: AliasCode_46
    standardCodeAliases: []
- id: 653
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_39
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_39
    name: VSLOC
- id: 667
  properties:
    _type: Code
    code: C174446
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: TEMP
    id: Code_237
    instanceType: Code
    label: Code_237
- id: 666
  properties:
    _type: AliasCode
    id: AliasCode_47
    instanceType: AliasCode
    label: AliasCode_47
    standardCodeAliases: []
- id: 637
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_4
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_4
    name: Temperature
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/TEMP
    synonyms:
    - Temperature
    - Body Temperature
- id: 671
  properties:
    _type: Code
    code: C25208
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: WEIGHT
    id: Code_238
    instanceType: Code
    label: Code_238
- id: 670
  properties:
    _type: AliasCode
    id: AliasCode_48
    instanceType: AliasCode
    label: AliasCode_48
    standardCodeAliases: []
- id: 669
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_40
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_40
    name: VSTESTCD
    responseCodes: []
- id: 674
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_239
    instanceType: Code
    label: Code_239
- id: 673
  properties:
    _type: AliasCode
    id: AliasCode_49
    instanceType: AliasCode
    label: AliasCode_49
    standardCodeAliases: []
- id: 672
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_41
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_41
    name: VSORRES
    responseCodes: []
- id: 677
  properties:
    _type: Code
    code: C48531
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Pound
    id: Code_240
    instanceType: Code
    label: Code_240
- id: 676
  properties:
    _type: ResponseCode
    id: ResponseCode_51
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_51
- id: 679
  properties:
    _type: Code
    code: C48155
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Gram
    id: Code_241
    instanceType: Code
    label: Code_241
- id: 678
  properties:
    _type: ResponseCode
    id: ResponseCode_52
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_52
- id: 681
  properties:
    _type: Code
    code: C28252
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Kilogram
    id: Code_242
    instanceType: Code
    label: Code_242
- id: 680
  properties:
    _type: ResponseCode
    id: ResponseCode_53
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_53
- id: 683
  properties:
    _type: Code
    code: C48208
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Weight
    id: Code_243
    instanceType: Code
    label: Code_243
- id: 682
  properties:
    _type: AliasCode
    id: AliasCode_50
    instanceType: AliasCode
    label: AliasCode_50
    standardCodeAliases: []
- id: 675
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_42
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_42
    name: VSORRESU
- id: 685
  properties:
    _type: Code
    code: C25208
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: WEIGHT
    id: Code_244
    instanceType: Code
    label: Code_244
- id: 684
  properties:
    _type: AliasCode
    id: AliasCode_51
    instanceType: AliasCode
    label: AliasCode_51
    standardCodeAliases: []
- id: 668
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_5
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_5
    name: Weight
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/WEIGHT
    synonyms:
    - Weight
    - Body Weight
- id: 689
  properties:
    _type: Code
    code: C25347
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: HEIGHT
    id: Code_245
    instanceType: Code
    label: Code_245
- id: 688
  properties:
    _type: AliasCode
    id: AliasCode_52
    instanceType: AliasCode
    label: AliasCode_52
    standardCodeAliases: []
- id: 687
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_43
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_43
    name: VSTESTCD
    responseCodes: []
- id: 692
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_246
    instanceType: Code
    label: Code_246
- id: 691
  properties:
    _type: AliasCode
    id: AliasCode_53
    instanceType: AliasCode
    label: AliasCode_53
    standardCodeAliases: []
- id: 690
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_44
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_44
    name: VSORRES
    responseCodes: []
- id: 695
  properties:
    _type: Code
    code: C49668
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Centimeter
    id: Code_247
    instanceType: Code
    label: Code_247
- id: 694
  properties:
    _type: ResponseCode
    id: ResponseCode_54
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_54
- id: 697
  properties:
    _type: Code
    code: C48500
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Inch
    id: Code_248
    instanceType: Code
    label: Code_248
- id: 696
  properties:
    _type: ResponseCode
    id: ResponseCode_55
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_55
- id: 699
  properties:
    _type: Code
    code: C41139
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Meter
    id: Code_249
    instanceType: Code
    label: Code_249
- id: 698
  properties:
    _type: ResponseCode
    id: ResponseCode_56
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_56
- id: 701
  properties:
    _type: Code
    code: C168688
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Height
    id: Code_250
    instanceType: Code
    label: Code_250
- id: 700
  properties:
    _type: AliasCode
    id: AliasCode_54
    instanceType: AliasCode
    label: AliasCode_54
    standardCodeAliases: []
- id: 693
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_45
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_45
    name: VSORRESU
- id: 703
  properties:
    _type: Code
    code: C25347
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: HEIGHT
    id: Code_251
    instanceType: Code
    label: Code_251
- id: 702
  properties:
    _type: AliasCode
    id: AliasCode_55
    instanceType: AliasCode
    label: AliasCode_55
    standardCodeAliases: []
- id: 686
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_6
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_6
    name: Height
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/HEIGHT
    synonyms:
    - Height
    - Body Height
- id: 707
  properties:
    _type: Code
    code: C64433
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALT
    id: Code_252
    instanceType: Code
    label: Code_252
- id: 706
  properties:
    _type: AliasCode
    id: AliasCode_56
    instanceType: AliasCode
    label: AliasCode_56
    standardCodeAliases: []
- id: 705
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_46
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_46
    name: LBTESTCD
    responseCodes: []
- id: 710
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_253
    instanceType: Code
    label: Code_253
- id: 709
  properties:
    _type: AliasCode
    id: AliasCode_57
    instanceType: AliasCode
    label: AliasCode_57
    standardCodeAliases: []
- id: 708
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_47
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_47
    name: LBORRES
    responseCodes: []
- id: 713
  properties:
    _type: Code
    code: C67456
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit per Liter
    id: Code_254
    instanceType: Code
    label: Code_254
- id: 712
  properties:
    _type: ResponseCode
    id: ResponseCode_57
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_57
- id: 715
  properties:
    _type: Code
    code: C67397
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Microkatal per Liter
    id: Code_255
    instanceType: Code
    label: Code_255
- id: 714
  properties:
    _type: ResponseCode
    id: ResponseCode_58
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_58
- id: 717
  properties:
    _type: Code
    code: C67376
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: International Unit per Liter
    id: Code_256
    instanceType: Code
    label: Code_256
- id: 716
  properties:
    _type: ResponseCode
    id: ResponseCode_59
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_59
- id: 719
  properties:
    _type: Code
    code: C70510
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Nanokatal per Liter
    id: Code_257
    instanceType: Code
    label: Code_257
- id: 718
  properties:
    _type: ResponseCode
    id: ResponseCode_60
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_60
- id: 721
  properties:
    _type: Code
    code: C67365
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Catalytic Activity Concentration
    id: Code_258
    instanceType: Code
    label: Code_258
- id: 720
  properties:
    _type: AliasCode
    id: AliasCode_58
    instanceType: AliasCode
    label: AliasCode_58
    standardCodeAliases: []
- id: 711
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_48
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_48
    name: LBORRESU
- id: 724
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_259
    instanceType: Code
    label: Code_259
- id: 723
  properties:
    _type: AliasCode
    id: AliasCode_59
    instanceType: AliasCode
    label: AliasCode_59
    standardCodeAliases: []
- id: 722
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_49
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_49
    name: LBSPEC
    responseCodes: []
- id: 727
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_260
    instanceType: Code
    label: Code_260
- id: 726
  properties:
    _type: ResponseCode
    id: ResponseCode_61
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_61
- id: 729
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_261
    instanceType: Code
    label: Code_261
- id: 728
  properties:
    _type: ResponseCode
    id: ResponseCode_62
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_62
- id: 731
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_262
    instanceType: Code
    label: Code_262
- id: 730
  properties:
    _type: AliasCode
    id: AliasCode_60
    instanceType: AliasCode
    label: AliasCode_60
    standardCodeAliases: []
- id: 725
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_50
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_50
    name: LBFAST
- id: 733
  properties:
    _type: Code
    code: C64433
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALT
    id: Code_263
    instanceType: Code
    label: Code_263
- id: 732
  properties:
    _type: AliasCode
    id: AliasCode_61
    instanceType: AliasCode
    label: AliasCode_61
    standardCodeAliases: []
- id: 704
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_7
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_7
    name: Alanine Aminotransferase Concentration in Serum/Plasma
    reference: /mdr/specializations/sdtm/packages/2023-07-06/datasetspecializations/ALTSERPL
    synonyms:
    - ALT
    - SGPT
    - Alanine Aminotransferase Measurement
- id: 737
  properties:
    _type: Code
    code: C64431
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALB
    id: Code_264
    instanceType: Code
    label: Code_264
- id: 736
  properties:
    _type: AliasCode
    id: AliasCode_62
    instanceType: AliasCode
    label: AliasCode_62
    standardCodeAliases: []
- id: 735
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_51
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_51
    name: LBTESTCD
    responseCodes: []
- id: 740
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_265
    instanceType: Code
    label: Code_265
- id: 739
  properties:
    _type: AliasCode
    id: AliasCode_63
    instanceType: AliasCode
    label: AliasCode_63
    standardCodeAliases: []
- id: 738
  properties:
    _type: BiomedicalConceptProperty
    datatype: text
    id: BiomedicalConceptProperty_52
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_52
    name: LBORRES
    responseCodes: []
- id: 743
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_266
    instanceType: Code
    label: Code_266
- id: 742
  properties:
    _type: AliasCode
    id: AliasCode_64
    instanceType: AliasCode
    label: AliasCode_64
    standardCodeAliases: []
- id: 741
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_53
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_53
    name: LBSPEC
    responseCodes: []
- id: 746
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_267
    instanceType: Code
    label: Code_267
- id: 745
  properties:
    _type: ResponseCode
    id: ResponseCode_63
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_63
- id: 748
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_268
    instanceType: Code
    label: Code_268
- id: 747
  properties:
    _type: ResponseCode
    id: ResponseCode_64
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_64
- id: 750
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_269
    instanceType: Code
    label: Code_269
- id: 749
  properties:
    _type: AliasCode
    id: AliasCode_65
    instanceType: AliasCode
    label: AliasCode_65
    standardCodeAliases: []
- id: 744
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_54
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_54
    name: LBFAST
- id: 752
  properties:
    _type: Code
    code: C64431
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALB
    id: Code_270
    instanceType: Code
    label: Code_270
- id: 751
  properties:
    _type: AliasCode
    id: AliasCode_66
    instanceType: AliasCode
    label: AliasCode_66
    standardCodeAliases: []
- id: 734
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_8
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_8
    name: Albumin Presence in Urine
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/ALBURINPRES
    synonyms:
    - Albumin
    - Albumin Measurement
- id: 756
  properties:
    _type: Code
    code: C64432
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALP
    id: Code_271
    instanceType: Code
    label: Code_271
- id: 755
  properties:
    _type: AliasCode
    id: AliasCode_67
    instanceType: AliasCode
    label: AliasCode_67
    standardCodeAliases: []
- id: 754
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_55
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_55
    name: LBTESTCD
    responseCodes: []
- id: 759
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_272
    instanceType: Code
    label: Code_272
- id: 758
  properties:
    _type: AliasCode
    id: AliasCode_68
    instanceType: AliasCode
    label: AliasCode_68
    standardCodeAliases: []
- id: 757
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_56
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_56
    name: LBORRES
    responseCodes: []
- id: 762
  properties:
    _type: Code
    code: C67456
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit per Liter
    id: Code_273
    instanceType: Code
    label: Code_273
- id: 761
  properties:
    _type: ResponseCode
    id: ResponseCode_65
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_65
- id: 764
  properties:
    _type: Code
    code: C67397
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Microkatal per Liter
    id: Code_274
    instanceType: Code
    label: Code_274
- id: 763
  properties:
    _type: ResponseCode
    id: ResponseCode_66
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_66
- id: 766
  properties:
    _type: Code
    code: C67376
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: International Unit per Liter
    id: Code_275
    instanceType: Code
    label: Code_275
- id: 765
  properties:
    _type: ResponseCode
    id: ResponseCode_67
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_67
- id: 768
  properties:
    _type: Code
    code: C67365
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Catalytic Activity Concentration
    id: Code_276
    instanceType: Code
    label: Code_276
- id: 767
  properties:
    _type: AliasCode
    id: AliasCode_69
    instanceType: AliasCode
    label: AliasCode_69
    standardCodeAliases: []
- id: 760
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_57
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_57
    name: LBORRESU
- id: 771
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_277
    instanceType: Code
    label: Code_277
- id: 770
  properties:
    _type: AliasCode
    id: AliasCode_70
    instanceType: AliasCode
    label: AliasCode_70
    standardCodeAliases: []
- id: 769
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_58
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_58
    name: LBSPEC
    responseCodes: []
- id: 774
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_278
    instanceType: Code
    label: Code_278
- id: 773
  properties:
    _type: ResponseCode
    id: ResponseCode_68
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_68
- id: 776
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_279
    instanceType: Code
    label: Code_279
- id: 775
  properties:
    _type: ResponseCode
    id: ResponseCode_69
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_69
- id: 778
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_280
    instanceType: Code
    label: Code_280
- id: 777
  properties:
    _type: AliasCode
    id: AliasCode_71
    instanceType: AliasCode
    label: AliasCode_71
    standardCodeAliases: []
- id: 772
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_59
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_59
    name: LBFAST
- id: 780
  properties:
    _type: Code
    code: C64432
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: ALP
    id: Code_281
    instanceType: Code
    label: Code_281
- id: 779
  properties:
    _type: AliasCode
    id: AliasCode_72
    instanceType: AliasCode
    label: AliasCode_72
    standardCodeAliases: []
- id: 753
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_9
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_9
    name: Alkaline Phosphatase Concentration in Serum/Plasma
    reference: /mdr/specializations/sdtm/packages/2023-07-06/datasetspecializations/ALPSERPL
    synonyms:
    - Alkaline Phosphatase
    - Alkaline Phosphatase Measurement
- id: 784
  properties:
    _type: Code
    code: C64467
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: AST
    id: Code_282
    instanceType: Code
    label: Code_282
- id: 783
  properties:
    _type: AliasCode
    id: AliasCode_73
    instanceType: AliasCode
    label: AliasCode_73
    standardCodeAliases: []
- id: 782
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_60
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_60
    name: LBTESTCD
    responseCodes: []
- id: 787
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_283
    instanceType: Code
    label: Code_283
- id: 786
  properties:
    _type: AliasCode
    id: AliasCode_74
    instanceType: AliasCode
    label: AliasCode_74
    standardCodeAliases: []
- id: 785
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_61
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_61
    name: LBORRES
    responseCodes: []
- id: 790
  properties:
    _type: Code
    code: C67456
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit per Liter
    id: Code_284
    instanceType: Code
    label: Code_284
- id: 789
  properties:
    _type: ResponseCode
    id: ResponseCode_70
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_70
- id: 792
  properties:
    _type: Code
    code: C67397
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Microkatal per Liter
    id: Code_285
    instanceType: Code
    label: Code_285
- id: 791
  properties:
    _type: ResponseCode
    id: ResponseCode_71
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_71
- id: 794
  properties:
    _type: Code
    code: C67376
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: International Unit per Liter
    id: Code_286
    instanceType: Code
    label: Code_286
- id: 793
  properties:
    _type: ResponseCode
    id: ResponseCode_72
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_72
- id: 796
  properties:
    _type: Code
    code: C67365
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Catalytic Activity Concentration
    id: Code_287
    instanceType: Code
    label: Code_287
- id: 795
  properties:
    _type: AliasCode
    id: AliasCode_75
    instanceType: AliasCode
    label: AliasCode_75
    standardCodeAliases: []
- id: 788
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_62
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_62
    name: LBORRESU
- id: 799
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_288
    instanceType: Code
    label: Code_288
- id: 798
  properties:
    _type: AliasCode
    id: AliasCode_76
    instanceType: AliasCode
    label: AliasCode_76
    standardCodeAliases: []
- id: 797
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_63
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_63
    name: LBSPEC
    responseCodes: []
- id: 802
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_289
    instanceType: Code
    label: Code_289
- id: 801
  properties:
    _type: ResponseCode
    id: ResponseCode_73
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_73
- id: 804
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_290
    instanceType: Code
    label: Code_290
- id: 803
  properties:
    _type: ResponseCode
    id: ResponseCode_74
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_74
- id: 806
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_291
    instanceType: Code
    label: Code_291
- id: 805
  properties:
    _type: AliasCode
    id: AliasCode_77
    instanceType: AliasCode
    label: AliasCode_77
    standardCodeAliases: []
- id: 800
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_64
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_64
    name: LBFAST
- id: 808
  properties:
    _type: Code
    code: C64467
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: AST
    id: Code_292
    instanceType: Code
    label: Code_292
- id: 807
  properties:
    _type: AliasCode
    id: AliasCode_78
    instanceType: AliasCode
    label: AliasCode_78
    standardCodeAliases: []
- id: 781
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_10
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_10
    name: Aspartate Aminotransferase in Serum/Plasma
    reference: /mdr/specializations/sdtm/packages/2023-07-06/datasetspecializations/ASTSERPL
    synonyms:
    - AST
    - SGOT
    - Aspartate Aminotransferase Measurement
- id: 812
  properties:
    _type: Code
    code: C64547
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: CREAT
    id: Code_293
    instanceType: Code
    label: Code_293
- id: 811
  properties:
    _type: AliasCode
    id: AliasCode_79
    instanceType: AliasCode
    label: AliasCode_79
    standardCodeAliases: []
- id: 810
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_65
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_65
    name: LBTESTCD
    responseCodes: []
- id: 815
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_294
    instanceType: Code
    label: Code_294
- id: 814
  properties:
    _type: AliasCode
    id: AliasCode_80
    instanceType: AliasCode
    label: AliasCode_80
    standardCodeAliases: []
- id: 813
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_66
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_66
    name: LBORRES
    responseCodes: []
- id: 818
  properties:
    _type: Code
    code: C67015
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Milligram per Deciliter
    id: Code_295
    instanceType: Code
    label: Code_295
- id: 817
  properties:
    _type: ResponseCode
    id: ResponseCode_75
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_75
- id: 820
  properties:
    _type: Code
    code: C64572
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Microgram per Milliliter
    id: Code_296
    instanceType: Code
    label: Code_296
- id: 819
  properties:
    _type: ResponseCode
    id: ResponseCode_76
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_76
- id: 822
  properties:
    _type: Code
    code: C64387
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Millimole per Liter
    id: Code_297
    instanceType: Code
    label: Code_297
- id: 821
  properties:
    _type: ResponseCode
    id: ResponseCode_77
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_77
- id: 824
  properties:
    _type: Code
    code: C48508
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Micromole per Liter
    id: Code_298
    instanceType: Code
    label: Code_298
- id: 823
  properties:
    _type: ResponseCode
    id: ResponseCode_78
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_78
- id: 826
  properties:
    _type: Code
    code: C48207
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Concentration
    id: Code_299
    instanceType: Code
    label: Code_299
- id: 825
  properties:
    _type: AliasCode
    id: AliasCode_81
    instanceType: AliasCode
    label: AliasCode_81
    standardCodeAliases: []
- id: 816
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_67
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_67
    name: LBORRESU
- id: 829
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_300
    instanceType: Code
    label: Code_300
- id: 828
  properties:
    _type: AliasCode
    id: AliasCode_82
    instanceType: AliasCode
    label: AliasCode_82
    standardCodeAliases: []
- id: 827
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_68
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_68
    name: LBSPEC
    responseCodes: []
- id: 832
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_301
    instanceType: Code
    label: Code_301
- id: 831
  properties:
    _type: ResponseCode
    id: ResponseCode_79
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_79
- id: 834
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_302
    instanceType: Code
    label: Code_302
- id: 833
  properties:
    _type: ResponseCode
    id: ResponseCode_80
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_80
- id: 836
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_303
    instanceType: Code
    label: Code_303
- id: 835
  properties:
    _type: AliasCode
    id: AliasCode_83
    instanceType: AliasCode
    label: AliasCode_83
    standardCodeAliases: []
- id: 830
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_69
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_69
    name: LBFAST
- id: 838
  properties:
    _type: Code
    code: C64547
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: CREAT
    id: Code_304
    instanceType: Code
    label: Code_304
- id: 837
  properties:
    _type: AliasCode
    id: AliasCode_84
    instanceType: AliasCode
    label: AliasCode_84
    standardCodeAliases: []
- id: 809
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_11
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_11
    name: Creatinine Concentration in Urine
    reference: /mdr/specializations/sdtm/packages/2023-10-03/datasetspecializations/CREATURIN
    synonyms:
    - Creatinine
    - Creatinine Measurement
- id: 842
  properties:
    _type: Code
    code: C64853
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: K
    id: Code_305
    instanceType: Code
    label: Code_305
- id: 841
  properties:
    _type: AliasCode
    id: AliasCode_85
    instanceType: AliasCode
    label: AliasCode_85
    standardCodeAliases: []
- id: 840
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_70
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_70
    name: LBTESTCD
    responseCodes: []
- id: 845
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_306
    instanceType: Code
    label: Code_306
- id: 844
  properties:
    _type: AliasCode
    id: AliasCode_86
    instanceType: AliasCode
    label: AliasCode_86
    standardCodeAliases: []
- id: 843
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_71
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_71
    name: LBORRES
    responseCodes: []
- id: 848
  properties:
    _type: Code
    code: C67474
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Milliequivalent per Liter
    id: Code_307
    instanceType: Code
    label: Code_307
- id: 847
  properties:
    _type: ResponseCode
    id: ResponseCode_81
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_81
- id: 850
  properties:
    _type: Code
    code: C67473
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Milliequivalent per Deciliter
    id: Code_308
    instanceType: Code
    label: Code_308
- id: 849
  properties:
    _type: ResponseCode
    id: ResponseCode_82
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_82
- id: 852
  properties:
    _type: Code
    code: C64387
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Millimole per Liter
    id: Code_309
    instanceType: Code
    label: Code_309
- id: 851
  properties:
    _type: ResponseCode
    id: ResponseCode_83
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_83
- id: 854
  properties:
    _type: Code
    code: C64567
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Molarity Unit
    id: Code_310
    instanceType: Code
    label: Code_310
- id: 853
  properties:
    _type: AliasCode
    id: AliasCode_87
    instanceType: AliasCode
    label: AliasCode_87
    standardCodeAliases: []
- id: 846
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_72
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_72
    name: LBORRESU
- id: 857
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_311
    instanceType: Code
    label: Code_311
- id: 856
  properties:
    _type: AliasCode
    id: AliasCode_88
    instanceType: AliasCode
    label: AliasCode_88
    standardCodeAliases: []
- id: 855
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_73
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_73
    name: LBSPEC
    responseCodes: []
- id: 860
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_312
    instanceType: Code
    label: Code_312
- id: 859
  properties:
    _type: ResponseCode
    id: ResponseCode_84
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_84
- id: 862
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_313
    instanceType: Code
    label: Code_313
- id: 861
  properties:
    _type: ResponseCode
    id: ResponseCode_85
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_85
- id: 864
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_314
    instanceType: Code
    label: Code_314
- id: 863
  properties:
    _type: AliasCode
    id: AliasCode_89
    instanceType: AliasCode
    label: AliasCode_89
    standardCodeAliases: []
- id: 858
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_74
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_74
    name: LBFAST
- id: 866
  properties:
    _type: Code
    code: C64853
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: K
    id: Code_315
    instanceType: Code
    label: Code_315
- id: 865
  properties:
    _type: AliasCode
    id: AliasCode_90
    instanceType: AliasCode
    label: AliasCode_90
    standardCodeAliases: []
- id: 839
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_12
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_12
    name: Potassium Concentration in Urine
    reference: /mdr/specializations/sdtm/packages/2023-07-06/datasetspecializations/KURIN
    synonyms:
    - Potassium
    - K
    - Potassium Measurement
- id: 870
  properties:
    _type: Code
    code: C64809
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: SODIUM
    id: Code_316
    instanceType: Code
    label: Code_316
- id: 869
  properties:
    _type: AliasCode
    id: AliasCode_91
    instanceType: AliasCode
    label: AliasCode_91
    standardCodeAliases: []
- id: 868
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_75
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_75
    name: LBTESTCD
    responseCodes: []
- id: 873
  properties:
    _type: Code
    code: C36292
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Result
    id: Code_317
    instanceType: Code
    label: Code_317
- id: 872
  properties:
    _type: AliasCode
    id: AliasCode_92
    instanceType: AliasCode
    label: AliasCode_92
    standardCodeAliases: []
- id: 871
  properties:
    _type: BiomedicalConceptProperty
    datatype: float
    id: BiomedicalConceptProperty_76
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_76
    name: LBORRES
    responseCodes: []
- id: 876
  properties:
    _type: Code
    code: C67474
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Milliequivalent per Liter
    id: Code_318
    instanceType: Code
    label: Code_318
- id: 875
  properties:
    _type: ResponseCode
    id: ResponseCode_86
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_86
- id: 878
  properties:
    _type: Code
    code: C67473
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Milliequivalent per Deciliter
    id: Code_319
    instanceType: Code
    label: Code_319
- id: 877
  properties:
    _type: ResponseCode
    id: ResponseCode_87
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_87
- id: 880
  properties:
    _type: Code
    code: C64387
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Millimole per Liter
    id: Code_320
    instanceType: Code
    label: Code_320
- id: 879
  properties:
    _type: ResponseCode
    id: ResponseCode_88
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_88
- id: 882
  properties:
    _type: Code
    code: C64567
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Molarity Unit
    id: Code_321
    instanceType: Code
    label: Code_321
- id: 881
  properties:
    _type: AliasCode
    id: AliasCode_93
    instanceType: AliasCode
    label: AliasCode_93
    standardCodeAliases: []
- id: 874
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_77
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_77
    name: LBORRESU
- id: 885
  properties:
    _type: Code
    code: C70713
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Biospecimen Type
    id: Code_322
    instanceType: Code
    label: Code_322
- id: 884
  properties:
    _type: AliasCode
    id: AliasCode_94
    instanceType: AliasCode
    label: AliasCode_94
    standardCodeAliases: []
- id: 883
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_78
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_78
    name: LBSPEC
    responseCodes: []
- id: 888
  properties:
    _type: Code
    code: C49487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'No'
    id: Code_323
    instanceType: Code
    label: Code_323
- id: 887
  properties:
    _type: ResponseCode
    id: ResponseCode_89
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_89
- id: 890
  properties:
    _type: Code
    code: C49488
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: 'Yes'
    id: Code_324
    instanceType: Code
    label: Code_324
- id: 889
  properties:
    _type: ResponseCode
    id: ResponseCode_90
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_90
- id: 892
  properties:
    _type: Code
    code: C83309
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laboratory Test Fasting Status
    id: Code_325
    instanceType: Code
    label: Code_325
- id: 891
  properties:
    _type: AliasCode
    id: AliasCode_95
    instanceType: AliasCode
    label: AliasCode_95
    standardCodeAliases: []
- id: 886
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_79
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_79
    name: LBFAST
- id: 894
  properties:
    _type: Code
    code: C64809
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: SODIUM
    id: Code_326
    instanceType: Code
    label: Code_326
- id: 893
  properties:
    _type: AliasCode
    id: AliasCode_96
    instanceType: AliasCode
    label: AliasCode_96
    standardCodeAliases: []
- id: 867
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_13
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_13
    name: Sodium Concentration in Urine
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/SODIUMURIN
    synonyms:
    - Sodium
    - NA
    - Sodium Measurement
- id: 898
  properties:
    _type: Code
    code: C25298
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: SYSBP
    id: Code_327
    instanceType: Code
    label: Code_327
- id: 897
  properties:
    _type: AliasCode
    id: AliasCode_97
    instanceType: AliasCode
    label: AliasCode_97
    standardCodeAliases: []
- id: 896
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_80
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_80
    name: VSTESTCD
    responseCodes: []
- id: 901
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_328
    instanceType: Code
    label: Code_328
- id: 900
  properties:
    _type: AliasCode
    id: AliasCode_98
    instanceType: AliasCode
    label: AliasCode_98
    standardCodeAliases: []
- id: 899
  properties:
    _type: BiomedicalConceptProperty
    datatype: integer
    id: BiomedicalConceptProperty_81
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_81
    name: VSORRES
    responseCodes: []
- id: 904
  properties:
    _type: Code
    code: C49669
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Pressure
    id: Code_329
    instanceType: Code
    label: Code_329
- id: 903
  properties:
    _type: AliasCode
    id: AliasCode_99
    instanceType: AliasCode
    label: AliasCode_99
    standardCodeAliases: []
- id: 902
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_82
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_82
    name: VSORRESU
    responseCodes: []
- id: 907
  properties:
    _type: Code
    code: C62122
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sitting
    id: Code_330
    instanceType: Code
    label: Code_330
- id: 906
  properties:
    _type: ResponseCode
    id: ResponseCode_91
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_91
- id: 909
  properties:
    _type: Code
    code: C62166
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Standing
    id: Code_331
    instanceType: Code
    label: Code_331
- id: 908
  properties:
    _type: ResponseCode
    id: ResponseCode_92
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_92
- id: 911
  properties:
    _type: Code
    code: C62167
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Supine Position
    id: Code_332
    instanceType: Code
    label: Code_332
- id: 910
  properties:
    _type: ResponseCode
    id: ResponseCode_93
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_93
- id: 913
  properties:
    _type: Code
    code: C62164
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Body Position
    id: Code_333
    instanceType: Code
    label: Code_333
- id: 912
  properties:
    _type: AliasCode
    id: AliasCode_100
    instanceType: AliasCode
    label: AliasCode_100
    standardCodeAliases: []
- id: 905
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_83
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_83
    name: VSPOS
- id: 916
  properties:
    _type: Code
    code: C12681
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Brachial Artery
    id: Code_334
    instanceType: Code
    label: Code_334
- id: 915
  properties:
    _type: ResponseCode
    id: ResponseCode_94
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_94
- id: 918
  properties:
    _type: Code
    code: C12687
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Common Carotid Artery
    id: Code_335
    instanceType: Code
    label: Code_335
- id: 917
  properties:
    _type: ResponseCode
    id: ResponseCode_95
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_95
- id: 920
  properties:
    _type: Code
    code: C32478
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Dorsalis Pedis Artery
    id: Code_336
    instanceType: Code
    label: Code_336
- id: 919
  properties:
    _type: ResponseCode
    id: ResponseCode_96
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_96
- id: 922
  properties:
    _type: Code
    code: C12715
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Femoral Artery
    id: Code_337
    instanceType: Code
    label: Code_337
- id: 921
  properties:
    _type: ResponseCode
    id: ResponseCode_97
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_97
- id: 924
  properties:
    _type: Code
    code: C12838
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Radial Artery
    id: Code_338
    instanceType: Code
    label: Code_338
- id: 923
  properties:
    _type: ResponseCode
    id: ResponseCode_98
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_98
- id: 926
  properties:
    _type: Code
    code: C13717
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Anatomic Site
    id: Code_339
    instanceType: Code
    label: Code_339
- id: 925
  properties:
    _type: AliasCode
    id: AliasCode_101
    instanceType: AliasCode
    label: AliasCode_101
    standardCodeAliases: []
- id: 914
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_84
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_84
    name: VSLOC
- id: 929
  properties:
    _type: Code
    code: C25229
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Left
    id: Code_340
    instanceType: Code
    label: Code_340
- id: 928
  properties:
    _type: ResponseCode
    id: ResponseCode_99
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_99
- id: 931
  properties:
    _type: Code
    code: C25228
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Right
    id: Code_341
    instanceType: Code
    label: Code_341
- id: 930
  properties:
    _type: ResponseCode
    id: ResponseCode_100
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_100
- id: 933
  properties:
    _type: Code
    code: C25185
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laterality
    id: Code_342
    instanceType: Code
    label: Code_342
- id: 932
  properties:
    _type: AliasCode
    id: AliasCode_102
    instanceType: AliasCode
    label: AliasCode_102
    standardCodeAliases: []
- id: 927
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_85
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_85
    name: VSLAT
- id: 935
  properties:
    _type: Code
    code: C25298
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: SYSBP
    id: Code_343
    instanceType: Code
    label: Code_343
- id: 934
  properties:
    _type: AliasCode
    id: AliasCode_103
    instanceType: AliasCode
    label: AliasCode_103
    standardCodeAliases: []
- id: 895
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_14
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_14
    name: Systolic Blood Pressure
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/SYSBP
    synonyms:
    - SYSBP
    - Systolic Blood Pressure
- id: 939
  properties:
    _type: Code
    code: C25299
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: DIABP
    id: Code_344
    instanceType: Code
    label: Code_344
- id: 938
  properties:
    _type: AliasCode
    id: AliasCode_104
    instanceType: AliasCode
    label: AliasCode_104
    standardCodeAliases: []
- id: 937
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_86
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_86
    name: VSTESTCD
    responseCodes: []
- id: 942
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_345
    instanceType: Code
    label: Code_345
- id: 941
  properties:
    _type: AliasCode
    id: AliasCode_105
    instanceType: AliasCode
    label: AliasCode_105
    standardCodeAliases: []
- id: 940
  properties:
    _type: BiomedicalConceptProperty
    datatype: integer
    id: BiomedicalConceptProperty_87
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_87
    name: VSORRES
    responseCodes: []
- id: 945
  properties:
    _type: Code
    code: C49669
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Pressure
    id: Code_346
    instanceType: Code
    label: Code_346
- id: 944
  properties:
    _type: AliasCode
    id: AliasCode_106
    instanceType: AliasCode
    label: AliasCode_106
    standardCodeAliases: []
- id: 943
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_88
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_88
    name: VSORRESU
    responseCodes: []
- id: 948
  properties:
    _type: Code
    code: C62122
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sitting
    id: Code_347
    instanceType: Code
    label: Code_347
- id: 947
  properties:
    _type: ResponseCode
    id: ResponseCode_101
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_101
- id: 950
  properties:
    _type: Code
    code: C62166
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Standing
    id: Code_348
    instanceType: Code
    label: Code_348
- id: 949
  properties:
    _type: ResponseCode
    id: ResponseCode_102
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_102
- id: 952
  properties:
    _type: Code
    code: C62167
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Supine Position
    id: Code_349
    instanceType: Code
    label: Code_349
- id: 951
  properties:
    _type: ResponseCode
    id: ResponseCode_103
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_103
- id: 954
  properties:
    _type: Code
    code: C62164
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Body Position
    id: Code_350
    instanceType: Code
    label: Code_350
- id: 953
  properties:
    _type: AliasCode
    id: AliasCode_107
    instanceType: AliasCode
    label: AliasCode_107
    standardCodeAliases: []
- id: 946
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_89
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_89
    name: VSPOS
- id: 957
  properties:
    _type: Code
    code: C12681
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Brachial Artery
    id: Code_351
    instanceType: Code
    label: Code_351
- id: 956
  properties:
    _type: ResponseCode
    id: ResponseCode_104
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_104
- id: 959
  properties:
    _type: Code
    code: C12687
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Common Carotid Artery
    id: Code_352
    instanceType: Code
    label: Code_352
- id: 958
  properties:
    _type: ResponseCode
    id: ResponseCode_105
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_105
- id: 961
  properties:
    _type: Code
    code: C32478
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Dorsalis Pedis Artery
    id: Code_353
    instanceType: Code
    label: Code_353
- id: 960
  properties:
    _type: ResponseCode
    id: ResponseCode_106
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_106
- id: 963
  properties:
    _type: Code
    code: C12715
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Femoral Artery
    id: Code_354
    instanceType: Code
    label: Code_354
- id: 962
  properties:
    _type: ResponseCode
    id: ResponseCode_107
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_107
- id: 965
  properties:
    _type: Code
    code: C12838
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Radial Artery
    id: Code_355
    instanceType: Code
    label: Code_355
- id: 964
  properties:
    _type: ResponseCode
    id: ResponseCode_108
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_108
- id: 967
  properties:
    _type: Code
    code: C13717
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Anatomic Site
    id: Code_356
    instanceType: Code
    label: Code_356
- id: 966
  properties:
    _type: AliasCode
    id: AliasCode_108
    instanceType: AliasCode
    label: AliasCode_108
    standardCodeAliases: []
- id: 955
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_90
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_90
    name: VSLOC
- id: 970
  properties:
    _type: Code
    code: C25229
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Left
    id: Code_357
    instanceType: Code
    label: Code_357
- id: 969
  properties:
    _type: ResponseCode
    id: ResponseCode_109
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_109
- id: 972
  properties:
    _type: Code
    code: C25228
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Right
    id: Code_358
    instanceType: Code
    label: Code_358
- id: 971
  properties:
    _type: ResponseCode
    id: ResponseCode_110
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_110
- id: 974
  properties:
    _type: Code
    code: C25185
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laterality
    id: Code_359
    instanceType: Code
    label: Code_359
- id: 973
  properties:
    _type: AliasCode
    id: AliasCode_109
    instanceType: AliasCode
    label: AliasCode_109
    standardCodeAliases: []
- id: 968
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_91
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_91
    name: VSLAT
- id: 976
  properties:
    _type: Code
    code: C25299
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: DIABP
    id: Code_360
    instanceType: Code
    label: Code_360
- id: 975
  properties:
    _type: AliasCode
    id: AliasCode_110
    instanceType: AliasCode
    label: AliasCode_110
    standardCodeAliases: []
- id: 936
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_15
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_15
    name: Diastolic Blood Pressure
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/DIABP
    synonyms:
    - DIABP
    - Diastolic Blood Pressure
- id: 980
  properties:
    _type: Code
    code: C49677
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: HR
    id: Code_361
    instanceType: Code
    label: Code_361
- id: 979
  properties:
    _type: AliasCode
    id: AliasCode_111
    instanceType: AliasCode
    label: AliasCode_111
    standardCodeAliases: []
- id: 978
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_92
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_92
    name: VSTESTCD
    responseCodes: []
- id: 983
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_362
    instanceType: Code
    label: Code_362
- id: 982
  properties:
    _type: AliasCode
    id: AliasCode_112
    instanceType: AliasCode
    label: AliasCode_112
    standardCodeAliases: []
- id: 981
  properties:
    _type: BiomedicalConceptProperty
    datatype: integer
    id: BiomedicalConceptProperty_93
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_93
    name: VSORRES
    responseCodes: []
- id: 986
  properties:
    _type: Code
    code: C73688
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Count per Minute
    id: Code_363
    instanceType: Code
    label: Code_363
- id: 985
  properties:
    _type: AliasCode
    id: AliasCode_113
    instanceType: AliasCode
    label: AliasCode_113
    standardCodeAliases: []
- id: 984
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_94
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_94
    name: VSORRESU
    responseCodes: []
- id: 989
  properties:
    _type: Code
    code: C62122
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sitting
    id: Code_364
    instanceType: Code
    label: Code_364
- id: 988
  properties:
    _type: ResponseCode
    id: ResponseCode_111
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_111
- id: 991
  properties:
    _type: Code
    code: C62166
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Standing
    id: Code_365
    instanceType: Code
    label: Code_365
- id: 990
  properties:
    _type: ResponseCode
    id: ResponseCode_112
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_112
- id: 993
  properties:
    _type: Code
    code: C62167
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Supine Position
    id: Code_366
    instanceType: Code
    label: Code_366
- id: 992
  properties:
    _type: ResponseCode
    id: ResponseCode_113
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_113
- id: 995
  properties:
    _type: Code
    code: C62164
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Body Position
    id: Code_367
    instanceType: Code
    label: Code_367
- id: 994
  properties:
    _type: AliasCode
    id: AliasCode_114
    instanceType: AliasCode
    label: AliasCode_114
    standardCodeAliases: []
- id: 987
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_95
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_95
    name: VSPOS
- id: 998
  properties:
    _type: Code
    code: C12681
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Brachial Artery
    id: Code_368
    instanceType: Code
    label: Code_368
- id: 997
  properties:
    _type: ResponseCode
    id: ResponseCode_114
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_114
- id: 1000
  properties:
    _type: Code
    code: C12687
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Common Carotid Artery
    id: Code_369
    instanceType: Code
    label: Code_369
- id: 999
  properties:
    _type: ResponseCode
    id: ResponseCode_115
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_115
- id: 1002
  properties:
    _type: Code
    code: C32478
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Dorsalis Pedis Artery
    id: Code_370
    instanceType: Code
    label: Code_370
- id: 1001
  properties:
    _type: ResponseCode
    id: ResponseCode_116
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_116
- id: 1004
  properties:
    _type: Code
    code: C12715
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Femoral Artery
    id: Code_371
    instanceType: Code
    label: Code_371
- id: 1003
  properties:
    _type: ResponseCode
    id: ResponseCode_117
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_117
- id: 1006
  properties:
    _type: Code
    code: C12838
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Radial Artery
    id: Code_372
    instanceType: Code
    label: Code_372
- id: 1005
  properties:
    _type: ResponseCode
    id: ResponseCode_118
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_118
- id: 1008
  properties:
    _type: Code
    code: C13717
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Anatomic Site
    id: Code_373
    instanceType: Code
    label: Code_373
- id: 1007
  properties:
    _type: AliasCode
    id: AliasCode_115
    instanceType: AliasCode
    label: AliasCode_115
    standardCodeAliases: []
- id: 996
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_96
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_96
    name: VSLOC
- id: 1011
  properties:
    _type: Code
    code: C25229
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Left
    id: Code_374
    instanceType: Code
    label: Code_374
- id: 1010
  properties:
    _type: ResponseCode
    id: ResponseCode_119
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_119
- id: 1013
  properties:
    _type: Code
    code: C25228
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Right
    id: Code_375
    instanceType: Code
    label: Code_375
- id: 1012
  properties:
    _type: ResponseCode
    id: ResponseCode_120
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_120
- id: 1015
  properties:
    _type: Code
    code: C25185
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laterality
    id: Code_376
    instanceType: Code
    label: Code_376
- id: 1014
  properties:
    _type: AliasCode
    id: AliasCode_116
    instanceType: AliasCode
    label: AliasCode_116
    standardCodeAliases: []
- id: 1009
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_97
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_97
    name: VSLAT
- id: 1017
  properties:
    _type: Code
    code: C49677
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: HR
    id: Code_377
    instanceType: Code
    label: Code_377
- id: 1016
  properties:
    _type: AliasCode
    id: AliasCode_117
    instanceType: AliasCode
    label: AliasCode_117
    standardCodeAliases: []
- id: 977
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_16
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_16
    name: Heart Rate
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/HR
    synonyms:
    - Heart Rate
- id: 1021
  properties:
    _type: Code
    code: C25298
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: SYSBP
    id: Code_378
    instanceType: Code
    label: Code_378
- id: 1020
  properties:
    _type: AliasCode
    id: AliasCode_118
    instanceType: AliasCode
    label: AliasCode_118
    standardCodeAliases: []
- id: 1019
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_98
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_98
    name: VSTESTCD
    responseCodes: []
- id: 1024
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_379
    instanceType: Code
    label: Code_379
- id: 1023
  properties:
    _type: AliasCode
    id: AliasCode_119
    instanceType: AliasCode
    label: AliasCode_119
    standardCodeAliases: []
- id: 1022
  properties:
    _type: BiomedicalConceptProperty
    datatype: integer
    id: BiomedicalConceptProperty_99
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_99
    name: VSORRES
    responseCodes: []
- id: 1027
  properties:
    _type: Code
    code: C49669
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Pressure
    id: Code_380
    instanceType: Code
    label: Code_380
- id: 1026
  properties:
    _type: AliasCode
    id: AliasCode_120
    instanceType: AliasCode
    label: AliasCode_120
    standardCodeAliases: []
- id: 1025
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_100
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_100
    name: VSORRESU
    responseCodes: []
- id: 1030
  properties:
    _type: Code
    code: C62122
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sitting
    id: Code_381
    instanceType: Code
    label: Code_381
- id: 1029
  properties:
    _type: ResponseCode
    id: ResponseCode_121
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_121
- id: 1032
  properties:
    _type: Code
    code: C62166
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Standing
    id: Code_382
    instanceType: Code
    label: Code_382
- id: 1031
  properties:
    _type: ResponseCode
    id: ResponseCode_122
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_122
- id: 1034
  properties:
    _type: Code
    code: C62167
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Supine Position
    id: Code_383
    instanceType: Code
    label: Code_383
- id: 1033
  properties:
    _type: ResponseCode
    id: ResponseCode_123
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_123
- id: 1036
  properties:
    _type: Code
    code: C62164
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Body Position
    id: Code_384
    instanceType: Code
    label: Code_384
- id: 1035
  properties:
    _type: AliasCode
    id: AliasCode_121
    instanceType: AliasCode
    label: AliasCode_121
    standardCodeAliases: []
- id: 1028
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_101
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_101
    name: VSPOS
- id: 1039
  properties:
    _type: Code
    code: C12681
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Brachial Artery
    id: Code_385
    instanceType: Code
    label: Code_385
- id: 1038
  properties:
    _type: ResponseCode
    id: ResponseCode_124
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_124
- id: 1041
  properties:
    _type: Code
    code: C12687
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Common Carotid Artery
    id: Code_386
    instanceType: Code
    label: Code_386
- id: 1040
  properties:
    _type: ResponseCode
    id: ResponseCode_125
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_125
- id: 1043
  properties:
    _type: Code
    code: C32478
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Dorsalis Pedis Artery
    id: Code_387
    instanceType: Code
    label: Code_387
- id: 1042
  properties:
    _type: ResponseCode
    id: ResponseCode_126
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_126
- id: 1045
  properties:
    _type: Code
    code: C12715
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Femoral Artery
    id: Code_388
    instanceType: Code
    label: Code_388
- id: 1044
  properties:
    _type: ResponseCode
    id: ResponseCode_127
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_127
- id: 1047
  properties:
    _type: Code
    code: C12838
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Radial Artery
    id: Code_389
    instanceType: Code
    label: Code_389
- id: 1046
  properties:
    _type: ResponseCode
    id: ResponseCode_128
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_128
- id: 1049
  properties:
    _type: Code
    code: C13717
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Anatomic Site
    id: Code_390
    instanceType: Code
    label: Code_390
- id: 1048
  properties:
    _type: AliasCode
    id: AliasCode_122
    instanceType: AliasCode
    label: AliasCode_122
    standardCodeAliases: []
- id: 1037
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_102
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_102
    name: VSLOC
- id: 1052
  properties:
    _type: Code
    code: C25229
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Left
    id: Code_391
    instanceType: Code
    label: Code_391
- id: 1051
  properties:
    _type: ResponseCode
    id: ResponseCode_129
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_129
- id: 1054
  properties:
    _type: Code
    code: C25228
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Right
    id: Code_392
    instanceType: Code
    label: Code_392
- id: 1053
  properties:
    _type: ResponseCode
    id: ResponseCode_130
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_130
- id: 1056
  properties:
    _type: Code
    code: C25185
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laterality
    id: Code_393
    instanceType: Code
    label: Code_393
- id: 1055
  properties:
    _type: AliasCode
    id: AliasCode_123
    instanceType: AliasCode
    label: AliasCode_123
    standardCodeAliases: []
- id: 1050
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_103
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_103
    name: VSLAT
- id: 1058
  properties:
    _type: Code
    code: C25298
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: SYSBP
    id: Code_394
    instanceType: Code
    label: Code_394
- id: 1057
  properties:
    _type: AliasCode
    id: AliasCode_124
    instanceType: AliasCode
    label: AliasCode_124
    standardCodeAliases: []
- id: 1018
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_17
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_17
    name: Systolic Blood Pressure
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/SYSBP
    synonyms:
    - SYSBP
    - Systolic Blood Pressure
- id: 1062
  properties:
    _type: Code
    code: C25299
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: DIABP
    id: Code_395
    instanceType: Code
    label: Code_395
- id: 1061
  properties:
    _type: AliasCode
    id: AliasCode_125
    instanceType: AliasCode
    label: AliasCode_125
    standardCodeAliases: []
- id: 1060
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_104
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_104
    name: VSTESTCD
    responseCodes: []
- id: 1065
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_396
    instanceType: Code
    label: Code_396
- id: 1064
  properties:
    _type: AliasCode
    id: AliasCode_126
    instanceType: AliasCode
    label: AliasCode_126
    standardCodeAliases: []
- id: 1063
  properties:
    _type: BiomedicalConceptProperty
    datatype: integer
    id: BiomedicalConceptProperty_105
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_105
    name: VSORRES
    responseCodes: []
- id: 1068
  properties:
    _type: Code
    code: C49669
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Unit of Pressure
    id: Code_397
    instanceType: Code
    label: Code_397
- id: 1067
  properties:
    _type: AliasCode
    id: AliasCode_127
    instanceType: AliasCode
    label: AliasCode_127
    standardCodeAliases: []
- id: 1066
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_106
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_106
    name: VSORRESU
    responseCodes: []
- id: 1071
  properties:
    _type: Code
    code: C62122
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sitting
    id: Code_398
    instanceType: Code
    label: Code_398
- id: 1070
  properties:
    _type: ResponseCode
    id: ResponseCode_131
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_131
- id: 1073
  properties:
    _type: Code
    code: C62166
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Standing
    id: Code_399
    instanceType: Code
    label: Code_399
- id: 1072
  properties:
    _type: ResponseCode
    id: ResponseCode_132
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_132
- id: 1075
  properties:
    _type: Code
    code: C62167
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Supine Position
    id: Code_400
    instanceType: Code
    label: Code_400
- id: 1074
  properties:
    _type: ResponseCode
    id: ResponseCode_133
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_133
- id: 1077
  properties:
    _type: Code
    code: C62164
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Body Position
    id: Code_401
    instanceType: Code
    label: Code_401
- id: 1076
  properties:
    _type: AliasCode
    id: AliasCode_128
    instanceType: AliasCode
    label: AliasCode_128
    standardCodeAliases: []
- id: 1069
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_107
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_107
    name: VSPOS
- id: 1080
  properties:
    _type: Code
    code: C12681
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Brachial Artery
    id: Code_402
    instanceType: Code
    label: Code_402
- id: 1079
  properties:
    _type: ResponseCode
    id: ResponseCode_134
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_134
- id: 1082
  properties:
    _type: Code
    code: C12687
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Common Carotid Artery
    id: Code_403
    instanceType: Code
    label: Code_403
- id: 1081
  properties:
    _type: ResponseCode
    id: ResponseCode_135
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_135
- id: 1084
  properties:
    _type: Code
    code: C32478
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Dorsalis Pedis Artery
    id: Code_404
    instanceType: Code
    label: Code_404
- id: 1083
  properties:
    _type: ResponseCode
    id: ResponseCode_136
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_136
- id: 1086
  properties:
    _type: Code
    code: C12715
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Femoral Artery
    id: Code_405
    instanceType: Code
    label: Code_405
- id: 1085
  properties:
    _type: ResponseCode
    id: ResponseCode_137
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_137
- id: 1088
  properties:
    _type: Code
    code: C12838
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Radial Artery
    id: Code_406
    instanceType: Code
    label: Code_406
- id: 1087
  properties:
    _type: ResponseCode
    id: ResponseCode_138
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_138
- id: 1090
  properties:
    _type: Code
    code: C13717
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Anatomic Site
    id: Code_407
    instanceType: Code
    label: Code_407
- id: 1089
  properties:
    _type: AliasCode
    id: AliasCode_129
    instanceType: AliasCode
    label: AliasCode_129
    standardCodeAliases: []
- id: 1078
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_108
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_108
    name: VSLOC
- id: 1093
  properties:
    _type: Code
    code: C25229
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Left
    id: Code_408
    instanceType: Code
    label: Code_408
- id: 1092
  properties:
    _type: ResponseCode
    id: ResponseCode_139
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_139
- id: 1095
  properties:
    _type: Code
    code: C25228
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Right
    id: Code_409
    instanceType: Code
    label: Code_409
- id: 1094
  properties:
    _type: ResponseCode
    id: ResponseCode_140
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_140
- id: 1097
  properties:
    _type: Code
    code: C25185
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laterality
    id: Code_410
    instanceType: Code
    label: Code_410
- id: 1096
  properties:
    _type: AliasCode
    id: AliasCode_130
    instanceType: AliasCode
    label: AliasCode_130
    standardCodeAliases: []
- id: 1091
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_109
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_109
    name: VSLAT
- id: 1099
  properties:
    _type: Code
    code: C25299
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: DIABP
    id: Code_411
    instanceType: Code
    label: Code_411
- id: 1098
  properties:
    _type: AliasCode
    id: AliasCode_131
    instanceType: AliasCode
    label: AliasCode_131
    standardCodeAliases: []
- id: 1059
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_18
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_18
    name: Diastolic Blood Pressure
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/DIABP
    synonyms:
    - DIABP
    - Diastolic Blood Pressure
- id: 1103
  properties:
    _type: Code
    code: C49677
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: HR
    id: Code_412
    instanceType: Code
    label: Code_412
- id: 1102
  properties:
    _type: AliasCode
    id: AliasCode_132
    instanceType: AliasCode
    label: AliasCode_132
    standardCodeAliases: []
- id: 1101
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_110
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_110
    name: VSTESTCD
    responseCodes: []
- id: 1106
  properties:
    _type: Code
    code: C77140
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Test Result
    id: Code_413
    instanceType: Code
    label: Code_413
- id: 1105
  properties:
    _type: AliasCode
    id: AliasCode_133
    instanceType: AliasCode
    label: AliasCode_133
    standardCodeAliases: []
- id: 1104
  properties:
    _type: BiomedicalConceptProperty
    datatype: integer
    id: BiomedicalConceptProperty_111
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_111
    name: VSORRES
    responseCodes: []
- id: 1109
  properties:
    _type: Code
    code: C73688
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Count per Minute
    id: Code_414
    instanceType: Code
    label: Code_414
- id: 1108
  properties:
    _type: AliasCode
    id: AliasCode_134
    instanceType: AliasCode
    label: AliasCode_134
    standardCodeAliases: []
- id: 1107
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_112
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_112
    name: VSORRESU
    responseCodes: []
- id: 1112
  properties:
    _type: Code
    code: C62122
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sitting
    id: Code_415
    instanceType: Code
    label: Code_415
- id: 1111
  properties:
    _type: ResponseCode
    id: ResponseCode_141
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_141
- id: 1114
  properties:
    _type: Code
    code: C62166
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Standing
    id: Code_416
    instanceType: Code
    label: Code_416
- id: 1113
  properties:
    _type: ResponseCode
    id: ResponseCode_142
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_142
- id: 1116
  properties:
    _type: Code
    code: C62167
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Supine Position
    id: Code_417
    instanceType: Code
    label: Code_417
- id: 1115
  properties:
    _type: ResponseCode
    id: ResponseCode_143
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_143
- id: 1118
  properties:
    _type: Code
    code: C62164
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Body Position
    id: Code_418
    instanceType: Code
    label: Code_418
- id: 1117
  properties:
    _type: AliasCode
    id: AliasCode_135
    instanceType: AliasCode
    label: AliasCode_135
    standardCodeAliases: []
- id: 1110
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_113
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_113
    name: VSPOS
- id: 1121
  properties:
    _type: Code
    code: C12681
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Brachial Artery
    id: Code_419
    instanceType: Code
    label: Code_419
- id: 1120
  properties:
    _type: ResponseCode
    id: ResponseCode_144
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_144
- id: 1123
  properties:
    _type: Code
    code: C12687
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Common Carotid Artery
    id: Code_420
    instanceType: Code
    label: Code_420
- id: 1122
  properties:
    _type: ResponseCode
    id: ResponseCode_145
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_145
- id: 1125
  properties:
    _type: Code
    code: C32478
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Dorsalis Pedis Artery
    id: Code_421
    instanceType: Code
    label: Code_421
- id: 1124
  properties:
    _type: ResponseCode
    id: ResponseCode_146
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_146
- id: 1127
  properties:
    _type: Code
    code: C12715
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Femoral Artery
    id: Code_422
    instanceType: Code
    label: Code_422
- id: 1126
  properties:
    _type: ResponseCode
    id: ResponseCode_147
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_147
- id: 1129
  properties:
    _type: Code
    code: C12838
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Radial Artery
    id: Code_423
    instanceType: Code
    label: Code_423
- id: 1128
  properties:
    _type: ResponseCode
    id: ResponseCode_148
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_148
- id: 1131
  properties:
    _type: Code
    code: C13717
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Anatomic Site
    id: Code_424
    instanceType: Code
    label: Code_424
- id: 1130
  properties:
    _type: AliasCode
    id: AliasCode_136
    instanceType: AliasCode
    label: AliasCode_136
    standardCodeAliases: []
- id: 1119
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_114
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_114
    name: VSLOC
- id: 1134
  properties:
    _type: Code
    code: C25229
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Left
    id: Code_425
    instanceType: Code
    label: Code_425
- id: 1133
  properties:
    _type: ResponseCode
    id: ResponseCode_149
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_149
- id: 1136
  properties:
    _type: Code
    code: C25228
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Right
    id: Code_426
    instanceType: Code
    label: Code_426
- id: 1135
  properties:
    _type: ResponseCode
    id: ResponseCode_150
    instanceType: ResponseCode
    isEnabled: true
    label: ResponseCode_150
- id: 1138
  properties:
    _type: Code
    code: C25185
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Laterality
    id: Code_427
    instanceType: Code
    label: Code_427
- id: 1137
  properties:
    _type: AliasCode
    id: AliasCode_137
    instanceType: AliasCode
    label: AliasCode_137
    standardCodeAliases: []
- id: 1132
  properties:
    _type: BiomedicalConceptProperty
    datatype: ''
    id: BiomedicalConceptProperty_115
    instanceType: BiomedicalConceptProperty
    isEnabled: true
    isRequired: true
    label: BiomedicalConceptProperty_115
    name: VSLAT
- id: 1140
  properties:
    _type: Code
    code: C49677
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: HR
    id: Code_428
    instanceType: Code
    label: Code_428
- id: 1139
  properties:
    _type: AliasCode
    id: AliasCode_138
    instanceType: AliasCode
    label: AliasCode_138
    standardCodeAliases: []
- id: 1100
  properties:
    _type: BiomedicalConcept
    id: BiomedicalConcept_19
    instanceType: BiomedicalConcept
    label: BiomedicalConcept_19
    name: Heart Rate
    reference: /mdr/specializations/sdtm/packages/2023-12-12/datasetspecializations/HR
    synonyms:
    - Heart Rate
- id: 1141
  properties:
    _type: BiomedicalConceptSurrogate
    description: Date of Birth
    id: BiomedicalConceptSurrogate_1
    instanceType: BiomedicalConceptSurrogate
    label: BiomedicalConceptSurrogate_1
    name: Date of Birth
    reference: None set
- id: 1143
  properties:
    _type: Code
    code: C174268
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Placebo Comparator Arm
    id: Code_123
    instanceType: Code
    label: Code_123
- id: 1144
  properties:
    _type: Code
    code: C188866
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Data Generated Within Study
    id: Code_124
    instanceType: Code
    label: Code_124
- id: 1142
  properties:
    _type: StudyArm
    dataOriginDescription: Data collected from subjects
    description: Placebo
    id: StudyArm_1
    instanceType: StudyArm
    label: StudyArm_1
    name: Placebo
- id: 1146
  properties:
    _type: Code
    code: C174267
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Active Comparator Arm
    id: Code_125
    instanceType: Code
    label: Code_125
- id: 1147
  properties:
    _type: Code
    code: C188866
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Data Generated Within Study
    id: Code_126
    instanceType: Code
    label: Code_126
- id: 1145
  properties:
    _type: StudyArm
    dataOriginDescription: Data collected from subjects
    description: Active Substance
    id: StudyArm_2
    instanceType: StudyArm
    label: StudyArm_2
    name: Xanomeline Low Dose
- id: 1149
  properties:
    _type: Code
    code: C174267
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Active Comparator Arm
    id: Code_127
    instanceType: Code
    label: Code_127
- id: 1150
  properties:
    _type: Code
    code: C188866
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Data Generated Within Study
    id: Code_128
    instanceType: Code
    label: Code_128
- id: 1148
  properties:
    _type: StudyArm
    dataOriginDescription: Data collected from subjects
    description: Active Substance
    id: StudyArm_3
    instanceType: StudyArm
    label: StudyArm_3
    name: Xanomeline High Dose
- id: 1151
  properties:
    _type: StudyCell
    id: StudyCell_1
    instanceType: StudyCell
    label: StudyCell_1
- id: 1152
  properties:
    _type: StudyCell
    id: StudyCell_2
    instanceType: StudyCell
    label: StudyCell_2
- id: 1153
  properties:
    _type: StudyCell
    id: StudyCell_3
    instanceType: StudyCell
    label: StudyCell_3
- id: 1154
  properties:
    _type: StudyCell
    id: StudyCell_4
    instanceType: StudyCell
    label: StudyCell_4
- id: 1155
  properties:
    _type: StudyCell
    id: StudyCell_5
    instanceType: StudyCell
    label: StudyCell_5
- id: 1156
  properties:
    _type: StudyCell
    id: StudyCell_6
    instanceType: StudyCell
    label: StudyCell_6
- id: 1157
  properties:
    _type: StudyCell
    id: StudyCell_7
    instanceType: StudyCell
    label: StudyCell_7
- id: 1158
  properties:
    _type: StudyCell
    id: StudyCell_8
    instanceType: StudyCell
    label: StudyCell_8
- id: 1159
  properties:
    _type: StudyCell
    id: StudyCell_9
    instanceType: StudyCell
    label: StudyCell_9
- id: 1160
  properties:
    _type: StudyCell
    id: StudyCell_10
    instanceType: StudyCell
    label: StudyCell_10
- id: 1161
  properties:
    _type: StudyCell
    id: StudyCell_11
    instanceType: StudyCell
    label: StudyCell_11
- id: 1162
  properties:
    _type: StudyCell
    id: StudyCell_12
    instanceType: StudyCell
    label: StudyCell_12
- id: 1163
  properties:
    _type: StudyCell
    id: StudyCell_13
    instanceType: StudyCell
    label: StudyCell_13
- id: 1164
  properties:
    _type: StudyCell
    id: StudyCell_14
    instanceType: StudyCell
    label: StudyCell_14
- id: 1165
  properties:
    _type: StudyCell
    id: StudyCell_15
    instanceType: StudyCell
    label: StudyCell_15
- id: 1167
  properties:
    _type: Code
    code: C15228
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Double Blind Study
    id: Code_136
    instanceType: Code
    label: Code_136
- id: 1166
  properties:
    _type: AliasCode
    id: AliasCode_4
    instanceType: AliasCode
    label: AliasCode_4
    standardCodeAliases: []
- id: 1169
  properties:
    _type: Code
    code: C202487
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Screening Epoch
    id: Code_129
    instanceType: Code
    label: Code_129
- id: 1168
  properties:
    _type: StudyEpoch
    description: Screening Epoch
    id: StudyEpoch_1
    instanceType: StudyEpoch
    label: StudyEpoch_1
    name: Screening
- id: 1171
  properties:
    _type: Code
    code: C101526
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Treatment Epoch
    id: Code_130
    instanceType: Code
    label: Code_130
- id: 1170
  properties:
    _type: StudyEpoch
    description: Treatment Epoch
    id: StudyEpoch_2
    instanceType: StudyEpoch
    label: StudyEpoch_2
    name: Treatment 1
- id: 1173
  properties:
    _type: Code
    code: C101526
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Treatment Epoch
    id: Code_131
    instanceType: Code
    label: Code_131
- id: 1172
  properties:
    _type: StudyEpoch
    description: Treatment Epoch
    id: StudyEpoch_3
    instanceType: StudyEpoch
    label: StudyEpoch_3
    name: Treatment 2
- id: 1175
  properties:
    _type: Code
    code: C101526
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Treatment Epoch
    id: Code_132
    instanceType: Code
    label: Code_132
- id: 1174
  properties:
    _type: StudyEpoch
    description: Treatment Epoch
    id: StudyEpoch_4
    instanceType: StudyEpoch
    label: StudyEpoch_4
    name: Treatment 3
- id: 1177
  properties:
    _type: Code
    code: C202578
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Follow-Up Epoch
    id: Code_133
    instanceType: Code
    label: Code_133
- id: 1176
  properties:
    _type: StudyEpoch
    description: Follow-up Epoch
    id: StudyEpoch_5
    instanceType: StudyEpoch
    label: StudyEpoch_5
    name: Follow-Up
- id: 1179
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_7
    instanceType: TransitionRule
    label: TransitionRule_7
    name: ELEMENT_START_RULE_1
    text: Informed consent
- id: 1180
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_8
    instanceType: TransitionRule
    label: TransitionRule_8
    name: ELEMENT_END_RULE_1
    text: Completion of all screening activities and no more than 2 weeks from informed
      consent
- id: 1178
  properties:
    _type: StudyElement
    description: Screening Element
    id: StudyElement_1
    instanceType: StudyElement
    label: StudyElement_1
    name: EL1
- id: 1182
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_9
    instanceType: TransitionRule
    label: TransitionRule_9
    name: ELEMENT_START_RULE_2
    text: "Administration\_of\_first\_dose"
- id: 1181
  properties:
    _type: StudyElement
    description: Placebo TTS (adhesive patches)
    id: StudyElement_2
    instanceType: StudyElement
    label: StudyElement_2
    name: EL2
    transitionEndRule: null
- id: 1184
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_14
    instanceType: TransitionRule
    label: TransitionRule_14
    name: ELEMENT_START_RULE_7
    text: "End\_of\_last\_scheduled\_visit\_on\_study\_(including\_early\_termination)"
- id: 1185
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_15
    instanceType: TransitionRule
    label: TransitionRule_15
    name: ELEMENT_END_RULE_7
    text: "Completion\_of\_all\_specified\_followup\_activities\_(which\_vary\_on\_\
      a\_patient-by-patient\_basis)"
- id: 1183
  properties:
    _type: StudyElement
    description: Follow Up Element
    id: StudyElement_7
    instanceType: StudyElement
    label: StudyElement_7
    name: EL7
- id: 1187
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_10
    instanceType: TransitionRule
    label: TransitionRule_10
    name: ELEMENT_START_RULE_3
    text: "Administration\_of\_first\_dose"
- id: 1186
  properties:
    _type: StudyElement
    description: Xanomeline TTS (adhesive patches) 50 cm2, 54 mg
    id: StudyElement_3
    instanceType: StudyElement
    label: StudyElement_3
    name: EL3
    transitionEndRule: null
- id: 1189
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_11
    instanceType: TransitionRule
    label: TransitionRule_11
    name: ELEMENT_START_RULE_4
    text: Randomized
- id: 1188
  properties:
    _type: StudyElement
    description: Xanomeline TTS (adhesive patches) 50 cm2, 54 mg
    id: StudyElement_4
    instanceType: StudyElement
    label: StudyElement_4
    name: EL4
    transitionEndRule: null
- id: 1191
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_12
    instanceType: TransitionRule
    label: TransitionRule_12
    name: ELEMENT_START_RULE_5
    text: "Administration\_of\_first\_dose\_(from\_patches\_supplied\_at\_Visit\_\
      4)"
- id: 1190
  properties:
    _type: StudyElement
    description: Xanomeline TTS (adhesive patches) 50 cm2, 54 mg + 25 cm2, 27 mg
    id: StudyElement_5
    instanceType: StudyElement
    label: StudyElement_5
    name: EL5
    transitionEndRule: null
- id: 1193
  properties:
    _type: TransitionRule
    description: null
    id: TransitionRule_13
    instanceType: TransitionRule
    label: TransitionRule_13
    name: ELEMENT_START_RULE_6
    text: "Administration\_of\_first\_dose\_(from\_patches\_supplied\_at\_Visit\_\
      12)"
- id: 1192
  properties:
    _type: StudyElement
    description: Xanomeline TTS (adhesive patches) 50 cm2, 54 mg
    id: StudyElement_6
    instanceType: StudyElement
    label: StudyElement_6
    name: EL6
    transitionEndRule: null
- id: 1195
  properties:
    _type: Code
    code: G30.9
    codeSystem: ICD-10-CM
    codeSystemVersion: '1'
    decode: Alzheimer's disease; unspecified
    id: Code_546
    instanceType: Code
    label: Code_546
- id: 1194
  properties:
    _type: Indication
    description: Alzheimer's disease
    id: Indication_1
    instanceType: Indication
    isRareDisease: false
    label: Indication_1
    name: IND1
- id: 1197
  properties:
    _type: Code
    code: '26929004'
    codeSystem: SNOMED
    codeSystemVersion: January 31, 2018
    decode: Alzheimer's disease
    id: Code_547
    instanceType: Code
    label: Code_547
- id: 1196
  properties:
    _type: Indication
    description: Alzheimer's disease
    id: Indication_2
    instanceType: Indication
    isRareDisease: false
    label: Indication_2
    name: IND2
- id: 1199
  properties:
    _type: Code
    code: C70793
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Sponsor
    id: Code_142
    instanceType: Code
    label: Code_142
- id: 1198
  properties:
    _type: Masking
    description: This is the sponsor masking description
    id: Masking_1
    instanceType: Masking
    label: Masking_1
- id: 1201
  properties:
    _type: Code
    code: C85826
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Trial Primary Objective
    id: Code_551
    instanceType: Code
    label: Code_551
- id: 1203
  properties:
    _type: Code
    code: C94496
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Primary Endpoint
    id: Code_550
    instanceType: Code
    label: Code_550
- id: 1202
  properties:
    _type: Endpoint
    description: ''
    id: Endpoint_1
    instanceType: Endpoint
    label: Endpoint_1
    name: END1
    purpose: ''
    text: Alzheimer's Disease Assessment Scale - Cognitive Subscale, total of 11 items
      [ADAS-Cog (11)] at Week 24
- id: 1205
  properties:
    _type: Code
    code: C94496
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Primary Endpoint
    id: Code_552
    instanceType: Code
    label: Code_552
- id: 1204
  properties:
    _type: Endpoint
    description: ''
    id: Endpoint_2
    instanceType: Endpoint
    label: Endpoint_2
    name: END2
    purpose: ''
    text: "Video-referenced Clinician\u2019s Interview-based Impression of Change\
      \ (CIBIC+) at Week 24"
- id: 1200
  properties:
    _type: Objective
    description: Main objective
    id: Objective_1
    instanceType: Objective
    label: Objective_1
    name: OBJ1
    text: To determine if there is a statistically significant relationship (overall
      Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+
      scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).
- id: 1207
  properties:
    _type: Code
    code: C85826
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Trial Primary Objective
    id: Code_554
    instanceType: Code
    label: Code_554
- id: 1209
  properties:
    _type: Code
    code: C94496
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Primary Endpoint
    id: Code_553
    instanceType: Code
    label: Code_553
- id: 1208
  properties:
    _type: Endpoint
    description: ''
    id: Endpoint_3
    instanceType: Endpoint
    label: Endpoint_3
    name: END3
    purpose: ''
    text: Adverse events
- id: 1211
  properties:
    _type: Code
    code: C94496
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Primary Endpoint
    id: Code_555
    instanceType: Code
    label: Code_555
- id: 1210
  properties:
    _type: Endpoint
    description: ''
    id: Endpoint_4
    instanceType: Endpoint
    label: Endpoint_4
    name: END4
    purpose: ''
    text: Vital signs (weight, standing and supine blood pressure, heart rate)
- id: 1213
  properties:
    _type: Code
    code: C94496
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Primary Endpoint
    id: Code_556
    instanceType: Code
    label: Code_556
- id: 1212
  properties:
    _type: Endpoint
    description: The change from baseline laboratory value will be  calculated as
      the difference between the baseline lab value and the endpoint value (i.e.,
      the value at the specified visit) or the end of treatment observation
    id: Endpoint_5
    instanceType: Endpoint
    label: Endpoint_5
    name: END5
    purpose: ''
    text: Laboratory evaluations (Change from Baseline)
- id: 1206
  properties:
    _type: Objective
    description: Safety
    id: Objective_2
    instanceType: Objective
    label: Objective_2
    name: OBJ2
    text: To document the safety profile of the xanomeline TTS.
- id: 1215
  properties:
    _type: Code
    code: C85827
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Trial Secondary Objective
    id: Code_558
    instanceType: Code
    label: Code_558
- id: 1217
  properties:
    _type: Code
    code: C139173
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Secondary Endpoint
    id: Code_557
    instanceType: Code
    label: Code_557
- id: 1216
  properties:
    _type: Endpoint
    description: ''
    id: Endpoint_6
    instanceType: Endpoint
    label: Endpoint_6
    name: END6
    purpose: ''
    text: Alzheimer's Disease Assessment Scale - Cognitive Subscale, total of 11 items
      [ADAS-Cog (11)] at Weeks 8 and 16
- id: 1219
  properties:
    _type: Code
    code: C139173
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Secondary Endpoint
    id: Code_559
    instanceType: Code
    label: Code_559
- id: 1218
  properties:
    _type: Endpoint
    description: ''
    id: Endpoint_7
    instanceType: Endpoint
    label: Endpoint_7
    name: END7
    purpose: ''
    text: "Video-referenced Clinician\u2019s Interview-based Impression of Change\
      \ (CIBIC+) at Weeks 8 and 16"
- id: 1221
  properties:
    _type: Code
    code: C139173
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Secondary Endpoint
    id: Code_560
    instanceType: Code
    label: Code_560
- id: 1220
  properties:
    _type: Endpoint
    description: ''
    id: Endpoint_8
    instanceType: Endpoint
    label: Endpoint_8
    name: END8
    purpose: ''
    text: Mean Revised Neuropsychiatric Inventory (NPI-X) from Week 4 to Week 24
- id: 1214
  properties:
    _type: Objective
    description: Behaviour
    id: Objective_3
    instanceType: Objective
    label: Objective_3
    name: OBJ3
    text: 'To assess the dose-dependent improvement in behavior. Improved scores on
      the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in
      these

      areas.'
- id: 1223
  properties:
    _type: Code
    code: C85827
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Trial Secondary Objective
    id: Code_562
    instanceType: Code
    label: Code_562
- id: 1225
  properties:
    _type: Code
    code: C139173
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Secondary Endpoint
    id: Code_561
    instanceType: Code
    label: Code_561
- id: 1224
  properties:
    _type: Endpoint
    description: ''
    id: Endpoint_9
    instanceType: Endpoint
    label: Endpoint_9
    name: END9
    purpose: ''
    text: '*** To be determined from protocol ***'
- id: 1222
  properties:
    _type: Objective
    description: ''
    id: Objective_4
    instanceType: Objective
    label: Objective_4
    name: OBJ4
    text: To assess the dose-dependent improvements in activities of daily living.
      Improved scores on the Disability Assessment for Dementia (DAD) will indicate
      improvement in these areas (see Attachment LZZT.5).
- id: 1227
  properties:
    _type: Code
    code: C85827
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Trial Secondary Objective
    id: Code_564
    instanceType: Code
    label: Code_564
- id: 1229
  properties:
    _type: Code
    code: C139173
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Secondary Endpoint
    id: Code_563
    instanceType: Code
    label: Code_563
- id: 1228
  properties:
    _type: Endpoint
    description: ''
    id: Endpoint_10
    instanceType: Endpoint
    label: Endpoint_10
    name: END10
    purpose: ''
    text: '*** To be determined from protocol ***'
- id: 1226
  properties:
    _type: Objective
    description: ''
    id: Objective_5
    instanceType: Objective
    label: Objective_5
    name: OBJ5
    text: To assess the dose-dependent improvements in an extended assessment of cognition
      that integrates attention/concentration tasks. The Alzheimer's Disease Assessment
      Scale-14 item Cognitive Subscale, hereafter referred to as ADAS-Cog (14), will
      be used for this assessment (see Attachment LZZT.2).
- id: 1231
  properties:
    _type: Code
    code: C85827
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Trial Secondary Objective
    id: Code_566
    instanceType: Code
    label: Code_566
- id: 1233
  properties:
    _type: Code
    code: C139173
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Secondary Endpoint
    id: Code_565
    instanceType: Code
    label: Code_565
- id: 1232
  properties:
    _type: Endpoint
    description: ''
    id: Endpoint_11
    instanceType: Endpoint
    label: Endpoint_11
    name: END11
    purpose: ''
    text: '*** To be determined from protocol ***'
- id: 1230
  properties:
    _type: Objective
    description: ''
    id: Objective_6
    instanceType: Objective
    label: Objective_6
    name: OBJ6
    text: To assess the treatment response as a function of Apo E genotype.
- id: 1235
  properties:
    _type: Range
    id: Range_2
    instanceType: Range
    isApproximate: false
    label: Range_2
    maxValue: 300.0
    minValue: 300.0
    unit: null
- id: 1236
  properties:
    _type: Range
    id: Range_1
    instanceType: Range
    isApproximate: false
    label: Range_1
    maxValue: 300.0
    minValue: 300.0
    unit: null
- id: 1237
  properties:
    _type: Code
    code: C49636
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Both
    id: Code_549
    instanceType: Code
    label: Code_549
- id: 1239
  properties:
    _type: Code
    code: C25532
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Inclusion Criteria
    id: Code_567
    instanceType: Code
    label: Code_567
- id: 1238
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_1
    identifier: '01'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_1
    name: IN01
    text: <p>Males and postmenopausal females at least <usdm:tag name="min_age"/>
      years of age.</p>
- id: 1241
  properties:
    _type: Code
    code: C25532
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Inclusion Criteria
    id: Code_568
    instanceType: Code
    label: Code_568
- id: 1240
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_2
    identifier: '02'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_2
    name: IN02
    text: <p><usdm:tag name="StudyPopulation"/> as defined by National Institute of
      Neurological and Communicative Disorders and Stroke (NINCDS) and the Alzheimer's
      Disease and Related Disorders Association (ADRDA) guidelines (Attachment LZZT.7).</p>
- id: 1243
  properties:
    _type: Code
    code: C25532
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Inclusion Criteria
    id: Code_569
    instanceType: Code
    label: Code_569
- id: 1242
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_3
    identifier: '03'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_3
    name: IN03
    text: <p><usdm:tag name="Activity1"/> score of 10 to 23.</p>
- id: 1245
  properties:
    _type: Code
    code: C25532
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Inclusion Criteria
    id: Code_570
    instanceType: Code
    label: Code_570
- id: 1244
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_4
    identifier: '04'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_4
    name: IN04
    text: "<p><usdm:tag name=\"Activity2\"/>  score of \u22644 (Attachment LZZT.8).</p>"
- id: 1247
  properties:
    _type: Code
    code: C25532
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Inclusion Criteria
    id: Code_571
    instanceType: Code
    label: Code_571
- id: 1246
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_5
    identifier: '05'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_5
    name: IN05
    text: "<p>CNS imaging (CT scan or MRI of brain) compatible with AD within past\
      \ 1 year.</p>\n<p>The following findings are incompatible with AD:</p>\n<ol\
      \ type=\"a\">\n  <li>\n    <p>Large vessel strokes</p>\n    <ol>\n      <li>\n\
      \        <p>Any definite area of encephalomalacia consistent with ischemic necrosis\
      \ in any cerebral artery territory.</p>\n      </li>\n      <li>\n        <p>Large,\
      \ confluent areas of encephalomalacia in parieto-occipital or frontal regions\
      \ consistent with watershed\n          infarcts.</p>\n        <p>The above are\
      \ exclusionary. Exceptions are made for small areas of cortical asymmetry which\
      \ may represent a\n          small cortical stroke or a focal area of atrophy\
      \ provided there is no abnormal signal intensity in the\n          immediately\
      \ underlying parenchyma. Only one such questionable area allowed per scan, and\
      \ size is restricted to\n          \u22641cm in frontal/parietal/temporal cortices\
      \ and \u22642 cm in occipital cortex.</p>\n      </li>\n    </ol>\n  </li>\n\
      \  <li>\n    <p>Small vessel ischemia</p>\n    <ol>\n      <li>\n        <p>Lacunar\
      \ infarct is defined as an area of abnormal intensity seen on CT scan or on\
      \ both T1 and T2 weighted MRI\n          images in the basal ganglia, thalamus\
      \ or deep white matter which is \u22641 cm in maximal diameter. A maximum of\n\
      \          one\n          lacune is allowed per scan.</p>\n      </li>\n   \
      \   <li>\n        <p>Leukoariosis or leukoencephalopathy is regarded as an abnormality\
      \ seen on T2 but not T1 weighted MRIs, or on\n          CT. This is accepted\
      \ if mild or moderate in extent, meaning involvement of less than 25% of cortical\
      \ white\n          matter.\n      </li>\n    </ol>\n  </li>\n  <li>\n    <p>Miscellaneous</p>\n\
      \    <ol>\n      <li>\n        <p>Benign small extra-axial tumors (ie, meningiomas)\
      \ are accepted if they do not contact or indent the brain\n          parenchyma.</p>\n\
      \      </li>\n      <li>\n        <p>Small extra-axial arachnoid cysts are accepted\
      \ if they do not indent or deform the brain parenchyma.</p>\n      </li>\n \
      \   </ol>\n  </li>\n</ol>"
- id: 1249
  properties:
    _type: Code
    code: C25532
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Inclusion Criteria
    id: Code_572
    instanceType: Code
    label: Code_572
- id: 1248
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_6
    identifier: '06'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_6
    name: IN06
    text: <p>Investigator has obtained informed consent signed by the patient (and/or
      legal representative) and by the caregiver.</p>
- id: 1251
  properties:
    _type: Code
    code: C25532
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Inclusion Criteria
    id: Code_573
    instanceType: Code
    label: Code_573
- id: 1250
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_7
    identifier: '07'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_7
    name: IN07
    text: <p>Geographic proximity to investigator's site that allows adequate follow-up.</p>
- id: 1253
  properties:
    _type: Code
    code: C25532
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Inclusion Criteria
    id: Code_574
    instanceType: Code
    label: Code_574
- id: 1252
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_8
    identifier: 08
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_8
    name: IN08
    text: <p>A reliable caregiver who is in frequent or daily contact with the patient
      and who will accompany the patient to the office and/or be available by telephone
      at designated times, will monitor administration of prescribed medications,
      and will be responsible for the overall care of the patient at home. The caregiver
      and the patient must be able to communicate in English and willing to comply
      with 26 weeks of transdermal therapy.</p>
- id: 1255
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_575
    instanceType: Code
    label: Code_575
- id: 1254
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_9
    identifier: 09
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_9
    name: EX01
    text: <p>Persons who have previously completed or withdrawn from this study or
      any other study investigating xanomeline TTS or the oral formulation of xanomeline.</p>
- id: 1257
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_576
    instanceType: Code
    label: Code_576
- id: 1256
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_10
    identifier: '10'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_10
    name: EX02
    text: <p>Use of any investigational agent or approved Alzheimer's therapeutic
      medication within 30 days prior to enrollment into the study.</p>
- id: 1259
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_577
    instanceType: Code
    label: Code_577
- id: 1258
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_11
    identifier: '11'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_11
    name: EX03
    text: <p>Serious illness which required hospitalization within 3 months of screening.</p>
- id: 1261
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_578
    instanceType: Code
    label: Code_578
- id: 1260
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_12
    identifier: '12'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_12
    name: EX04
    text: '<p>Diagnosis of serious neurological conditions, including </p>

      <ol type="a">

      <li><p>Stroke or vascular dementia documented by clinical history and/or radiographic
      findings interpretable by the investigator as indicative of these disorders</p></li>

      <li><p>Seizure disorder other than simple childhood febrile seizures</p></li>

      <li><p>Severe head trauma resulting in protracted loss of consciousness within
      the last 5 years, or multiple episodes of head trauma</p></li>

      <li><p>Parkinson''s disease</p></li>

      <li><p>Multiple sclerosis</p></li>

      <li><p>Amyotrophic lateral sclerosis</p></li>

      <li><p>Myasthenia gravis.</p></li>

      </ol>'
- id: 1263
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_579
    instanceType: Code
    label: Code_579
- id: 1262
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_13
    identifier: '13'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_13
    name: EX05
    text: <p>Episode of depression meeting DSM-IV criteria within 3 months of screening.</p>
- id: 1265
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_580
    instanceType: Code
    label: Code_580
- id: 1264
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_14
    identifier: '14'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_14
    name: EX06
    text: '<p>A history within the last 5 years of the following:</p>

      <ol type="a">

      <li><p>Schizophrenia</p></li>

      <li><p>Bipolar Disease</p></li>

      <li><p>Ethanol or psychoactive drug abuse or dependence. </p></li>

      </ol>'
- id: 1267
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_581
    instanceType: Code
    label: Code_581
- id: 1266
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_15
    identifier: '15'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_15
    name: EX07
    text: <p>A history of syncope within the last 5 years.</p>
- id: 1269
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_582
    instanceType: Code
    label: Code_582
- id: 1268
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_16
    identifier: 16b
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_16
    name: EX08
    text: "<p>Evidence from ECG recording at screening of any of the following conditions\
      \ :</p>\n<ol type=\"a\">\n<li><p>Left bundle branch block</p></li>\n<li><p>Bradycardia\
      \ \u226450 beats per minute</p></li>\n<li><p>Sinus pauses &gt;2 seconds</p></li>\n\
      <li><p>Second or third degree heart block unless treated with a pacemaker</p></li>\n\
      <li><p>Wolff-Parkinson-White syndrome</p></li>\n<li><p>Sustained supraventricular\
      \ tachyarrhythmia including SVT\u226510 sec, atrial fibrillation, atrial flutter.</p></li>\n\
      <li><p>Ventricular tachycardia at a rate of \u2265120 beats per minute lasting\u2265\
      10 seconds.</p></li>\n</ol>"
- id: 1271
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_583
    instanceType: Code
    label: Code_583
- id: 1270
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_17
    identifier: '17'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_17
    name: EX09
    text: '<p>A history within the last 5 years of a serious cardiovascular disorder,
      including</p>

      <ol type="a">

      <li><p>Clinically significant arrhythmia</p></li>

      <li><p>Symptomatic sick sinus syndrome not treated with a pacemaker</p></li>

      <li><p>Congestive heart failure refractory to treatment</p></li>

      <li><p>Angina except angina controlled with PRN nitroglycerin</p></li>

      <li><p>Resting heart rate &lt;50 or &gt;100 beats per minute, on physical exam</p></li>

      <li><p>Uncontrolled hypertension.</p></li>

      </ol>'
- id: 1273
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_584
    instanceType: Code
    label: Code_584
- id: 1272
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_18
    identifier: '18'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_18
    name: EX10
    text: "<p>A history within the last 5 years of a serious gastrointestinal disorder,\
      \ including \n<ol type=\"a\">\n<li><p>Chronic peptic/duodenal/gastric/esophageal\
      \ ulcer that are untreated or refractory to treatment</p></li>\n<li><p>Symptomatic\
      \ diverticular disease</p></li>\n<li><p>Inflammatory bowel disease</p></li>\n\
      <li><p>Pancreatitis</p></li>\n<li><p>Hepatitis</p></li>\n<li><p>Cirrhosis of\
      \ the liver.</p></li>\n</ol>"
- id: 1275
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_585
    instanceType: Code
    label: Code_585
- id: 1274
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_19
    identifier: '19'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_19
    name: EX11
    text: '<p>A history within the last 5 years of a serious endocrine disorder, including</p>

      <ol type="a">

      <li><p>Uncontrolled Insulin Dependent Diabetes Mellitus (IDDM)</p></li>

      <li><p>Diabetic ketoacidosis</p></li>

      <li><p>Untreated hyperthyroidism</p></li>

      <li><p>Untreated hypothyroidism</p></li>

      <li><p>Other untreated endocrinological disorder</p></li>

      </ol>'
- id: 1277
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_586
    instanceType: Code
    label: Code_586
- id: 1276
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_20
    identifier: '20'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_20
    name: EX12
    text: '<p> A history within the last 5 years of a serious respiratory disorder,
      including</p>

      <ol type="a">

      <li><p>Asthma with bronchospasm refractory to treatment</p></li>

      <li><p>Decompensated chronic obstructive pulmonary disease.</p></li>

      </ol>'
- id: 1279
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_587
    instanceType: Code
    label: Code_587
- id: 1278
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_21
    identifier: '21'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_21
    name: EX13
    text: '<p>A history within the last 5 years of a serious genitourinary disorder,
      including</p>

      <ol type="a">

      <li><p>Renal failure</p></li>

      <li><p>Uncontrolled urinary retention.</p></li>

      </ol>'
- id: 1281
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_588
    instanceType: Code
    label: Code_588
- id: 1280
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_22
    identifier: '22'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_22
    name: EX14
    text: '<p>A history within the last 5 years of a serious rheumatologic disorder,
      including</p>

      <ol type="a">

      <li><p>Lupus</p></li>

      <li><p>Temporal arteritis</p></li>

      <li><p>Severe rheumatoid arthritis.</p></li>

      </ol>'
- id: 1283
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_589
    instanceType: Code
    label: Code_589
- id: 1282
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_23
    identifier: '23'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_23
    name: EX15
    text: <p>A known history of human immunodeficiency virus (HIV) within the last
      5 years.</p>
- id: 1285
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_590
    instanceType: Code
    label: Code_590
- id: 1284
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_24
    identifier: '24'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_24
    name: EX16
    text: '<p>A history within the last 5 years of a serious infectious disease including</p>

      <ol type="a">

      <li><p>a)  Neurosyphilis</p></li>

      <li><p>b)  Meningitis</p></li>

      <li><p>c)  Encephalitis.</p></li>

      </ol>'
- id: 1287
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_591
    instanceType: Code
    label: Code_591
- id: 1286
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_25
    identifier: '25'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_25
    name: EX17
    text: <p>A history within the last 5 years of a primary or recurrent malignant
      disease with the exception of resected cutaneous squamous cell carcinoma in
      situ, basal cell carcinoma, cervical carcinoma in situ, or in situ prostate
      cancer with a normal PSA postresection.</p>
- id: 1289
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_592
    instanceType: Code
    label: Code_592
- id: 1288
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_26
    identifier: '26'
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_26
    name: EX18
    text: <p>Visual, hearing, or communication disabilities impairing the ability
      to participate in the study; (for example, inability to speak or understand
      English, illiteracy).</p>
- id: 1291
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_593
    instanceType: Code
    label: Code_593
- id: 1290
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_27
    identifier: 27b
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_27
    name: EX19
    text: "<p>Laboratory test values exceeding the Lilly Reference Range III for the\
      \ patient's age in any of the following analytes: \u2191 creatinine, \u2191\
      \ total bilirubin, \u2191 SGOT, \u2191 SGPT, \u2191 alkaline phosphatase, \u2191\
      \ GGT, \u2191\u2193 hemoglobin, \u2191\u2193 white blood cell count, \u2191\u2193\
      \ platelet count, \u2191\u2193 serum sodium, potassium, or calcium.</p>\n<p>If\
      \ values exceed these laboratory reference ranges, clinical significance will\
      \ be judged by the monitoring physicians. If the monitoring physician determines\
      \ that the deviation from the reference range is not clinically significant,\
      \ the patient may be included in the study. This decision will be documented.</p>"
- id: 1293
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_594
    instanceType: Code
    label: Code_594
- id: 1292
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_28
    identifier: 28b
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_28
    name: EX20
    text: "<p>Central laboratory test values below reference range for folate, and\
      \ Vitamin B 12 , and outside reference range for thyroid function tests.</p>\n\
      <ol type=\"a\">\n<li><p>Folate reference range 2.0 to 25.0 ng/mL. Patients will\
      \ be allowed to enroll if their folate levels are above the upper end of the\
      \ range if patients are taking vitamin supplements.</p>\n<li><p>Vitamin B 12\
      \ reference range 130 to 900 pg/mL. Patients will be \nallowed to enroll if\
      \ their B 12 levels are above the upper reference \nrange if patients are taking\
      \ oral vitamin supplements.</p>\n<li><p>Thyroid functions</p>\n<ol type=\"i\"\
      >\n<li><p>Thyroid Uptake reference range 25 to 38%. Patients will be allowed\
      \ to enroll with results of 23 to 51% provided the remainder of the thyroid\
      \ profile is normal and there are no clinical signs or symptoms of thyroid abnormality.</p></li>\n\
      <li><p>TSH reference range 0.32 to 5.0. Patients will be allowed to enroll with\
      \ results of 0.03 to 6.2 if patients are taking stable doses of exogenous thyroid\
      \ supplements, with normal free thyroid index, and show no clinical signs or\
      \ symptoms of thyroid abnormality.</p></li>\n<li><p>Total T4 reference range\
      \ 4.5 to 12.5. Patients will be allowed to enroll with results of 4.1 to 13.4\
      \ if patients are taking stable doses of exogenous thyroid hormone, with normal\
      \ free thyroid index, and show no clinical signs or symptoms of thyroid \nabnormality.</p></li>\n\
      <li><p>Free Thyroid Index reference range 1.1 to 4.6.</p></li>\n</ol>\n</ol>"
- id: 1295
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_595
    instanceType: Code
    label: Code_595
- id: 1294
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_29
    identifier: 29b
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_29
    name: EX21
    text: '<p>Positive syphilis screening.</p>

      <p>Positive syphilis screening. As determined by positive RPR followed up by
      confirmatory FTA-Abs. Confirmed patients are excluded unless there is a documented
      medical history of an alternative disease (for example, yaws) which caused the
      lab abnormality.</p>'
- id: 1297
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_596
    instanceType: Code
    label: Code_596
- id: 1296
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_30
    identifier: 30b
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_30
    name: EX22
    text: <p>Glycosylated hemoglobin (A1C). Required only on patients with known diabetes
      mellitus or random blood sugar &gt;200 on screening labs. Patients will be excluded
      if levels are &gt;9.5%</p>
- id: 1299
  properties:
    _type: Code
    code: C25370
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Exclusion Criteria
    id: Code_597
    instanceType: Code
    label: Code_597
- id: 1298
  properties:
    _type: EligibilityCriterion
    description: ''
    id: EligibilityCriterion_31
    identifier: 31b
    instanceType: EligibilityCriterion
    label: EligibilityCriterion_31
    name: EX23
    text: "<p>Treatment with the following medications within the specified washout\
      \ periods prior to enrollment and during the study:</p>\n<ol type=\"a\">\n \
      \ <li>\n    <p>Anticonvulsants including but not limited to </p>\n    <table\
      \ class=\"table\">\n      <tr>\n        <td>Depakote&#174; (valproic acid) </td>\n\
      \        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Dilantin&#174;\
      \ (phenytoin)</td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n    \
      \    <td>Felbatol&#174;\n          (felbamate)</td>\n        <td>1 month</td>\n\
      \      </tr>\n      <tr>\n        <td>Klonopin&#174; (clonazepam)</td>\n   \
      \     <td>2\n          weeks</td>\n      </tr>\n      <tr>\n        <td>Lamictal&#174;\
      \ (lamotrigine)</td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n  \
      \      <td>Mysoline&#174; (primidone)</td>\n        <td>1 month</td>\n     \
      \ </tr>\n      <tr>\n        <td>Neurontin&#174;\n          (gabapentin)</td>\n\
      \        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Phenobarbitol</td>\n\
      \        <td>1 month</td>\n      </tr>\n      <tr>\n        <td>Tegretol&#174;\
      \ (carbamazepine)</td>\n        <td>2 weeks</td>\n      </tr>\n    </table>\n\
      \  </li>\n  <li>\n    <p>Alpha receptor blockers including but not limited to\
      \ </p>\n    <table class=\"table\">\n      <tr>\n        <td>Aldomet&#174; (methyldopa)\
      \ </td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Cardura&#174;\n\
      \          (doxazosin) </td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n\
      \        <td>Catapres&#174; (clonidine)\n        </td>\n        <td>2 weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>Hytrin&#174; (terazosin) </td>\n     \
      \   <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Minipress&#174; (prazosin)</td>\n\
      \        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Tenex&#174;\
      \ (guanfacine)</td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n   \
      \     <td>Wytensin&#174;\n          (guanabenz) </td>\n        <td>2 weeks</td>\n\
      \      </tr>\n    </table>\n    <p><b>The use of low doses\n        (2 mg daily)\
      \ of either Hytrin</b>&#174; <b>or Cardura</b>&#174; <b>for relief of\n    \
      \    urinary retention for patients with prostatic hypertrophy will be considered\n\
      \        on a case-by-case basis provided blood pressure is stable and the medication\n\
      \        has not had demonstrable effect on dementia symptoms in the opinion\
      \ of the treating\n        physician. Contact CRO medical monitor.</b></p>\n\
      \  </li>\n  <li>\n    <p>Calcium channel blockers\n      that are CNS active\
      \ including but not limited to </p>\n    <table class=\"table\">\n      <tr>\n\
      \        <td>Calan&#174; , Isoptin&#174; , Verelan&#174; (verapamil) </td>\n\
      \        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Cardizem&#174;\
      \ (diltiazem) </td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n   \
      \     <td>Nimotop&#174;\n          (nimodipine) </td>\n        <td>2 weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>Adalat&#174; , Procardia XL&#174;\n  \
      \        (nifedipine) </td>\n        <td>2 weeks</td>\n      </tr>\n    </table>\n\
      \    <p><b>Cardene</b>&#174; <b>(nicardipine),\n        Norvasc</b>&#174; <b>,\
      \ (amlodipine), and DynaCirc</b>&#174; <b>(isradipine) will\n        be allowed\
      \ during the study. If a patient is taking an excluded calcium channel\n   \
      \     blocker and is changed to an equivalent dose of an allowed calcium channel\
      \ blocker,\n        enrollment may proceed in as little as 24 hours though 1\
      \ week is preferred when\n        possible.</b></p>\n  </li>\n  <li>\n    <p>Beta\
      \ blockers including but not limited to </p>\n    <table class=\"table\">\n\
      \      <tr>\n        <td>Betapace&#174; (sotalol) </td>\n        <td>2 weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>Inderal&#174; (propranolol) </td>\n  \
      \      <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Lopressor&#174;\n\
      \          , Toprol XL&#174; (metoprolol) </td>\n        <td>2 weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>Corgard&#174; (nadolol) </td>\n      \
      \  <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Sectral&#174; (acebutolol)</td>\n\
      \        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Tenormin&#174;\
      \ (atenolol) </td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n    \
      \    <td>Visken&#174; (pindolol)</td>\n        <td>2 weeks</td>\n      </tr>\n\
      \    </table>\n    <p><b>Beta\n        blocker eye drops for glaucoma will be\
      \ considered on a case-by-case basis. Call\n        medical monitor.</b></p>\n\
      \  </li>\n  <li>\n    <p>Beta sympathomimetics (unless inhaled) including\n\
      \      but not limited to </p>\n    <table class=\"table\">\n      <tr>\n  \
      \      <td>Alupent&#174; tablets\n          (metaproterenol) </td>\n       \
      \ <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Brethine&#174; tablets\n\
      \          (terbutaline) </td>\n        <td>2 weeks</td>\n      </tr>\n    \
      \  <tr>\n        <td>Dopamine </td>\n        <td>2 weeks\n\n      <tr>\n   \
      \     <td>Proventil Repetabs&#174; , Ventolin&#174; tablets (albuterol tablets)\n\
      \        </td>\n        <td>2 weeks</td>\n      </tr>\n    </table>\n  </li>\n\
      \  <li>Parasympathomimetics (cholinergics)\n    (unless opthalmic) including\
      \ but not limited to <table class=\"table\">\n      <tr>\n        <td>Antilirium&#174;\
      \ (physostigmine) </td>\n        <td>1 month</td>\n      </tr>\n      <tr>\n\
      \        <td>Aricept&#174; (donepezil) </td>\n        <td>1 month</td>\n   \
      \   </tr>\n      <tr>\n        <td>Cognex&#174; (tacrine) </td>\n        <td>1\n\
      \          month</td>\n      </tr>\n      <tr>\n        <td>Mestinon&#174; (pyridostigmine)\
      \ </td>\n        <td>1 week</td>\n      </tr>\n      <tr>\n        <td>Reglan&#174;\
      \ (metoclopramide)</td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n\
      \        <td>Urecholine&#174;\n          , Duvoid (bethanechol) </td>\n    \
      \    <td>2 weeks</td>\n      </tr>\n    </table>\n    <p><b>Cholinergic eye\
      \ drops for treatment of glaucoma will be allowed during the study on a case-by-case\
      \ basis.\n        Please contact the CRO medical monitor.</b></p>\n  </li>\n\
      \  <li>\n    <p>Muscle relaxants-centrally active including but not limited\
      \ to </p>\n    <table class=\"table\">\n      <tr>\n        <td>Equanil&#174;\
      \ (meprobamate) </td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n \
      \       <td>Flexeril&#174; (cyclobenzaprine)</td>\n        <td>2 weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>Lioresal&#174; (baclofen) </td>\n    \
      \    <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Norflex&#174; (orphenadrine)\
      \ </td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Parafon\
      \ Forte&#174; (chlorzoxazone)</td>\n        <td>2 weeks</td>\n      </tr>\n\
      \      <tr>\n        <td>Robaxin&#174; (methocarbamol) </td>\n        <td>2\
      \ weeks</td>\n      </tr>\n      <tr>\n        <td>Skelaxin&#174; (metaxalone)\n\
      \        </td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Soma&#174;\
      \ (carisoprodol) </td>\n        <td>2 weeks</td>\n      </tr>\n    </table>\n\
      \  </li>\n  <li>\n    <p>Monamine oxidase inhibitors (MAOI) including but not\
      \ limited to</p>\n    <table class=\"table\">\n      <tr>\n        <td>Eldepryl&#174;\
      \ (selegiline)</td>\n        <td>1 month</td>\n      </tr>\n      <tr>\n   \
      \     <td>Nardil&#174; (phenelzine) </td>\n        <td>1 month</td>\n      </tr>\n\
      \      <tr>\n        <td>Parnate&#174; (tranylcypromine) </td>\n        <td>1\
      \ month</td>\n      </tr>\n    </table>\n  </li>\n  <li>\n    <p>Parasympatholytics\
      \ including but not limited to </p>\n    <table class=\"table\">\n      <tr>\n\
      \        <td>Antivert&#174; , Bonine&#174; , Dramamine II&#174; (meclizine)</td>\n\
      \        <td>3 days </td>\n      </tr>\n      <tr>\n        <td>Artane&#174;\
      \ (trihexyphenidyl)</td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n\
      \        <td>Bellergal-S&#174; (alkaloids of belladonna and ergotamine) </td>\n\
      \        <td>2 weeks </td>\n      </tr>\n      <tr>\n        <td>Bentyl&#174;\
      \ (dicyclomine) </td>\n        <td>3 days </td>\n      </tr>\n      <tr>\n \
      \       <td>Cogentin&#174; (benztropine) </td>\n        <td>2 weeks</td>\n \
      \     </tr>\n      <tr>\n        <td>Cystospaz&#174;, Levsin&#174; , Levsinex&#174;\
      \ (hyoscyamine)</td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n  \
      \      <td>Ditropan&#174;\n          (oxybutynin) </td>\n        <td>2 weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>Donnatal&#174; , Hyosophen&#174;\n   \
      \       (atropine, scopolamine, hyoscyamine and phenobarbitol) </td>\n     \
      \   <td>1 month </td>\n      </tr>\n      <tr>\n        <td>Dramamine&#174;\
      \ (dimenhydrinate)</td>\n         <td>3 days</td>\n      </tr>\n      <tr>\n\
      \        <td>Lomotil&#174;, Lonox&#174; (atropine, diphenoxylate) </td>\n  \
      \      <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Pro-Banthine&#174;\n\
      \          (propantheline) </td>\n        <td>2 weeks</td>\n      </tr>\n  \
      \    <tr>\n        <td>Robinul&#174; (glycopyrrolate)</td>\n        <td>3 days\
      \ </td>\n      </tr>\n      <tr>\n        <td>Tigan&#174; (trimethobenzamide)\
      \ </td>\n        <td>3 days </td>\n      </tr>\n      <tr>\n        <td>Transderm-Scop&#174;\
      \ (scopolamine) </td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n \
      \       <td>Urispas&#174; (flavoxate) 2 weeks</td>\n      </tr>\n    </table>\n\
      \  </li>\n  <li>\n    <p>Antidepressants including but not limited to </p>\n\
      \    <table class=\"table\">\n      <tr>\n        <td>Anafranil&#174; (clomipramine)</td>\n\
      \        <td> 1 month</td>\n      </tr>\n      <tr>\n        <td>Asendin&#174;\n\
      \          (amoxapine)</td>\n        <td> 1 month</td>\n      </tr>\n      <tr>\n\
      \        <td>Desyrel&#174; (trazodone)</td>\n        <td>\n          1 month</td>\n\
      \      </tr>\n      <tr>\n        <td>Effexor&#174; (venlafaxine) </td>\n  \
      \      <td> 1 month</td>\n      </tr>\n      <tr>\n        <td>Elavil&#174;\
      \ (amitriptyline)</td>\n        <td> 1 month</td>\n      </tr>\n      <tr>\n\
      \        <td>Ludiomil&#174;\n          (maprotiline)</td>\n        <td> 1 month</td>\n\
      \      </tr>\n      <tr>\n        <td>Norpramin&#174; (desipramine)</td>\n \
      \       <td>\n          1 month</td>\n      </tr>\n      <tr>\n        <td>Pamelor&#174;\
      \ , Aventyl&#174; (nortriptyline)</td>\n        <td> 1\n          month</td>\n\
      \      </tr>\n      <tr>\n        <td>Paxil&#174; (paroxetine)</td>\n      \
      \  <td> 1 month</td>\n      </tr>\n      <tr>\n        <td>Prozac&#174;\n  \
      \        (fluoxetine</td>\n        <td> 1 month</td>\n      </tr>\n      <tr>\n\
      \        <td>Remeron&#174; (mirtazapine)</td>\n        <td>\n          1 month</td>\n\
      \      </tr>\n      <tr>\n        <td>Serzone&#174; (nefazodone) </td>\n   \
      \     <td> 1 month</td>\n      </tr>\n      <tr>\n        <td>Sinequan&#174;\n\
      \          (doxepin)</td>\n        <td> 1 month</td>\n      </tr>\n      <tr>\n\
      \        <td>Tofranil&#174; (imipramine)</td>\n        <td>\n          1 month</td>\n\
      \      </tr>\n      <tr>\n        <td>Vivactil&#174; (protriptyline)</td>\n\
      \        <td> 1 month</td>\n      </tr>\n      <tr>\n        <td>Wellbutrin&#174;\
      \ (bupropion)</td>\n        <td> 1 month</td>\n      </tr>\n      <tr>\n   \
      \     <td>Zoloft&#174;\n          (sertraline)</td>\n        <td> 1 month</td>\n\
      \      </tr>\n    </table>\n  </li>\n  <li>\n    <p>Systemic corticosteroids\
      \ including but not limited to </p>\n    <table class=\"table\">\n      <tr>\n\
      \        <td>Cortisone</td>\n        <td>2\n          weeks</td>\n        <td>\n\
      \      </tr>\n      <tr>\n        <td>Decadron&#174; (dexamethasone)</td>\n\
      \        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Depo-Medrol&#174;\
      \ (methylprednisolone)</td>\n        <td>1 month</td>\n        <td>\n      </tr>\n\
      \      <tr>\n        <td>Prednisone</td>\n        <td>2 weeks</td>\n       \
      \ <td>\n      </tr>\n    </table>\n  </li>\n  <li>\n    <p>Xanthine derivatives\n\
      \      including but not limited to </p>\n    <table class=\"table\">\n    \
      \  <tr>\n        <td>Aminophylline</td>\n        <td>2 weeks</td>\n        <td>\n\
      \      </tr>\n      <tr>\n        <td>Fioricet&#174; , Esgic&#174; , Phrenilin\
      \ Forte&#174; (caffeine, butalbital)</td>\n        <td>3 days</td>\n       \
      \ <td>\n      </tr>\n      <tr>\n        <td>Theo-Dur&#174; (theophylline)</td>\n\
      \        <td>2 weeks</td>\n        <td>\n      </tr>\n      <tr>\n        <td>Wigraine&#174;\
      \ , Cafergot&#174; (caffeine, ergotamine)</td>\n        <td>3 days</td>\n  \
      \      <td>\n      </tr>\n    </table>\n  </li>\n  <li>\n    <p>Histamine (H2\
      \ ) antagonists including but not limited to </p>\n    <table class=\"table\"\
      >\n      <tr>\n        <td>Axid&#174; (nizatidine)</td>\n        <td>1 week</td>\n\
      \      </tr>\n      <tr>\n        <td>Pepcid&#174; (famotidine)</td>\n     \
      \   <td>1 week</td>\n      </tr>\n      <tr>\n        <td>Tagamet&#174; (cimetidine)</td>\n\
      \        <td>1 week</td>\n      </tr>\n      <tr>\n        <td>Zantac&#174;\
      \ (ranitidine)</td>\n        <td>1 week</td>\n      </tr>\n    </table>\n  \
      \  <p><b>If an H 2 antagonist is needed by the patient, Axid</b>&#174; <b>will\
      \ be</b> <b>allowed on a case-by-case\n        basis. Please consult CRO</b>\
      \ <b>medical monitor.</b></p>\n  </li>\n  <li>\n    <p>Narcotic Analgesics including\
      \ but not limited to </p>\n    <table class=\"table\">\n      <tr>\n       \
      \ <td>Darvocet-N\n          100&#174; , (propoxyphene)</td>\n        <td>1 week\
      \ </td>\n      </tr>\n      <tr>\n        <td>Demerol&#174; (meperidine)</td>\n\
      \        <td>1\n          week </td>\n      </tr>\n      <tr>\n        <td>Dilaudid&#174;\
      \ (hydromorphone)</td>\n        <td>1 week </td>\n      </tr>\n      <tr>\n\
      \        <td>Duragesic&#174; (fentanyl)</td>\n        <td>1 week </td>\n   \
      \   </tr>\n      <tr>\n        <td>MS\n          Contin&#174; , Roxanol&#174;\
      \ , Oramorph&#174; (morphine) </td>\n        <td>1 week </td>\n      </tr>\n\
      \      <tr>\n        <td>Percocet&#174; , Roxicet&#174; (oxycodone with acetaminophen)</td>\n\
      \        <td>3\n          days </td>\n      </tr>\n      <tr>\n        <td>Percodan&#174;\
      \ , Roxiprin</td>\n        <td>1 week</td>\n      </tr>\n      <tr>\n      \
      \  <td>Stadol&#174; (butorphanol)</td>\n        <td>1 week </td>\n      </tr>\n\
      \      <tr>\n        <td>Talacen&#174;\n          (pentazocine)</td>\n     \
      \   <td>1 week </td>\n      </tr>\n      <tr>\n        <td>Tylenol #2&#174;\
      \ , #3&#174;\n          , #4&#174; (codeine and acetaminophen) </td>\n     \
      \   <td>3 days </td>\n      </tr>\n      <tr>\n        <td>Tylox&#174;\n   \
      \       , Roxilox&#174; (oxycodone)</td>\n        <td>3 days </td>\n      </tr>\n\
      \      <tr>\n        <td>Vicodin&#174;, Lorcet&#174; (hydrocodone)</td>\n  \
      \      <td>1 week</td>\n      </tr>\n    </table>\n    <p><b>Percocet\n    \
      \    (oxycodone with acetaminophen) and Tylenol</b>&#174; <b>with codeine #2,\
      \ #3, #4\n        (acetaminophen + codeine) ARE allowed in the month prior to\
      \ enrollment, but\n        are not permitted in the 3 days prior to enrollment.</b></p>\n\
      \  </li>\n  <li>\n    <p>Neuroleptics\n      (antipsychotics) including but\
      \ not limited to </p>\n    <table class=\"table\">\n      <tr>\n        <td>Clozaril&#174;\n\
      \          (clozapine)</td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n\
      \        <td>Haldol&#174; (haloperidol)</td>\n        <td>2\n          weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>Loxitane&#174; (loxapine)</td>\n     \
      \   <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Mellaril&#174; (thioridazine)</td>\n\
      \        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Moban&#174;\n\
      \          (molindone)</td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n\
      \        <td>Navane&#174; (thiothixene)</td>\n        <td>2\n          weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>Orap&#174; (pimozide)</td>\n        <td>2\
      \ weeks</td>\n      </tr>\n      <tr>\n        <td>Prolixin&#174; (fluphenazine)</td>\n\
      \        <td>1 month</td>\n      </tr>\n      <tr>\n        <td>Risperdal&#174;\n\
      \          (risperidone)</td>\n        <td>2 weeks</td>\n      </tr>\n     \
      \ <tr>\n        <td>Stelazine&#174; (trifluoperazine)</td>\n        <td>2\n\
      \          weeks</td>\n      </tr>\n      <tr>\n        <td>Thorazine&#174;\
      \ (chlorpromazine)</td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n\
      \        <td>Trilafon&#174; (perphenazine)</td>\n        <td>2 weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>Serentil&#174;\n          (mesoridazine)</td>\n\
      \        <td>2 weeks</td>\n      </tr>\n    </table>\n    <p><b>The use of neuroleptics\n\
      \        on a daily basis must be discontinued 2 to 4 weeks prior to enrollment.\
      \ The\n        use of neuroleptics on an as-needed basis is allowable during\
      \ the screening\n        period, but the last dose must be at least 7 days prior\
      \ to enrollment.</b></p>\n  </li>\n  <li>\n    <p>Antianxiety agents including\
      \ but not limited to </p>\n    <table class=\"table\">\n      <tr>\n       \
      \ <td>Atarax&#174; (hydroxyzine)</td>\n        <td>2 weeks</td>\n      </tr>\n\
      \      <tr>\n        <td>BuSpar&#174;\n          (buspirone)</td>\n        <td>2\
      \ weeks</td>\n      </tr>\n      <tr>\n        <td>Librium&#174; (chlordiazepoxide)</td>\n\
      \        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Serax&#174;\
      \ (oxazepam)</td>\n        <td>2 weeks</td>\n      </tr>\n      <tr>\n     \
      \   <td>Tranxene&#174; (clorazepate)</td>\n        <td>2 weeks</td>\n      </tr>\n\
      \      <tr>\n        <td>Valium&#174; (diazepam)</td>\n        <td>2 weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>Vistaril&#174; (hydroxyzine pamoate)</td>\n\
      \        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Xanax&#174;\
      \ (alprazolam)</td>\n        <td>2 weeks</td>\n      </tr>\n    </table>\n \
      \   <p><b>Ativan</b>&#174; <b>(lorazepam) should be discontinued on a daily\n\
      \        basis 2 weeks</b></p>\n    <p><b>prior to enrollment. It may be used\
      \ on an as-needed\n        basis during the screening period, but is not permitted\
      \ in the 24 hours prior\n        to enrollment.</b></p>\n  </li>\n  <li>\n \
      \   <p>Hypnotics/Sedatives including but not limited\n      to\n    <table class=\"\
      table\">\n      <tr>\n        <td>Ambien&#174; (zolpidem)</td>\n        <td>\
      \ 3 days\n        </td>\n      </tr>\n      <tr>\n        <td>Dalmane&#174;\
      \ (flurazepam)</td>\n         <td>3 days</td>\n      </tr>\n      <tr>\n   \
      \     <td>Doral&#174; (quazepam)</td>\n         <td>3 days</td>\n      </tr>\n\
      \      <tr>\n        <td>Halcion&#174; (triazolam)</td>\n         <td>3 days</td>\n\
      \      </tr>\n      <tr>\n        <td>Nembutal&#174; </td>\n        <td>2 weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>ProSom&#174; (estazolam)</td>\n      \
      \  <td>3 days</td>\n      </tr>\n      <tr>\n        <td>Restoril&#174;\n  \
      \        (temazepam)</td>\n         <td>3 days</td>\n      </tr>\n      <tr>\n\
      \        <td>Seconal&#174;</td>\n        <td>2 weeks</td>\n      </tr>\n   \
      \ </table>\n    <p><b>Chloral Hydrate is allowed on an as-needed basis during</b>\n\
      \      <b>screening, but is not permitted in the 24 hours prior to</b> <b>enrollment.</b>\n\
      \    </p>\n  </li>\n  <li>\n    <p>Histamine (H1 ) antagonists including but\
      \ not limited to </p>\n    <table class=\"table\">\n      <tr>\n        <td>Actifed&#174;\
      \ , Actifed Plus&#174; (triprolidine) Benadryl&#174;\n          , Unisom&#174;\
      \ , Tylenol P.M.&#174; </td>\n        <td>3 days </td>\n      </tr>\n      <tr>\n\
      \        <td>(diphenhydramine)</td>\n        <td>3\n          days</td>\n  \
      \    </tr>\n      <tr>\n        <td>Compazine&#174; (prochlorperazine)</td>\n\
      \        <td>3 days</td>\n      </tr>\n      <tr>\n        <td>Contac&#174;\
      \ , Coricidin D&#174; , Sinutab&#174; , Novahistine&#174; , Alka\n         \
      \ Seltzer Plus&#174; , Naldecon&#174; , Sudafed Plus&#174; , Tylenol Cold&#174;\
      \ , Tylenol\n          Cold and Flu&#174; (chlorpheniramine)</td>\n        <td>3\
      \ days</td>\n      <tr>\n        <td>Dimetapp&#174;\n          (brompheniramine)</td>\n\
      \        <td>3 days</td>\n      <tr>\n        <td>Drixoral&#174; (dexbrompheniramine)</td>\n\
      \        <td>3\n          days</td>\n      <tr>\n        <td>Hismanal&#174;\
      \ (astemizole)</td>\n        <td>1 week</td>\n      <tr>\n        <td>Phenergan&#174;\n\
      \          (promethazine)</td>\n        <td>3 days</td>\n      <tr>\n      \
      \  <td>Seldane&#174; (terfenadine)</td>\n        <td>1\n          week</td>\n\
      \      <tr>\n        <td>Tavist&#174; (clemastine fumarate)</td>\n        <td>3\
      \ days</td>\n      <tr>\n        <td>Zyrtec&#174; (cetrizine) </td>\n      \
      \  <td>1 week</td>\n    </table>\n    <p><b>Allegra</b>&#174;\n      <b>(fexofenadine\
      \ hydrochloride) or Claritin</b>&#174; <b>(loratadine) may be taken\n      \
      \  on as-needed basis during screening but must be discontinued within 24 hours\n\
      \        of enrollment.</b>\n    </p>\n  </li>\n  <li>\n    <p>Stimulants including\
      \ but not limited to </p>\n    <table class=\"table\">\n      <tr>\n       \
      \ <td>Cylert&#174; (pemoline) </td>\n        <td>1 month</td>\n      </tr>\n\
      \      <tr>\n        <td>Ritalin&#174; (methylphenidate)</td>\n        <td>1\
      \ month</td>\n      </tr>\n    </table>\n  </li>\n  <li>\n    <p>Antiarrhythmics\
      \ including but not limited to the following\n    <table class=\"table\">\n\
      \      <tr>\n        <td>Adenocard&#174; (adenosine) </td>\n      </tr>\n  \
      \    <tr>\n        <td>Cordarone&#174;\n          (amiodarone) </td>\n     \
      \ </tr>\n      <tr>\n        <td>Ethmozine&#174; (moricizine) </td>\n      </tr>\n\
      \      <tr>\n        <td>Mexitil&#174; (mexiletine) </td>\n      </tr>\n   \
      \   <tr>\n        <td>Norpace&#174; (disopyramide)\n        </td>\n      </tr>\n\
      \      <tr>\n        <td>Procan&#174; (procainamide) </td>\n      </tr>\n  \
      \    <tr>\n        <td>Quinaglute&#174;\n          (quinidine) </td>\n     \
      \ </tr>\n      <tr>\n        <td>Rythmol&#174; (propafenone) </td>\n      </tr>\n\
      \      <tr>\n        <td>Tambocor&#174;\n          (flecainide) </td>\n    \
      \  </tr>\n      <tr>\n        <td>Tonocard&#174; (tocainide)</td>\n      </tr>\n\
      \    </table>\n    <p><b>Requirement of these drugs for control of cardiac arrhythmia\
      \ indicates that\n        the patient should be excluded from the study. If\
      \ discontinuation of an antiarrhythmic\n        is considered, please discuss\
      \ case with CRO medical monitor.</b></p>\n  <li>\n    <p>Miscellaneous\n   \
      \   drugs including but not limited to </p>\n    <table class=\"table\">\n \
      \     <tr>\n        <td>Coenzyme\n          Q</td>\n        <td>2 weeks</td>\n\
      \      </tr>\n      <tr>\n        <td>Eskalith&#174; , Lithobid&#174; (lithium)</td>\n\
      \        <td>2\n          weeks </td>\n      </tr>\n      <tr>\n        <td>Ginkgo\
      \ biloba</td>\n        <td>1 week</td>\n      </tr>\n      <tr>\n        <td>Lecithin\n\
      \        </td>\n        <td>1 week</td>\n      </tr>\n      <tr>\n        <td>Lecithin\
      \ </td>\n        <td>1 week </td>\n      </tr>\n      <tr>\n        <td>Lupron</td>\n\
      \        <td>2 weeks</td>\n      </tr>\n      <tr>\n        <td>Tamoxifen</td>\n\
      \        <td>1 month</td>\n      </tr>\n    </table>\n  </li>\n  <li>\n    <p>Estrogen\
      \ supplements are permitted during the study, but dosage must be stable for\
      \ at least 3 months prior to\n      enrollment.</p>\n  </li>\n</ol>"
- id: 1301
  properties:
    _type: Code
    code: C29848
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Year
    id: Code_548
    instanceType: Code
    label: Code_548
- id: 1300
  properties:
    _type: Range
    id: Range_3
    instanceType: Range
    isApproximate: false
    label: Range_3
    maxValue: 100.0
    minValue: 50.0
- id: 1234
  properties:
    _type: StudyDesignPopulation
    cohorts: []
    description: Patients with Probable Mild to Moderate Alzheimer's Disease
    id: StudyDesignPopulation_1
    includesHealthySubjects: false
    instanceType: StudyDesignPopulation
    label: StudyDesignPopulation_1
    name: POP1
- id: 1303
  properties:
    _type: ScheduleTimelineExit
    id: ScheduleTimelineExit_4
    instanceType: ScheduleTimelineExit
    label: ScheduleTimelineExit_4
- id: 1305
  properties:
    _type: Code
    code: C201357
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Before
    id: Code_14
    instanceType: Code
    label: Code_14
- id: 1306
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_15
    instanceType: Code
    label: Code_15
- id: 1304
  properties:
    _type: Timing
    description: Screening timing
    id: Timing_1
    instanceType: Timing
    label: Timing_1
    name: TIM1
    value: P2W
    valueLabel: 2 weeks
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1308
  properties:
    _type: Code
    code: C201357
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Before
    id: Code_16
    instanceType: Code
    label: Code_16
- id: 1309
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_17
    instanceType: Code
    label: Code_17
- id: 1307
  properties:
    _type: Timing
    description: Pre dose timing
    id: Timing_2
    instanceType: Timing
    label: Timing_2
    name: TIM2
    value: P2D
    valueLabel: 2 days
    windowLabel: -4..0 hours
    windowLower: PT4H
    windowUpper: PT0H
- id: 1311
  properties:
    _type: Code
    code: C201358
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Fixed Reference
    id: Code_19
    instanceType: Code
    label: Code_19
- id: 1312
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_20
    instanceType: Code
    label: Code_20
- id: 1310
  properties:
    _type: Timing
    description: Dosing anchor
    id: Timing_3
    instanceType: Timing
    label: Timing_3
    name: TIM3
    value: P1D
    valueLabel: 1 Day
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1314
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_21
    instanceType: Code
    label: Code_21
- id: 1315
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_22
    instanceType: Code
    label: Code_22
- id: 1313
  properties:
    _type: Timing
    description: Week 2 timing
    id: Timing_4
    instanceType: Timing
    label: Timing_4
    name: TIM4
    value: P2W
    valueLabel: 2 Weeks
    windowLabel: -3..3 days
    windowLower: P3D
    windowUpper: P3D
- id: 1317
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_24
    instanceType: Code
    label: Code_24
- id: 1318
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_25
    instanceType: Code
    label: Code_25
- id: 1316
  properties:
    _type: Timing
    description: Week 4 timing
    id: Timing_5
    instanceType: Timing
    label: Timing_5
    name: TIM5
    value: P4W
    valueLabel: 4 Weeks
    windowLabel: -3..3 days
    windowLower: P3D
    windowUpper: P3D
- id: 1320
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_27
    instanceType: Code
    label: Code_27
- id: 1321
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_28
    instanceType: Code
    label: Code_28
- id: 1319
  properties:
    _type: Timing
    description: Week 6 timing
    id: Timing_6
    instanceType: Timing
    label: Timing_6
    name: TIM6
    value: P6W
    valueLabel: 6 Weeks
    windowLabel: -3..3 days
    windowLower: P3D
    windowUpper: P3D
- id: 1323
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_30
    instanceType: Code
    label: Code_30
- id: 1324
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_31
    instanceType: Code
    label: Code_31
- id: 1322
  properties:
    _type: Timing
    description: Week 8 timing
    id: Timing_7
    instanceType: Timing
    label: Timing_7
    name: TIM7
    value: P8W
    valueLabel: 8 Weeks
    windowLabel: -3..3 days
    windowLower: P3D
    windowUpper: P3D
- id: 1326
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_35
    instanceType: Code
    label: Code_35
- id: 1327
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_36
    instanceType: Code
    label: Code_36
- id: 1325
  properties:
    _type: Timing
    description: Week 12 timing
    id: Timing_9
    instanceType: Timing
    label: Timing_9
    name: TIM9
    value: P12W
    valueLabel: 12 Weeks
    windowLabel: -4..4 days
    windowLower: P4D
    windowUpper: P4D
- id: 1329
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_40
    instanceType: Code
    label: Code_40
- id: 1330
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_41
    instanceType: Code
    label: Code_41
- id: 1328
  properties:
    _type: Timing
    description: Week 16 timing
    id: Timing_11
    instanceType: Timing
    label: Timing_11
    name: TIM11
    value: P16W
    valueLabel: 16 Weeks
    windowLabel: -4..4 days
    windowLower: P4D
    windowUpper: P4D
- id: 1332
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_45
    instanceType: Code
    label: Code_45
- id: 1333
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_46
    instanceType: Code
    label: Code_46
- id: 1331
  properties:
    _type: Timing
    description: Week 20 timing
    id: Timing_13
    instanceType: Timing
    label: Timing_13
    name: TIM13
    value: P20W
    valueLabel: 20 Weeks
    windowLabel: -4..4 days
    windowLower: P4D
    windowUpper: P4D
- id: 1335
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_50
    instanceType: Code
    label: Code_50
- id: 1336
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_51
    instanceType: Code
    label: Code_51
- id: 1334
  properties:
    _type: Timing
    description: Week 24 timing
    id: Timing_15
    instanceType: Timing
    label: Timing_15
    name: TIM15
    value: P24W
    valueLabel: 24 Weeks
    windowLabel: -4..4 days
    windowLower: P4D
    windowUpper: P4D
- id: 1338
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_53
    instanceType: Code
    label: Code_53
- id: 1339
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_54
    instanceType: Code
    label: Code_54
- id: 1337
  properties:
    _type: Timing
    description: Week 26 timing
    id: Timing_16
    instanceType: Timing
    label: Timing_16
    name: TIM16
    value: P26W
    valueLabel: 26 Weeks
    windowLabel: -3..3 days
    windowLower: P3D
    windowUpper: P3D
- id: 1341
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_33
    instanceType: Code
    label: Code_33
- id: 1342
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_34
    instanceType: Code
    label: Code_34
- id: 1340
  properties:
    _type: Timing
    description: Week 8 at home timing
    id: Timing_8
    instanceType: Timing
    label: Timing_8
    name: TIM8
    value: P2W
    valueLabel: 2 Weeks
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1344
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_38
    instanceType: Code
    label: Code_38
- id: 1345
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_39
    instanceType: Code
    label: Code_39
- id: 1343
  properties:
    _type: Timing
    description: Week 12 at home timing
    id: Timing_10
    instanceType: Timing
    label: Timing_10
    name: TIM10
    value: P2W
    valueLabel: 2 Weeks
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1347
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_43
    instanceType: Code
    label: Code_43
- id: 1348
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_44
    instanceType: Code
    label: Code_44
- id: 1346
  properties:
    _type: Timing
    description: Week 16 at home timing
    id: Timing_12
    instanceType: Timing
    label: Timing_12
    name: TIM12
    value: P2W
    valueLabel: 2 Weeks
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1350
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_48
    instanceType: Code
    label: Code_48
- id: 1351
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_49
    instanceType: Code
    label: Code_49
- id: 1349
  properties:
    _type: Timing
    description: Week 20 at home timing
    id: Timing_14
    instanceType: Timing
    label: Timing_14
    name: TIM14
    value: P2W
    valueLabel: 2 Weeks
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1352
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_9
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_9
    name: SCREEN1
- id: 1353
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_10
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_10
    name: SCREEN2
- id: 1354
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_11
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_11
    name: DOSE
- id: 1355
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_12
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_12
    name: WK2
- id: 1356
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_13
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_13
    name: WK4
- id: 1357
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_14
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_14
    name: WK6
- id: 1358
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_15
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_15
    name: WK8
- id: 1359
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_16
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_16
    name: WK8N
- id: 1360
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_17
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_17
    name: WK12
- id: 1361
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_18
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_18
    name: WK12N
- id: 1362
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_19
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_19
    name: WK16
- id: 1363
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_20
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_20
    name: WK16N
- id: 1364
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_21
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_21
    name: WK20
- id: 1365
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_22
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_22
    name: WK20N
- id: 1366
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_23
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_23
    name: WK24
- id: 1367
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_24
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_24
    name: WK26
- id: 1302
  properties:
    _type: ScheduleTimeline
    description: This is the main timeline for the study design.
    entryCondition: Potential subject identified
    id: ScheduleTimeline_4
    instanceType: ScheduleTimeline
    label: ScheduleTimeline_4
    mainTimeline: true
    name: Main Timeline
- id: 1369
  properties:
    _type: ScheduleTimelineExit
    id: ScheduleTimelineExit_1
    instanceType: ScheduleTimelineExit
    label: ScheduleTimelineExit_1
- id: 1371
  properties:
    _type: Code
    code: C201358
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Fixed Reference
    id: Code_56
    instanceType: Code
    label: Code_56
- id: 1372
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_57
    instanceType: Code
    label: Code_57
- id: 1370
  properties:
    _type: Timing
    description: Adverse Event
    id: Timing_17
    instanceType: Timing
    label: Timing_17
    name: TIM17
    value: P1D
    valueLabel: 1 Day
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1373
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_1
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_1
    name: AE
- id: 1368
  properties:
    _type: ScheduleTimeline
    description: This is the adverse event timeline
    entryCondition: Subject suffers an adverse event
    id: ScheduleTimeline_1
    instanceType: ScheduleTimeline
    label: ScheduleTimeline_1
    mainTimeline: false
    name: Adverse Event Timeline
- id: 1375
  properties:
    _type: ScheduleTimelineExit
    id: ScheduleTimelineExit_2
    instanceType: ScheduleTimelineExit
    label: ScheduleTimelineExit_2
- id: 1377
  properties:
    _type: Code
    code: C201358
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Fixed Reference
    id: Code_58
    instanceType: Code
    label: Code_58
- id: 1378
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_59
    instanceType: Code
    label: Code_59
- id: 1376
  properties:
    _type: Timing
    description: Early Termination
    id: Timing_18
    instanceType: Timing
    label: Timing_18
    name: TIM18
    value: P1D
    valueLabel: 1 Day
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1379
  properties:
    _type: ScheduledActivityInstance
    description: '-'
    id: ScheduledActivityInstance_2
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_2
    name: ET
- id: 1374
  properties:
    _type: ScheduleTimeline
    description: This is the early termination processing
    entryCondition: Subject terminates the study early
    id: ScheduleTimeline_2
    instanceType: ScheduleTimeline
    label: ScheduleTimeline_2
    mainTimeline: false
    name: Early Termination Timeline
- id: 1381
  properties:
    _type: ScheduleTimelineExit
    id: ScheduleTimelineExit_3
    instanceType: ScheduleTimelineExit
    label: ScheduleTimelineExit_3
- id: 1383
  properties:
    _type: Code
    code: C201358
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Fixed Reference
    id: Code_60
    instanceType: Code
    label: Code_60
- id: 1384
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_61
    instanceType: Code
    label: Code_61
- id: 1382
  properties:
    _type: Timing
    description: Supine
    id: Timing_19
    instanceType: Timing
    label: Timing_19
    name: TIM19
    value: PT0M
    valueLabel: 0 mins
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1386
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_62
    instanceType: Code
    label: Code_62
- id: 1387
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_63
    instanceType: Code
    label: Code_63
- id: 1385
  properties:
    _type: Timing
    description: VS while supine
    id: Timing_20
    instanceType: Timing
    label: Timing_20
    name: TIM20
    value: PT5M
    valueLabel: 5 mins
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1389
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_64
    instanceType: Code
    label: Code_64
- id: 1390
  properties:
    _type: Code
    code: C201353
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: End to Start
    id: Code_65
    instanceType: Code
    label: Code_65
- id: 1388
  properties:
    _type: Timing
    description: Standing
    id: Timing_21
    instanceType: Timing
    label: Timing_21
    name: TIM21
    value: PT0M
    valueLabel: 0 min
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1392
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_66
    instanceType: Code
    label: Code_66
- id: 1393
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_67
    instanceType: Code
    label: Code_67
- id: 1391
  properties:
    _type: Timing
    description: VS while standing
    id: Timing_22
    instanceType: Timing
    label: Timing_22
    name: TIM22
    value: PT1M
    valueLabel: 1 min
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1395
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_68
    instanceType: Code
    label: Code_68
- id: 1396
  properties:
    _type: Code
    code: C201353
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: End to Start
    id: Code_69
    instanceType: Code
    label: Code_69
- id: 1394
  properties:
    _type: Timing
    description: Standing
    id: Timing_23
    instanceType: Timing
    label: Timing_23
    name: TIM23
    value: PT0M
    valueLabel: 0 min
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1398
  properties:
    _type: Code
    code: C201356
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: After
    id: Code_70
    instanceType: Code
    label: Code_70
- id: 1399
  properties:
    _type: Code
    code: C201355
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Start to Start
    id: Code_71
    instanceType: Code
    label: Code_71
- id: 1397
  properties:
    _type: Timing
    description: VS while standing
    id: Timing_24
    instanceType: Timing
    label: Timing_24
    name: TIM24
    value: PT2M
    valueLabel: 2 min
    windowLabel: ''
    windowLower: null
    windowUpper: null
- id: 1400
  properties:
    _type: ScheduledActivityInstance
    description: ''
    id: ScheduledActivityInstance_3
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_3
    name: VS_5MIN
- id: 1401
  properties:
    _type: ScheduledActivityInstance
    description: ''
    id: ScheduledActivityInstance_4
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_4
    name: VS_SUPINE
- id: 1402
  properties:
    _type: ScheduledActivityInstance
    description: ''
    id: ScheduledActivityInstance_5
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_5
    name: VS_1MIN
- id: 1403
  properties:
    _type: ScheduledActivityInstance
    description: ''
    id: ScheduledActivityInstance_6
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_6
    name: VS_STAND1
- id: 1404
  properties:
    _type: ScheduledActivityInstance
    description: ''
    id: ScheduledActivityInstance_7
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_7
    name: VS_2MIN
- id: 1405
  properties:
    _type: ScheduledActivityInstance
    description: ''
    id: ScheduledActivityInstance_8
    instanceType: ScheduledActivityInstance
    label: ScheduledActivityInstance_8
    name: VS_STAND3
- id: 1380
  properties:
    _type: ScheduleTimeline
    description: BP Profile
    entryCondition: Automatic execution
    id: ScheduleTimeline_3
    instanceType: ScheduleTimeline
    label: ScheduleTimeline_3
    mainTimeline: false
    name: Vital Sign Blood Pressure Timeline
- id: 1407
  properties:
    _type: ParameterMap
    id: ParameterMap_1
    instanceType: ParameterMap
    label: ParameterMap_1
    reference: <usdm:ref klass="Range" id="Range_3" attribute="minValue"></usdm:ref>
    tag: min_age
- id: 1408
  properties:
    _type: ParameterMap
    id: ParameterMap_2
    instanceType: ParameterMap
    label: ParameterMap_2
    reference: <usdm:ref klass="Range" id="Range_3" attribute="maxValue"></usdm:ref>
    tag: max_age
- id: 1409
  properties:
    _type: ParameterMap
    id: ParameterMap_3
    instanceType: ParameterMap
    label: ParameterMap_3
    reference: <usdm:ref klass="StudyDesignPopulation" id="StudyDesignPopulation_1"
      attribute="description"></usdm:ref>
    tag: StudyPopulation
- id: 1406
  properties:
    _type: SyntaxTemplateDictionary
    description: Dictionary for IE
    id: SyntaxTemplateDictionary_1
    instanceType: SyntaxTemplateDictionary
    label: SyntaxTemplateDictionary_1
    name: IE_Dict
- id: 1411
  properties:
    _type: ParameterMap
    id: ParameterMap_4
    instanceType: ParameterMap
    label: ParameterMap_4
    reference: <usdm:ref klass="Activity" id="Activity_6" attribute="label"></usdm:ref>
    tag: Activity1
- id: 1412
  properties:
    _type: ParameterMap
    id: ParameterMap_5
    instanceType: ParameterMap
    label: ParameterMap_5
    reference: <usdm:ref klass="Activity" id="Activity_5" attribute="label"></usdm:ref>
    tag: Activity2
- id: 1410
  properties:
    _type: SyntaxTemplateDictionary
    description: Dictionary for Study Assessments
    id: SyntaxTemplateDictionary_2
    instanceType: SyntaxTemplateDictionary
    label: SyntaxTemplateDictionary_2
    name: AS_Dict
- id: 1413
  properties:
    _type: Condition
    description: Hemoglobin A<sup>1C</sup> and insulin-dependent subjects
    id: Condition_1
    instanceType: Condition
    label: Condition_1
    name: COND1
    text: Performed if patient is an insulin-dependent diabetic
- id: 1414
  properties:
    _type: Condition
    description: Questionnaire practice condition
    id: Condition_2
    instanceType: Condition
    label: Condition_2
    name: COND2
    text: Practice only - It is recommended that a sampling of the CIBIC+, ADAS-Cog,
      DAD, and NPI-X be administered at Visit 1. Data from this sampling would not
      be considered as study data and would not be collected.
- id: 1416
  properties:
    _type: Code
    code: C70793
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Clinical Study Sponsor
    id: Code_598
    instanceType: Code
    label: Code_598
- id: 1418
  properties:
    _type: Code
    code: GBR
    codeSystem: ISO 3166 1 alpha3
    codeSystemVersion: 2020-08
    decode: United Kingdom of Great Britain and Northern Ireland
    id: Code_599
    instanceType: Code
    label: Code_599
- id: 1417
  properties:
    _type: Address
    city: city
    district: district
    id: Address_3
    instanceType: Address
    label: Address_3
    line: line
    postalCode: postal_code
    state: state
    text: line, city, district, state, postal_code, United Kingdom of Great Britain
      and Northern Ireland
- id: 1419
  properties:
    _type: StudySite
    currentEnrollment: null
    description: Main Site
    id: StudySite_1
    instanceType: StudySite
    label: StudySite_1
    name: SITE_1
- id: 1415
  properties:
    _type: ResearchOrganization
    id: ResearchOrganization_1
    identifier: '123456789'
    identifierScheme: DUNS
    instanceType: ResearchOrganization
    label: ResearchOrganization_1
    name: SITE_ORG_1
- id: 31
  properties:
    _type: StudyDesign
    bcCategories: []
    description: The main design for the study
    estimands: []
    id: StudyDesign_1
    instanceType: StudyDesign
    label: StudyDesign_1
    name: Study Design 1
    rationale: The discontinuation rate associated with this oral dosing regimen was
      58.6% in previous studies, and alternative clinical strategies have been sought
      to improve tolerance for the compound. To that end, development of a Transdermal
      Therapeutic System (TTS) has been initiated.
    studyInterventions: []
- id: 1421
  properties:
    _type: Code
    code: C94108
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Study Acronym
    id: Code_3
    instanceType: Code
    label: Code_3
- id: 1420
  properties:
    _type: StudyTitle
    id: StudyTitle_1
    instanceType: StudyTitle
    label: StudyTitle_1
    text: LZZT
- id: 1423
  properties:
    _type: Code
    code: C99905x1
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Brief Study Title
    id: Code_5
    instanceType: Code
    label: Code_5
- id: 1422
  properties:
    _type: StudyTitle
    id: StudyTitle_2
    instanceType: StudyTitle
    label: StudyTitle_2
    text: Xanomeline (LY246708)
- id: 1425
  properties:
    _type: Code
    code: C99905x2
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Official Study Title
    id: Code_6
    instanceType: Code
    label: Code_6
- id: 1424
  properties:
    _type: StudyTitle
    id: StudyTitle_3
    instanceType: StudyTitle
    label: StudyTitle_3
    text: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS)
      in Patients with Mild to Moderate Alzheimer's Disease
- id: 1427
  properties:
    _type: Code
    code: C99905x3
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Public Study Title
    id: Code_7
    instanceType: Code
    label: Code_7
- id: 1426
  properties:
    _type: StudyTitle
    id: StudyTitle_4
    instanceType: StudyTitle
    label: StudyTitle_4
    text: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS)
      in Patients with Mild to Moderate Alzheimer's Disease
- id: 2
  properties:
    _type: StudyVersion
    id: StudyVersion_1
    instanceType: StudyVersion
    label: StudyVersion_1
    rationale: The discontinuation rate associated with this oral dosing regimen was
      58.6% in previous studies, and alternative clinical strategies have been sought
      to improve tolerance for the compound. To that end, development of a Transdermal
      Therapeutic System (TTS) has been initiated.
    versionIdentifier: '2'
- id: 1430
  properties:
    _type: Code
    code: C25508
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Final
    id: Code_8
    instanceType: Code
    label: Code_8
- id: 1432
  properties:
    _type: Code
    code: C99903x1
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Protocol Effective Date
    id: Code_11
    instanceType: Code
    label: Code_11
- id: 1434
  properties:
    _type: Code
    code: C41129
    codeSystem: http://www.cdisc.org
    codeSystemVersion: '2023-12-15'
    decode: Region
    id: Code_13
    instanceType: Code
    label: Code_13
- id: 1436
  properties:
    _type: Code
    code: '150'
    codeSystem: ISO 3166 1 alpha3
    codeSystemVersion: 2020-08
    decode: Europe
    id: Code_12
    instanceType: Code
    label: Code_12
- id: 1435
  properties:
    _type: AliasCode
    id: AliasCode_2
    instanceType: AliasCode
    label: AliasCode_2
    standardCodeAliases: []
- id: 1433
  properties:
    _type: GeographicScope
    id: GeographicScope_2
    instanceType: GeographicScope
    label: GeographicScope_2
- id: 1431
  properties:
    _type: GovernanceDate
    dateValue: '2006-07-01'
    description: Protocol document approval date
    id: GovernanceDate_2
    instanceType: GovernanceDate
    label: GovernanceDate_2
    name: P_APPROVE
- id: 1437
  properties:
    _type: NarrativeContent
    id: NarrativeContent_1
    instanceType: NarrativeContent
    label: NarrativeContent_1
    name: ROOT
    sectionNumber: '0'
    sectionTitle: Root
    text: ''
- id: 1438
  properties:
    _type: NarrativeContent
    id: NarrativeContent_2
    instanceType: NarrativeContent
    label: NarrativeContent_2
    name: SECTION 0
    sectionNumber: '0'
    sectionTitle: Title Page
    text: "<div><div class=\"container\">\n<div class=\"row mt-5\">\n<div class=\"\
      col-md-10 offset-md-1 text-center border\">\n<p><small>The information contained\
      \ in this clinical study protocol is</small></p><p><small>Copyright \xA9 2006\
      \ Eli Lilly and Company.</small></p>\n</div>\n</div>\n<div class=\"row mt-5\"\
      >\n<div class=\"col-md-8 offset-md-2 text-center\">\n<p><strong><usdm:ref attribute=\"\
      text\" id=\"StudyTitle_2\" klass=\"StudyTitle\"></usdm:ref></strong></p>\n</div>\n\
      </div>\n<div class=\"row mt-3\">\n<div class=\"col-md-8 offset-md-2 text-center\"\
      >\n<p><strong><usdm:ref attribute=\"studyIdentifier\" id=\"StudyIdentifier_1\"\
      \ klass=\"StudyIdentifier\"></usdm:ref></strong></p>\n</div>\n</div>\n<div class=\"\
      row mt-3\">\n<div class=\"col-md-8 offset-md-2 text-center\">\n<p><strong><usdm:ref\
      \ attribute=\"text\" id=\"StudyTitle_3\" klass=\"StudyTitle\"></usdm:ref></strong></p>\n\
      </div>\n</div>\n</div></div>"
- id: 1439
  properties:
    _type: NarrativeContent
    id: NarrativeContent_3
    instanceType: NarrativeContent
    label: NarrativeContent_3
    name: SECTION 1
    sectionNumber: '1'
    sectionTitle: Introduction
    text: '<div><p>The M1 muscarinic-cholinergic receptor is 1 of 5 characterized
      muscarinic-cholinergic receptor subtypes (Fisher and Barak 1994). M1 receptors
      in the cerebral cortex and hippocampus are, for the most part, preserved in
      Alzheimer''s disease (AD), while the presynaptic neurons projecting to these
      receptors from the nucleus basalis of Meynert degenerate (Bierer et al. 1995).
      The presynaptic loss of cholinergic neurons has been correlated to the antimortum
      cognitive impairment in AD patients, prompting speculation that replacement
      therapy with cholinomimetics will alleviate the cognitive dysfunction of the
      disorder (Fisher and Barak 1994).</p>

      <p>Xanomeline is a novel M1 agonist which has shown high affinity for the M1
      receptor subtype (in transfected cells), and substantially less or no affinity
      for other muscarinic subtypes. Positron emission tomography (PET) studies of
      11C-labeled xanomeline in cynomolgus monkeys have suggested that the compound
      crosses the blood-brain barrier and preferentially binds the striatum and neocortex.</p>

      <p>Clinical development of an oral formulation of xanomeline for the indication
      of mild and moderate AD was initiated approximately 4 years ago. A large-scale
      study of safety and efficacy provided evidence that an oral dosing regimen of
      75 mg three times daily (TID) may be associated with enhanced cognition and
      improved clinical global impression, relative to placebo. As well, a dramatic
      reduction in psychosis, agitation, and other problematic behaviors, which often
      complicate the course of the disease, was documented. However, the discontinuation
      rate associated with this oral dosing regimen was 58.6%, and alternative clinical
      strategies have been sought to improve tolerance for the compound.</p>

      <p>To that end, development of a Transdermal Therapeutic System (TTS) has been
      initiated. Relative to the oral formulation, the transdermal formulation eliminates
      high concentrations of xanomeline in the gastrointestinal (GI) tract and presystemic
      (firstpass) metabolism. Three transdermal delivery systems, hereafter referred
      to as the xanomeline TTS Formulation A, xanomeline TTS Formulation B, and xanomeline
      TTS formulation E have been manufactured by Lohman Therapy Systems GmbH of Andernach
      Germany. TTS Formulation A is 27 mg xanomeline freebase in a 25-cm2 matrix.
      TTS Formulation B is 57.6 mg xanomeline freebase in a 40-cm2 matrix. Formulation
      E has been produced in 2 patch sizes: 1) 54 mg xanomeline freebase with 0.06
      mg Vitamin E USP in a 50-cm2 matrix and 2) 27 mg xanomeline freebase with 0.03
      mg Vitamin E USP in a 25-cm2 matrix. For a detailed description of the composition
      of these formulations please refer to Part II, Section 14 of the Xanomeline
      (LY246708) Clinical Investigator''s Brochure. For characterization of the safety,
      tolerance, and pharmacokinetics of xanomeline TTS Formulations A, B, and E,
      please refer to Part II, Sections 7, 8, and 10 of the Xanomeline (LY246708)
      Clinical Investigator''s Brochure. Formulation E will be studied in this protocol,
      H2Q-MC-LZZT(c).</p></div>'
- id: 1440
  properties:
    _type: NarrativeContent
    id: NarrativeContent_4
    instanceType: NarrativeContent
    label: NarrativeContent_4
    name: SECTION 2
    sectionNumber: '2'
    sectionTitle: Objectives
    text: <div></div>
- id: 1441
  properties:
    _type: NarrativeContent
    id: NarrativeContent_5
    instanceType: NarrativeContent
    label: NarrativeContent_5
    name: SECTION 2.1.
    sectionNumber: 2.1.
    sectionTitle: Primary Objectives
    text: '<div><p>The primary objectives of this study are</p>

      <ul>

      <li><usdm:ref attribute="text" id="Objective_1" klass="Objective"></usdm:ref></li>

      <li><usdm:ref attribute="text" id="Objective_2" klass="Objective"></usdm:ref></li>

      </ul></div>'
- id: 1442
  properties:
    _type: NarrativeContent
    id: NarrativeContent_6
    instanceType: NarrativeContent
    label: NarrativeContent_6
    name: SECTION 2.2
    sectionNumber: '2.2'
    sectionTitle: Secondary Objectives
    text: '<div><p>The secondary objectives of this study are</p>

      <ul>

      <li><usdm:ref attribute="text" id="Objective_3" klass="Objective"></usdm:ref></li>

      <li><usdm:ref attribute="text" id="Objective_4" klass="Objective"></usdm:ref></li>

      <li><usdm:ref attribute="text" id="Objective_5" klass="Objective"></usdm:ref></li>

      <li><usdm:ref attribute="text" id="Objective_6" klass="Objective"></usdm:ref></li>

      </ul></div>'
- id: 1443
  properties:
    _type: NarrativeContent
    id: NarrativeContent_7
    instanceType: NarrativeContent
    label: NarrativeContent_7
    name: SECTION 3
    sectionNumber: '3'
    sectionTitle: Investigational Plan
    text: <div></div>
- id: 1444
  properties:
    _type: NarrativeContent
    id: NarrativeContent_8
    instanceType: NarrativeContent
    label: NarrativeContent_8
    name: SECTION 3.1.
    sectionNumber: 3.1.
    sectionTitle: Summary of Study Design
    text: '<div><p>Patients with probable mild to moderate AD will be studied in a
      randomized, double-blind, parallel (3 arm), placebo-controlled trial of 26 weeks
      duration. The study will be conducted on an outpatient basis. Approximately
      300 patients will be enrolled (see Schedule of Events for Protocol H2Q-MC-LZZT(c),
      Attachment LZZT.1).</p>

      <p>Following informed consent, patients will be screened at Visit 1. At screening,
      patients will undergo complete neuropsychiatric assessment, psychometric testing,
      and general medical assessment (including medical history, pre-existing conditions,
      physical examination). In addition, vital signs, temperature, medication history,
      electrocardiogram (ECG), chest x-ray, and safety laboratories will be obtained.
      During the screening visit, patients will wear a placebo TTS to determine willingness
      and ability to comply with transdermal administration procedures. If patients
      have not had central nervous system (CNS) imaging in the previous 12 months,
      a computed tomography (CT) or magnetic resonance imaging (MRI) scan will be
      obtained. If patients are insulin dependent diabetics, a hemoglobin A 1c will
      be obtained. Screening exams and procedures may be performed after Visit 1;
      however, their results must be completed and available prior to randomization.
      The screening process should occur within 2 weeks of randomization (Visit 3
      of the study).</p>

      <p>Patients who meet enrollment criteria from Visit 1 will proceed to Visit
      2 at which time they will undergo a 24-hour Ambulatory ECG. At Visit 3 the Ambulatory
      ECG will be removed and patients will be randomized to 1 of 3 treatment arms.
      The treatment arms will include a placebo arm, a low-dose xanomeline arm (50
      cm 2 TTS Formulation E, 54 mg xanomeline), and a high-dose xanomeline arm (75
      cm 2 TTS Formulation E, 81 mg xanomeline). All patients receiving xanomeline
      will be started at 50 cm 2 TTS Formulation E. For the first 8 weeks of treatment,
      patients will be assessed at clinic visits every 2 weeks and, thereafter, at
      clinic visits every 4 weeks. Patients who discontinue prior to Visit 12 (Week
      24) will be brought back for full efficacy assessments at or near to 24 weeks,
      whenever possible.</p>

      <p>A Data Safety Monitoring Board (DSMB), chaired by an external cardiologist,
      will meet after 75, 150, 225, and 300 patients have completed 1 month of treatment.
      The DSMB will review cardiovascular findings to decide if discontinuation of
      the study or any treatment arm is appropriate, if additional cardiovascular
      monitoring is required, if further cardiovascular monitoring is unnecessary,
      or if adjustment of dose within a treatment arm (or arms) is appropriate (see
      Section 3.9.4).</p>

      <p>At Visits 3, 8, 10, and 12, efficacy instruments (ADAS-Cog, CIBIC+, and DAD)
      will be administered. NPI-X will be administered at 2-week intervals either
      at clinic visits or via a telephone interview. Vital signs, temperature, and
      an assessment of adverse events will</p>

      <p>be obtained at all clinic visits. An electrocardiogram (ECG), and chemistry/hematology
      safety labs will be obtained at Visits 4, 5, 7, 8, 9, 10, 11, 12, and 13. Urinalysis
      will be done at Visits 4, 9, and 12. Use of concomitant medications will be
      collected at Visits 3, 4, 5, 7, 8, 9, 10, 11, 12, and 13. Plasma levels of xanomeline
      and metabolites will be obtained at Visits 3, 4, 5, 7, 9, and 11. At Visits
      3, 4, 5, 7, 8, 9, 10, 11, and 12, medications will be dispensed to the patients.</p>

      <p>Visits 1 through 13 should be scheduled relative to Visit 3 (Week 0 - randomization).
      Visits 4, 5, 7, 8, and 13 should occur within 3 days of their scheduled date.
      Visits 9, 10, 11, and 12 should occur within 4 days of their scheduled date.
      At Visit 13 patients will be given the option to enter the open-label extension
      phase (see Section 3.10.3. Study Extensions).</p>

      <img src="data:image/{''png''};base64,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"/>

      <p><b>Figure LZZT.1. Illustration of study design for Protocol H2Q-MC-LZZT(c).</b></p></div>'
- id: 1445
  properties:
    _type: NarrativeContent
    id: NarrativeContent_9
    instanceType: NarrativeContent
    label: NarrativeContent_9
    name: SECTION 3.2.
    sectionNumber: 3.2.
    sectionTitle: Discussion of Design and Control
    text: '<div><p>Previous studies of the oral formulation have shown that xanomeline
      tartrate may improve behavior and cognition. Effects on behavior are manifest
      within 2 to 4 weeks of initiation of treatment. The same studies have shown
      that 8 to 12 weeks are required to demonstrate effects on cognition and clinical
      global assessment. This study is intended to determine the acute and chronic
      effects of the TTS formulation in AD; for that reason, the study is of 26 weeks
      duration. Dosage specification has been made on the basis of tolerance to the
      xanomeline TTS in a clinical pharmacology study (H2Q-EW-LKAA), and target plasma
      levels as determined in studies of the oral formulation of xanomeline (H2Q-MC-LZZA).</p>

      <p>The parallel dosing regimen maximizes the ability to make direct comparisons
      between the treatment groups. The use of placebo allows for a blinded, thus
      minimally biased, study. The placebo treatment group is a comparator group for
      efficacy and safety assessment.</p>

      <p>Two interim analyses are planned for this study. The first interim analysis
      will occur when 50% of the patients have completed Visit 8 (8 weeks). If required,
      the second interim analysis will occur when 50% of the patients have completed
      Visit 12 (24 weeks). (See Section 4.6, Interim Analyses.)</p></div>'
- id: 1446
  properties:
    _type: NarrativeContent
    id: NarrativeContent_10
    instanceType: NarrativeContent
    label: NarrativeContent_10
    name: SECTION 3.3.
    sectionNumber: 3.3.
    sectionTitle: Investigator Information
    text: <div><p>The name, title, and institution of the investigator(s) is/are listed
      on the Investigator/Contacts cover pages provided with this protocol. If the
      investigator is changed after the study has been approved by an ethical review
      board, or a regulatory agency, or by Lilly, this addition will not be considered
      a change to the protocol. However, the Investigator/Contacts cover pages will
      be updated to provide this information.</p></div>
- id: 1447
  properties:
    _type: NarrativeContent
    id: NarrativeContent_11
    instanceType: NarrativeContent
    label: NarrativeContent_11
    name: SECTION 3.3.1.
    sectionNumber: 3.3.1.
    sectionTitle: Final Report Signature
    text: '<div><p>The final report coordinating investigator will sign the final
      clinical study report for this study, indicating agreement with the analyses,
      results, and conclusions of the report.</p>

      <p>The investigator who will serve as the final report coordinating investigator
      will be an individual that is involved with the design and analysis of the study.
      This final report coordinating investigator will be named by the sponsor of
      the study.</p></div>'
- id: 1448
  properties:
    _type: NarrativeContent
    id: NarrativeContent_12
    instanceType: NarrativeContent
    label: NarrativeContent_12
    name: SECTION 3.4.
    sectionNumber: 3.4.
    sectionTitle: Study Population
    text: <div></div>
- id: 1449
  properties:
    _type: NarrativeContent
    id: NarrativeContent_13
    instanceType: NarrativeContent
    label: NarrativeContent_13
    name: SECTION 3.4.1.
    sectionNumber: 3.4.1.
    sectionTitle: Entry Procedures
    text: <div><p>An Ethical Review Board (ERB) approved informed consent will be
      signed by the patient (and/or legal representative) and caregiver after the
      nature of the study is explained.</p></div>
- id: 1450
  properties:
    _type: NarrativeContent
    id: NarrativeContent_14
    instanceType: NarrativeContent
    label: NarrativeContent_14
    name: SECTION 3.4.2.
    sectionNumber: 3.4.2.
    sectionTitle: Criteria for Enrollment
    text: "<div><p>For Lilly studies, the following definitions are used:</p>\n<div\
      \ class=\"row\">\n<div class=\"col-2\"><strong>Screen</strong></div>\n<div class=\"\
      col\">\n<p>Screening is the act of determining if an individual meets minimum\
      \ requirements to become part of a pool of potential candidates for participation\
      \ in a clinical study.</p>\n<p>In this study, <strong>screening</strong> will\
      \ include asking the candidate preliminary questions (such as age and general\
      \ health status) and conducting invasive or diagnostic procedures and/or tests\
      \ (for example, diagnostic psychological tests, x-rays, blood draws). Patients\
      \ will sign the consent at their screening visit, thereby consenting to undergo\
      \ the screening procedures and to participate in the study if they qualify.</p>\n\
      </div>\n</div>\n<div class=\"row\">\n<div class=\"col-2\">To <strong>enter</strong></div>\n\
      <div class=\"col\">\n<p>Patients <strong>entered</strong> into the study are\
      \ those from whom informed consent for the study has been obtained. Adverse\
      \ events will be reported for each patient who has <strong>entered</strong>\
      \ the study, even if the patient is never assigned to a treatment group (<strong>enrolled</strong>).</p>\n\
      </div>\n</div>\n<div class=\"row\">\n<div class=\"col-2\">To <strong>enroll</strong></div>\n\
      <div class=\"col\">\n<p>Patients who are enrolled in the study are those who\
      \ have been assigned to a treatment group. Patients who are entered into the\
      \ study but fail to meet criteria specified in the protocol for treatment assignment\
      \ will not be enrolled in the study.</p>\n</div>\n</div>\n<p>At Visit 1, patients\
      \ who meet the enrollment criteria of Mini-Mental State Examination (MMSE) score\
      \ of 10 to 23 (Attachment LZZT.6), Hachinski Ischemia Score \u22644 (Attachment\
      \ LZZT.8), a physical exam, safety labs, ECG, and urinalysis, will proceed to\
      \ Visit 2 and Visit 3. At Visit 3, patients whose CNS imaging and other pending\
      \ labs from Visit 1 satisfy the inclusion criteria (Section 3.4.2.1) will be\
      \ enrolled in the study. Approximately 300 patients with a diagnosis of probable\
      \ mild to moderate AD will be enrolled in the study.</p></div>"
- id: 1451
  properties:
    _type: NarrativeContent
    id: NarrativeContent_15
    instanceType: NarrativeContent
    label: NarrativeContent_15
    name: SECTION 3.4.2.1.
    sectionNumber: 3.4.2.1.
    sectionTitle: Inclusion Criteria
    text: '<div><p>Patients may be included in the study only if they meet <b>all</b>
      the following criteria:</p>

      <table class="table"><tr><td>01</td><td><usdm:ref attribute="text" id="EligibilityCriterion_1"
      klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>02</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_2" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>03</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_3" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>04</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_4" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>05</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_5" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>06</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_6" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>07</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_7" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>08</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_8" klass="EligibilityCriterion"></usdm:ref></td></tr></table></div>'
- id: 1452
  properties:
    _type: NarrativeContent
    id: NarrativeContent_16
    instanceType: NarrativeContent
    label: NarrativeContent_16
    name: SECTION 3.4.2.2.
    sectionNumber: 3.4.2.2.
    sectionTitle: Exclusion Criteria
    text: '<div><p>Patients will be excluded from the study for <b>any</b> of the
      following reasons:</p>

      <table class="table"><tr><td>09</td><td><usdm:ref attribute="text" id="EligibilityCriterion_9"
      klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>10</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_10" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>11</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_11" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>12</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_12" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>13</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_13" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>14</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_14" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>15</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_15" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>16b</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_16" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>17</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_17" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>18</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_18" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>19</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_19" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>20</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_20" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>21</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_21" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>22</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_22" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>23</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_23" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>24</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_24" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>25</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_25" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>26</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_26" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>27b</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_27" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>28b</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_28" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>29b</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_29" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>30b</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_30" klass="EligibilityCriterion"></usdm:ref></td></tr><tr><td>31b</td><td><usdm:ref
      attribute="text" id="EligibilityCriterion_31" klass="EligibilityCriterion"></usdm:ref></td></tr></table></div>'
- id: 1453
  properties:
    _type: NarrativeContent
    id: NarrativeContent_17
    instanceType: NarrativeContent
    label: NarrativeContent_17
    name: SECTION 3.4.2.3
    sectionNumber: 3.4.2.3
    sectionTitle: Violation of Criteria for Enrollment
    text: <div><p>The criteria for enrollment must be followed explicitly. If there
      is inadvertent enrollment of individuals who do not meet enrollment criteria,
      these individuals should be discontinued from the study. Such individuals can
      remain in the study only if there are ethical reasons to have them continue.
      In these cases, the investigator must obtain approval from the Lilly research
      physician for the study participant to continue in the study (even if the study
      is being conducted through a contract research organization).</p></div>
- id: 1454
  properties:
    _type: NarrativeContent
    id: NarrativeContent_18
    instanceType: NarrativeContent
    label: NarrativeContent_18
    name: SECTION 3.4.3.
    sectionNumber: 3.4.3.
    sectionTitle: Disease Diagnostic Criteria
    text: "<div><p>Probable AD will be defined clinically by NINCDS/ADRDA guidelines\
      \ as follows:</p>\n<ul>\n<li><p>Diagnosis of probable AD as defined by National\
      \ Institute of Neurological and Communicative Disorders and Stroke (NINCDS)\
      \ and the Alzheimer's Disease and Related Disorders Association (ADRDA) guidelines.</p></li>\n\
      <li><p>Mild to moderate severity of AD will be defined by the Mini-Mental State\
      \ Exam as follows:</p></li>\n<li><p>Mini-Mental State Examination (MMSE) score\
      \ of 10 to 23.</p></li>\n<li><p>The absence of other causes of dementia will\
      \ be performed by clinical opinion and by the following:</p></li>\n<li><p>Hachinski\
      \ Ischemic Scale score of \u22644.</p></li>\n<li><p>CNS imaging (CT scan or\
      \ MRI of brain) compatible with AD within past 1 year (see Section 3.4.2.1).</p></li>\n\
      </ul></div>"
- id: 1455
  properties:
    _type: NarrativeContent
    id: NarrativeContent_19
    instanceType: NarrativeContent
    label: NarrativeContent_19
    name: SECTION 3.4.4.
    sectionNumber: 3.4.4.
    sectionTitle: Sample Size
    text: <div><p>Approximately 100 patients will be randomized to each of the 3 treatment
      groups. Previous experience with the oral formulation of xanomeline suggests
      that this sample size has 90% power to detect a 3.0 mean treatment difference
      in ADAS-Cog (p&lt;.05, two-sided), based on a standard deviation of 6.5. Furthermore,
      this sample size has 80% power to detect a 0.36 mean treatment difference in
      CIBIC+ (p&lt;.05, two-sided), based on a standard deviation of 0.9.</p></div>
- id: 1456
  properties:
    _type: NarrativeContent
    id: NarrativeContent_20
    instanceType: NarrativeContent
    label: NarrativeContent_20
    name: SECTION 3.5.
    sectionNumber: 3.5.
    sectionTitle: Patient Assignment
    text: '<div><p>Commencing at Visit 1, all patients will be assigned an identification
      number. This identification number and the patient''s three initials must appear
      on all patient-related documents submitted to Lilly.</p>

      <p>When qualified for enrollment at Visit 3 the patient will be randomized to
      1 of 3 treatment arms.</p></div>'
- id: 1457
  properties:
    _type: NarrativeContent
    id: NarrativeContent_21
    instanceType: NarrativeContent
    label: NarrativeContent_21
    name: SECTION 3.6.
    sectionNumber: 3.6.
    sectionTitle: Dosage and Administration
    text: <div></div>
- id: 1458
  properties:
    _type: NarrativeContent
    id: NarrativeContent_22
    instanceType: NarrativeContent
    label: NarrativeContent_22
    name: SECTION 3.6.1.
    sectionNumber: 3.6.1.
    sectionTitle: Materials and Supplies
    text: '<div><table class="table small">

      <tr>

      <td><p>Primary Study Material:</p></td><td><p>Xanomeline</p></td><td><p>TTS
      (adhesive patches)</p></td><td><p>50 cm 2 , 54 mg* 25 cm 2 , 27 mg<sup>*</sup></p></td>

      </tr>

      <tr>

      <td><p>Comparator Material:</p></td><td><p>Placebo</p></td><td><p>TTS</p></td><td><p>Identical
      in appearance to primary study material</p></td>

      </tr>

      </table>

      <p class="small"><sup>*</sup>All doses are measured in terms of the xanomeline
      base.</p>

      <p>Patches should be stored at controlled room temperature, and all used patches
      must be handled and disposed of as biohazardous waste.</p>

      <p>For a detailed description of the composition of these formulations please
      refer to Part II, Section 14 of the Xanomeline (LY246708) Clinical Investigator''s
      Brochure.</p></div>'
- id: 1459
  properties:
    _type: NarrativeContent
    id: NarrativeContent_23
    instanceType: NarrativeContent
    label: NarrativeContent_23
    name: SECTION 3.6.2.
    sectionNumber: 3.6.2.
    sectionTitle: TTS Administration Procedures
    text: '<div><p>To test acute tolerance of transdermal formulation, patients will
      have a TTS (placebo) administered at the start of Visit 1, and removed at the
      conclusion of Visit 1. The patient''s and caregiver''s willingness to comply
      with 26 weeks of transdermal therapy should be elicited, and those patients/caregivers
      unwilling to comply should be excluded.</p>

      <p>Upon enrollment at Visit 3, and on the morning of each subsequent day of
      therapy , xanomeline or placebo will be administered with the application of
      2 adhesive patches, one 50 cm2 in area, the other 25 cm2 in area. Each morning,
      prior to the application of the patches, hydrocortisone cream (1%) should be
      applied to the skin at the intended site of administration, rubbed in, and allowed
      to penetrate for approximately 30 minutes. Thereafter, excess cream should be
      wiped away and the patches applied.</p>

      <p>The patches are to be worn continuously throughout the day, for a period
      of approximately 12 to 14 hours, and removed in the evening. After removal of
      the patches, hydrocortisone cream (1%) should be applied locally to the site
      of administration.</p>

      <p>Patches should be applied to a dry, intact, non-hairy area. Applying the
      patch to a shaved area is not recommended. The application site of the patches
      should be rotated according to the following schedule:</p>

      <table class="table">

      <tr>

      <th><p>Day</p></th><th><p>Patch Location</p></th>

      </tr>

      <tr>

      <td><p>Sunday </p></td><td><p>right or left upper arm </p></td>

      </tr>

      <tr>

      <td><p>Monday </p></td><td><p>right or left upper back </p></td>

      </tr>

      <tr>

      <td><p>Tuesday </p></td><td><p>right or left lower back (above belt line) </p></td>

      </tr>

      <tr>

      <td><p>Wednesday </p></td><td><p>right or left buttocks </p></td>

      </tr>

      <tr>

      <td><p>Thursday </p></td><td><p>right or left mid-axillary region </p></td>

      </tr>

      <tr>

      <td><p>Friday </p></td><td><p>right or left upper thigh </p></td>

      </tr>

      <tr>

      <td><p>Saturday</p></td><td><p>right or left upper chest</p></td>

      </tr>

      </table>

      <p>Patients and caregivers are free to select either the left or right site
      within the constraints of the rotation schedule noted above. Patches should
      be applied at approximately the same time each day. For patients who habitually
      bathe in the morning, the patient should bathe prior to application of new patches.
      Every effort should be taken to allow for morning administration of the patches.
      Exceptions allowing administration of TTS patches at night instead of in the
      morning will be made on a case-by-case basis by the CRO medical monitor. In
      the event that some adhesive remains on the patient''s skin and cannot be removed
      with normal bathing, a special solution will be provided to remove the adhesive.</p>

      <p>Following randomization at Visit 3, patients will be instructed to call the
      site if they have difficulty with application or wearing of patches. In the
      event that a patch becomes detached, a new patch of the same size should be
      applied (at earliest convenience) to an area of the dermis adjacent to the detachment
      site, and the rotation schedule should be resumed the following morning. If
      needed, the edges of the patch may be secured with a special adhesive tape that
      will be provided. If daily doses are reduced, improperly administered, or if
      a patch becomes detached and requires application of a new patch on three or
      more days in any 30-day period, the CRO research physician will be notified.</p>

      <p>If the daily dose is reduced or improperly administered in the 24 hours prior
      to any scheduled clinic visit, the visit should be rescheduled (except for early
      termination and retrieval visits).</p>

      <p>Patients must be instructed to return all used and unused study drug to the
      investigator at each visit for proper disposal and CT reconciliation by the
      investigator.</p></div>'
- id: 1460
  properties:
    _type: NarrativeContent
    id: NarrativeContent_24
    instanceType: NarrativeContent
    label: NarrativeContent_24
    name: SECTION 3.7.
    sectionNumber: 3.7.
    sectionTitle: Blinding
    text: '<div><p>The study will be double-blind. To further preserve the blinding
      of the study, only a minimum number of Lilly and CRO personnel will see the
      randomization table and codes before the study is complete.</p>

      <p>Emergency codes generated by a computer drug-labeling system will be available
      to the investigator. These codes, which reveal the patients treatment group,
      may be opened during the study only if the choice of follow-up treatment depends
      on the patient''s therapy assignment.</p>

      <p>The investigator should make every effort to contact the clinical research
      physician prior to unblinding a patient''s therapy assignment. If a patient''s
      therapy assignment is unblinded, Lilly must be notified immediately by telephone.
      After the study, the investigator must return all sealed and any opened codes.</p></div>'
- id: 1461
  properties:
    _type: NarrativeContent
    id: NarrativeContent_25
    instanceType: NarrativeContent
    label: NarrativeContent_25
    name: SECTION 3.8.
    sectionNumber: 3.8.
    sectionTitle: Concomitant Therapy
    text: "<div><p>Intermittent use of chloral hydrate, zolpidem, or lorazepam is\
      \ permitted during this clinical trial as indicated for agitation or sleep.\
      \ If medication is required for agitation for a period exceeding 1 week, a review\
      \ of the patient's status should be made in consultation with the CRO research\
      \ physician. Caregivers and patients should be reminded that these medications\
      \ should not be taken within 24 hours of a clinic visit (including the enrollment\
      \ visit), and administration of efficacy measures should be deferred if the\
      \ patient has been treated with these medications within the previous 24 hours.</p>\n\
      <p>If an antihistamine is required during the study, Claritin\xAE (loratadine)\
      \ or Allegra\xAE (fexofenadine hydrochloride) are the preferred agents, but\
      \ should not be taken within 24 hours of a clinic visit. Intermittent use (per\
      \ package insert) of antitussives (containing antihistamines or codeine) and\
      \ select narcotic analgesics (acetaminophen with oxycodone, acetaminophen with\
      \ codeine) are permitted during the trial. Caregivers and patients should be\
      \ reminded that antihistamines and narcotics should not be taken within 3 days\
      \ of a clinic efficacy visit (including enrollment visit). If an H 2 blocker\
      \ is required during the study, Axid\xAE (nizatidine) will be permitted on a\
      \ case-by-case basis by the CRO medical monitor. For prostatic hypertrophy,\
      \ small doses (2 mg per day) of Hytrin\xAE (terazosin) or Cardura\xAE (doxazosin)\
      \ will be permitted on a case-by-case basis. Please consult the medical monitor.\
      \ The calcium channel blockers Cardene\xAE (nicardipine),</p>\n<p>Norvasc\xAE\
      \ (amlodipine), and DynaCirc\xAE (isradipine) are allowed during the study.\
      \ If a patient has been treated with any medication within disallowed time periods\
      \ prior to the clinic visit, efficacy measures should be deferred.</p>\n<p>Other\
      \ classes of medications not stated in Exclusion Criteria, Section 3.4.2.2,\
      \ will be permitted. Patients who require treatment with an excluded medication\
      \ (Section 3.4.2.2) will be discontinued from the study following consultation\
      \ with the CRO research physician.</p></div>"
- id: 1462
  properties:
    _type: NarrativeContent
    id: NarrativeContent_26
    instanceType: NarrativeContent
    label: NarrativeContent_26
    name: SECTION 3.9.
    sectionNumber: 3.9.
    sectionTitle: Efficacy, Pharmacokinetic, and Safety Evaluations
    text: <div></div>
- id: 1463
  properties:
    _type: NarrativeContent
    id: NarrativeContent_27
    instanceType: NarrativeContent
    label: NarrativeContent_27
    name: SECTION 3.9.1.
    sectionNumber: 3.9.1.
    sectionTitle: Efficacy
    text: <div><p>See Schedule of Events, Attachment LZZT.1 for the times of the study
      at which efficacy data will be collected.</p></div>
- id: 1464
  properties:
    _type: NarrativeContent
    id: NarrativeContent_28
    instanceType: NarrativeContent
    label: NarrativeContent_28
    name: SECTION 3.9.1.1.
    sectionNumber: 3.9.1.1.
    sectionTitle: Efficacy Measures
    text: "<div><p>The following measures will be performed in the course of the study.\
      \ At Visits 3, 8, 10, and 12, ADAS-Cog, CIBIC+, and DAD will be administered.\
      \ NPI-X will be administered at 2-week intervals either at clinic visits or\
      \ via a telephone interview. Efficacy measures will also be collected at early\
      \ termination visits, and at the retrieval visit. The neuropsychological assessment\
      \ should be performed first; other protocol requirements, such as labs and the\
      \ physical, should follow.</p>\n<ol type=\"a\">\n<li><p><b>Alzheimer's Disease\
      \ Assessment Scale - Cognitive Subscale (ADAS-Cog):</b> ADAS-Cog is an established\
      \ measure of cognitive function in Alzheimer's Disease. This scale has been\
      \ incorporated into this study by permission of Dr. Richard C. Mohs and the\
      \ American Journal of Psychiatry and was adapted from an article entitled, \u201C\
      The Alzheimer's Disease Assessment Scale (ADAS),\u201D which was published in\
      \ the American Journal of Psychiatry, Volume No.141, pages 1356-1364, November,\
      \ 1984, Copyright 1984.</p>\n<p><b>The ADAS-Cog (11) and the ADAS-Cog (14):</b>\
      \ The ADAS-Cog (11) is a standard 11-item instrument used to assess word recall,\
      \ naming objects, commands, constructional praxis, ideational praxis, orientation,\
      \ word recognition tasks, spoken language ability, comprehension, word finding\
      \ difficulty, and recall of test instructions. For the purposes of this study,\
      \ three items (delayed word recall, attention/visual search task, and maze solution)\
      \ have been added to the ADAS-Cog (11) to assess the patient's attention and\
      \ concentration. The 14 item instrument will be referred to as the ADAS-Cog\
      \ (14). At each efficacy visit, all 14 items will be assessed, and in subsequent\
      \ data analyses, performance on the ADAS-Cog (14) and performance on the subset\
      \ ADAS-Cog (11) will be considered.</p></li>\n<li><p><b>Video-referenced Clinician's\
      \ Interview-Based Impression of Change (CIBIC+):</b> The CIBIC+ is an assessment\
      \ of the global clinical status relative to baseline. The CIBIC+ used in this\
      \ study is derived from the Clinical Global Impression of Change, an instrument\
      \ in the public domain, developed by the National Institute on Aging Alzheimer's\
      \ Disease Study Units Program (1 U01 AG10483; Leon Thal, Principal Investigator).\
      \ The instrument employs semi-structured interviews with the patient and caregiver,\
      \ to assess mental/cognitive state, behavior, and function. These domains are\
      \ not individually scored, but rather are aggregated in the assignment of a\
      \ global numeric score on a 1 to 7 scale (1 = marked improvement; 4 = no change;\
      \ and 7 = marked worsening).</p>\n<p>The clinician assessing CIBIC+ will have\
      \ at least one year of experience with the instrument and will remain blinded\
      \ to all other efficacy and safety measures.</p></li>\n<li><p><b>Revised Neuropsychiatric\
      \ Inventory (NPI-X):</b> The NPI-X is an assessment of change in psychopathology\
      \ in patients with dementia. The NPI-X is administered to the designated caregiver.\
      \ This instrument has been revised from its original version (Cummings et al.\
      \ 1994) and incorporated into this study with the permission of Dr. Jeffrey\
      \ L. Cummings.</p></li>\n<li><p><b>Disability Assessment for Dementia (DAD):</b>\
      \ The DAD is used to assess functional abilities of activities of daily living\
      \ (ADL) in individuals with cognitive impairment. This scale has been revised\
      \ and incorporated into this study by permission of Louise Gauthier, M.Sc.,\
      \ and Dr. Isabelle Gelinas. The DAD is administered to the designated caregiver.</p></li>\n\
      </ol>\n<p>For each instrument, each assessment is to be performed by the same\
      \ trained health care professional. If circumstances preclude meeting this requirement,\
      \ the situation is to be documented on the Clinical Report Form (CRF), and the\
      \ CRO research physician is to be notified.</p>\n<p>In addition to the efficacy\
      \ measures noted above, a survey form will be used to collect information from\
      \ the caregiver on TTS acceptability (Attachment LZZT.9).</p></div>"
- id: 1465
  properties:
    _type: NarrativeContent
    id: NarrativeContent_29
    instanceType: NarrativeContent
    label: NarrativeContent_29
    name: SECTION 3.9.1.2.
    sectionNumber: 3.9.1.2.
    sectionTitle: Efficacy Criteria
    text: '<div><p>Group mean changes from baseline in the primary efficacy parameters
      will serve as efficacy criteria. The ADAS-Cog (11) and the video-referenced
      CIBIC+ will serve as the primary efficacy instruments. Secondary efficacy instruments
      will include the DAD, the NPI-X, and the ADAS-Cog (14). The procedures and types
      of analyses to be done are outlined in Section 4.</p>

      <p>The primary analysis of efficacy will include only the data obtained up to
      and including the visit of discontinuation of study drug. Furthermore, the primary
      analysis will not include efficacy data obtained at any visit where the study
      drug was not administered in the preceding three days. Analyses that include
      the retrieved dropouts are considered secondary.</p></div>'
- id: 1466
  properties:
    _type: NarrativeContent
    id: NarrativeContent_30
    instanceType: NarrativeContent
    label: NarrativeContent_30
    name: SECTION 3.9.2.
    sectionNumber: 3.9.2.
    sectionTitle: Pharmacokinetics
    text: "<div><p>Blood samples (7 mL) for the determination of xanomeline concentrations\
      \ in plasma will be collected from each patient at Visits 3, 4, 5, 7, 9, and\
      \ 11. The blood sample drawn at Visit 3 is a baseline sample. The remaining\
      \ 5 clinic visits should be scheduled so that 1 blood sample is collected at\
      \ any time during each of the following intervals: early AM visit (hold application\
      \ of new patch until after blood sample is collected); 9AM to 11AM; 11AM to\
      \ 1PM; 1PM to 3PM; and 3PM to 5PM. Collection of blood samples during each of\
      \ these intervals should not occur in any particular order, nor should they\
      \ occur in the same order for each patient. Every effort should be made to comply\
      \ with the suggested sampling times. This blood-sampling schedule is based on\
      \ a sparse sampling strategy where only a few samples will be collected from\
      \ each patient. The most crucial aspect of the sampling design is to record\
      \ the date and exact time the sample was drawn and to record the date and time\
      \ of patch application on the day of the clinic visit and the previous 2 days.</p>\n\
      <p>If a patient is discontinued from the study prior to protocol completion,\
      \ a pharmacokinetic blood sample should be drawn at the early discontinuation\
      \ visit. The date and exact time the sample was drawn and the date of the last\
      \ patch application should be recorded.</p>\n<p>Immediately after collection,\
      \ each sample will be centrifuged at approximately 177 \xD7 <i>G</i> for 15\
      \ minutes. The plasma will be transferred into a polypropylene tube bearing\
      \ the identical label as the blood collection tube. Samples will be capped and\
      \ frozen at approximately \u221220\xB0C. Care must be taken to insure that the\
      \ samples remain frozen during transit.</p>\n<p>The samples will be shipped\
      \ on dry ice to Central Laboratory.</p></div>"
- id: 1467
  properties:
    _type: NarrativeContent
    id: NarrativeContent_31
    instanceType: NarrativeContent
    label: NarrativeContent_31
    name: SECTION 3.9.3.
    sectionNumber: 3.9.3.
    sectionTitle: Safety
    text: '<div><p>Investigators are responsible for monitoring the safety of patients
      who have entered this study and for alerting CRO to any event that seems unusual,
      even if this event may be considered an unanticipated benefit to the patient.
      See Section 3.9.3.2.1.</p>

      <p>Investigators must ensure that appropriate medical care is maintained throughout
      the study and after the trial (for example, to follow adverse events).</p></div>'
- id: 1468
  properties:
    _type: NarrativeContent
    id: NarrativeContent_32
    instanceType: NarrativeContent
    label: NarrativeContent_32
    name: SECTION 3.9.3.1.
    sectionNumber: 3.9.3.1.
    sectionTitle: Safety Measures
    text: <div><p>Safety measures will be performed at designated times by recording
      adverse events, laboratory test results, vital signs (including supine/standing
      pulse and blood pressure readings) ECG monitoring, and Ambulatory ECGs (see
      Schedule of Events, Attachment LZZT.1).</p></div>
- id: 1469
  properties:
    _type: NarrativeContent
    id: NarrativeContent_33
    instanceType: NarrativeContent
    label: NarrativeContent_33
    name: SECTION 3.9.3.2.
    sectionNumber: 3.9.3.2.
    sectionTitle: Clinical Adverse Events
    text: '<div><p>Lilly has standards for reporting adverse events that are to be
      followed, regardless of applicable regulatory requirements that are less stringent.
      For purposes of collecting and evaluating <i>all</i> information about Lilly
      drugs used in clinical trials, an adverse event is defined as any undesirable
      experience or an unanticipated benefit (see Section 3.9.3.2.1) that occurs after
      informed consent for the study has been obtained, without regard to treatment
      group assignment, even if no study medication has been taken. Lack of drug effect
      is not an adverse event in clinical trials, because the purpose of the clinical
      trial is to establish drug effect.</p>

      <p>At the first visit, study site personnel will question the patient and will
      note the occurrence and nature of presenting condition(s) and of any preexisting
      condition(s). At subsequent visits, site personnel will again question the patient
      and will note any change in the presenting condition(s), any change in the preexisting
      condition(s), and/or the occurrence and nature of any adverse events.</p></div>'
- id: 1470
  properties:
    _type: NarrativeContent
    id: NarrativeContent_34
    instanceType: NarrativeContent
    label: NarrativeContent_34
    name: SECTION 3.9.3.2.1.
    sectionNumber: 3.9.3.2.1.
    sectionTitle: Adverse Event Reporting Requirements
    text: "<div><p>All adverse events must be reported to CRO via case report form.</p>\n\
      <p>Study site personnel must report to CRO immediately, by telephone, any <b>serious</b>\
      \ adverse event (see Section 3.9.3.2.2 below), or if the investigator <b>unblinds</b>\
      \ a patient's treatment group assignment because of an adverse event or for\
      \ any other reason.</p>\n<p>If a patient's dosage is reduced or if a patient\
      \ is discontinued from the study because of any significant laboratory abnormality,\
      \ inadequate response to treatment, or any other reason, the circumstances and\
      \ data leading to any such dosage reduction or discontinuation must be reported\
      \ and clearly documented by study site personnel on the clinical report form.</p>\n\
      <p>An event that may be considered an unanticipated benefit to the patient (for\
      \ example, sleeping longer) should be reported to CRO as an adverse event on\
      \ the clinical report form. \u201CUnanticipated benefit\u201D is a COSTART classification\
      \ term. In cases where the investigator notices an unanticipated benefit to\
      \ the patient, study site personnel should enter the actual term such as \u201C\
      sleeping longer,\u201D and code \u201Cunanticipated benefit\u201D in the clinical\
      \ report form adverse event section.</p>\n<p>Solicited adverse events from the\
      \ skin rash questionnaire (see Section 3.9.3.4) should be reported on the questionnaire\
      \ only and not also on the adverse event clinical report form</p></div>"
- id: 1471
  properties:
    _type: NarrativeContent
    id: NarrativeContent_35
    instanceType: NarrativeContent
    label: NarrativeContent_35
    name: SECTION 3.9.3.2.2.
    sectionNumber: 3.9.3.2.2.
    sectionTitle: Serious Adverse Events
    text: '<div><p>Study site personnel must report to CRO immediately, by telephone,
      any adverse event from this study that is alarming or that:</p>

      <ul>

      <li><p>Results in death</p></li>

      <li><p>Results in initial or prolonged inpatient hospitalization</p></li>

      <li><p>Is life-threatening</p></li>

      <li><p>Results in severe or permanent disability</p></li>

      <li><p>Results in cancer [(other than cancers diagnosed prior to enrollment
      in studies involving patients with cancer)]</p></li>

      <li><p>Results in a congenital anomaly</p></li>

      <li><p>Is a drug overdose</p></li>

      <li><p>Is significant for any other reason.</p></li>

      </ul>

      <p>Definition of <i>overdose</i>: For a drug under clinical investigation, an
      overdose is any intentional or unintentional consumption of the drug (by any
      route) that exceeds the dose recommended in the Clinical Investigator''s Brochure
      or in an investigational protocol, whichever dose is larger. For a marketed
      drug, a drug overdose is any intentional or unintentional consumption of the
      drug (by any route) that exceeds the dose listed in product labeling, even if
      the larger dose is prescribed by a physician.</p></div>'
- id: 1472
  properties:
    _type: NarrativeContent
    id: NarrativeContent_36
    instanceType: NarrativeContent
    label: NarrativeContent_36
    name: SECTION 3.9.3.3.
    sectionNumber: 3.9.3.3.
    sectionTitle: Clinical Laboratory Tests
    text: "<div><p>Table LZZT.1 lists the clinical laboratory tests that will be performed\
      \ at Visit 1.</p>\n<p><b>Table LZZT.1. Laboratory Tests Performed at Admission\
      \ (Visit 1)</b></p>\n<style>\n  ul.no-bullets {\n    list-style-type: none;\n\
      \    margin: 0;\n    padding: 5;\n  }\n</style>\n<p><b>Safety Laboratory Tests</b></p>\n\
      <table class=\"table\">\n<tr>\n<td>\n<p><b>Hematology:</b></p>\n<p><ul class=\"\
      no-bullets\">\n<li>Hemoglobin</li>\n<li>Hematocrit</li>\n<li>Erythrocyte count\
      \ (RBC)</li>\n<li>Mean cell volume (MCV)</li>\n<li>Mean cell hemoglobin (MCH)\
      \ </li>\n<li>Mean cell hemoglobin concentration (MCHC) </li>\n<li>Leukocytes\
      \ (WBC)</li>\n<li>Neutrophils, segmented </li>\n<li>Neutrophils, juvenile (bands)</li>\n\
      <li>Lymphocytes </li>\n<li>Monocytes </li>\n<li>Eosinophils </li>\n<li>Basophils\
      \ </li>\n<li>Platelet </li>\n<li>Cell morphology</li>\n</ul></p>\n<p><b>Urinalysis:</b></p>\n\
      <p><ul class=\"no-bullets\">\n<li>Color </li>\n<li>Specific gravity</li>\n<li>pH</li>\n\
      <li>Protein</li>\n<li>Glucose</li>\n<li>Ketones</li>\n<li>Bilirubin</li>\n<li>Urobilinogen</li>\n\
      <li>Blood </li>\n<li>Nitrite</li>\n<li>Microscopic examination of sediment</li>\n\
      </ul></p>\n</td>\n<td>\n<p><b>Clinical Chemistry - Serum Concentration of:</b></p>\n\
      <p><ul class=\"no-bullets\">\n<li>Sodium</li>\n<li>Potassium</li>\n<li>Bicarbonate</li>\n\
      <li>Total bilirubin </li>\n<li>Alkaline phosphatase (ALP) </li>\n<li>Gamma-glutamyl\
      \ transferase (GGT) </li>\n<li>Alanine transaminase (ALT/SGPT) </li>\n<li>Aspartate\
      \ transaminase (AST/SGOT) </li>\n<li>Blood urea nitrogen (BUN) </li>\n<li>Serum\
      \ creatinine </li>\n<li>Uric acid </li>\n<li>Phosphorus </li>\n<li>Calcium </li>\n\
      <li>Glucose, nonfasting </li>\n<li>Total protein </li>\n<li>Albumin </li>\n\
      <li>Cholesterol </li>\n<li>Creatine kinase (CK)</li>\n</ul></p>\n<p><b>Thyroid\
      \ Function Test (Visit 1 only):</b></p>\n<ul class=\"no-bullets\">\n<li>Free\
      \ thyroid index</li>\n<li>T<sub>3</sub> Uptake</li>\n<li>T<sub>4</sub></li>\n\
      <li>Thyroid-stimulating hormone (TSH)</li>\n</ul>\n<p><b>Other Tests (Visit\
      \ 1 only):</b></p>\n<ul class=\"no-bullets\">\n<li>Folate</li>\n<li>Vitamin\
      \ B 12</li>\n<li>Syphilis screening</li>\n<li>Hemoglobin A<sup>1C</sup> (IDDM\
      \ patients only)</li></ul>\n</td>\n</tr>\n</table>\n<p>Laboratory values that\
      \ fall outside a clinically accepted reference range or values that differ significantly\
      \ from previous values must be evaluated and commented on by the investigator\
      \ by marking CS (for clinically significant) or NCS (for not clinically significant)\
      \ next to the values. Any clinically significant laboratory values that are\
      \ outside a clinically acceptable range or differ importantly from a previous\
      \ value should be further commented on in the clinical report form comments\
      \ page.</p>\n<p>Hematology, and clinical chemistry will also be performed at\
      \ Visits 4, 5, 7, 8, 9, 10, 11, 12, and 13. Patients that experience a rash\
      \ and/or eosinophilia may have additional hematology samples obtained as described\
      \ in 3.9.3.4 (Other Safety Measures).</p>\n<p>Urinalysis will also be performed\
      \ at Visits 4, 9, and 12. The following criteria have been developed to monitor\
      \ hepatic function.</p>\n<ul>\n<li><p>Patients with ALT/SGPT levels &gt;120\
      \ IU will be retested weekly.</p>\n<li><p>Patients with ALT/SGPT values &gt;400\
      \ IU, or alternatively, an elevated ALT/SGPT accompanied by GGT and/or ALP values\
      \ &gt;500 IU will be retested within 2 days. The sponsor's clinical research\
      \ administrator or clinical research physician is to be notified. If the retest\
      \ value does not decrease by at least 10%, the study drug will be discontinued;\
      \ additional laboratory tests will be performed until levels return to normal.\
      \ If the retest value does decrease by 10% or more, the study drug may be continued\
      \ with monitoring at 3 day intervals until ALT/SGPT values decrease to &lt;400\
      \ IU or GGT and/or ALP values decrease to &lt;500 IU. \n</p></li></li></ul></div>"
- id: 1473
  properties:
    _type: NarrativeContent
    id: NarrativeContent_37
    instanceType: NarrativeContent
    label: NarrativeContent_37
    name: SECTION 3.9.3.4
    sectionNumber: 3.9.3.4
    sectionTitle: Other Safety Measures
    text: "<div><b>Patients experiencing Rash and/or Eosinophilia</b>\n<p>The administration\
      \ of placebo and xanomeline TTS is associated with a rash and/or eosinophilia\
      \ in some patients. The rash is characterized in the following ways:</p>\n<ul>\n\
      <li><p>The rash is confined to sites of application.</p></li>\n<li><p>The rash\
      \ may be associated with pruritus.</p></li>\n<li><p>In 5% of cases of rash observed\
      \ in the Interim Analysis, blistering has been observed.</p></li>\n<li><p>The\
      \ onset of rash may occur at any time during the course of the study.</p></li>\n\
      <li><p>A moderate eosinophilia (0.6-1.5 x 103 /microliter) is associated with\
      \ rash and has been noted in approximately 10% of patients.</p></li>\n</ul>\n\
      <p>It does not appear that the rash constitutes a significant safety risk; however,\
      \ it could affect the well-being of the patients. The following monitoring is\
      \ specified:</p>\n<p><b>Skin Rash Follow-up</b></p>\n<p>For patients who exit\
      \ the study or its extension with rash at the site(s) of application:</p>\n\
      <ol type=\"a\">\n<li><p>Approximately 2 weeks after the last visit, the study\
      \ site personnel should contact the patient/caregiver by phone and complete\
      \ the skin rash questionnaire. (Note: those patients with rash who have previously\
      \ exited the study or its extension should be contacted at earliest convenience.)</p></li>\n\
      <li><p>If caregiver states unequivocally that skin problems have completely\
      \ resolved, no further follow-up is needed.</p></li>\n<li><p>If caregiver reports\
      \ scarring and/or other problems, patient should return to clinic for a follow-up\
      \ visit. The skin rash questionnaire should again be completed. If in the opinion\
      \ of the investigator, further follow-up is required, contact the CRO medical\
      \ monitor. Completed skin rash questionnaires should be faxed to CRO.</p></li>\n\
      </ol>\n<p>Completion of the questionnaires will create a separate data set for\
      \ solicited adverse events. In completing these forms please note the following:</p>\n\
      <ol>\n<li><p>Solicited events (events discovered as result of completion of\
      \ follow-up questionnaires) should be reported on questionnaire page only.</p></li>\n\
      <li><p>Spontaneously reported adverse events (events presented by the patient\
      \ without direct questioning of the event) should be reported as described in\
      \ 3.9.3.2 .1 (Adverse Event Reporting Requirements).</p></li>\n</ol>\n<p>Serious\
      \ adverse events should be handled and reported as described in 3.9.3.2.1 without\
      \ regard to whether the event is solicited or spontaneously reported.</p>\n\
      <p><b>Eosinophilia Follow-up</b></p>\n<ol>\n<li><p>For patients that are currently\
      \ in the study with eosinophil counts greater than 0. 6x10 3 /microliter:</p>\n\
      <ul><li><p>Repeat hematology at each visit until resolved in the opinion of\
      \ the investigator.</p></li></ul>\n<li><p>For patients that are currently in\
      \ the study with eosinophil counts greater than 1.5x10 3 /microliter:</p>\n\
      <ul><li><p>Obtain hematology profile every 2 weeks until resolved or explained\
      \ by other causes in the opinion of the investigator.</p></li>\n<li><p>Notify\
      \ CRO medical monitor.</p></li>\n</ul>\n<li><p>For patients with eosinophil\
      \ counts greater than 0.6x10 3 /microliter at exit \nfrom the study or its extension:</p>\n\
      <ul>\n<li><p>Obtain hematology profile approximately every 2 weeks until resolved\
      \ or, in the opinion of the investigator, explained by other causes. (Note:\
      \ patients with eosinophil counts greater than 0.6x10 3 /microliter who have\
      \ previously exited the study or its extension should return for hematology\
      \ profile at earliest convenience.)</p></li>\n</ul>\n<ol></ol></li></li></li></ol></div>"
- id: 1474
  properties:
    _type: NarrativeContent
    id: NarrativeContent_38
    instanceType: NarrativeContent
    label: NarrativeContent_38
    name: SECTION 3.9.3.4.1
    sectionNumber: 3.9.3.4.1
    sectionTitle: Vital Sign Determination
    text: '<div><p>Patient should lie supine quietly for at least 5 minutes prior
      to vital signs measurement. Blood pressure should be measured in the dominant
      arm with a standardized mercury manometer according to the American Heart Association
      standard recommendations. Diastolic blood pressure will be measured as the point
      of disappearance of the Korotkoff sounds (phase V). Heart rate will be measured
      by auscultation. Patient should then stand up. Blood pressure should again be
      measured in the dominant arm and heart rate should be measured after approximately
      1 and 3 minutes.</p>

      <p>An automated blood pressure cuff may be used in place of a mercury manometer
      if it is regularly (at least monthly) standardized against a mercury manometer.</p></div>'
- id: 1475
  properties:
    _type: NarrativeContent
    id: NarrativeContent_39
    instanceType: NarrativeContent
    label: NarrativeContent_39
    name: SECTION 3.9.3.4.2
    sectionNumber: 3.9.3.4.2
    sectionTitle: Cardiovascular Safety Measures
    text: "<div><p>Cardiovascular status will be assessed during the trial with the\
      \ following measures:</p>\n<ul>\n<li><p>All patients will be screened by obtaining\
      \ a 12-lead ECG, and will have repeat ECGs performed at Visits 4, 5, 7, 8, 9,\
      \ 10, 11, 12, 13, and early termination (ET) (see Schedule of Events, Attachment\
      \ LZZT.1).</p></li>\n<li><p>All patients will undergo a 24-hour Ambulatory ECG\
      \ at Visit 2 (prior to the initiation of study medication). Although every effort\
      \ will be made to obtain the entire 24-hour ambulatory ECG recording, this may\
      \ not always be feasible because of patient behavior or technical difficulties.\
      \ The minimal recording period for an ambulatory ECG to be considered interpretable\
      \ will be 8 hours, of which at least 3 hours must be sleep.</p></li>\n<li><p>The\
      \ incidence of syncope, defined as an observed loss of consciousness and muscle\
      \ tone not attributable to transient ischemic attack or to seizure, will be\
      \ closely monitored. Caregivers will be instructed to report any instance of\
      \ syncopal episodes to the investigator within 24 hours. The investigator should\
      \ immediately report such events to the CRO research physician. The CRO research\
      \ physician will make a clinical assessment of each episode, and with the investigator\
      \ determine if continuation of \ntherapy is appropriate. These findings will\
      \ be reported to the Lilly research physician immediately.</p></li>\n<ul></ul></ul></div>"
- id: 1476
  properties:
    _type: NarrativeContent
    id: NarrativeContent_40
    instanceType: NarrativeContent
    label: NarrativeContent_40
    name: SECTION 3.9.4.
    sectionNumber: 3.9.4.
    sectionTitle: Safety Monitoring
    text: "<div><p>The CRO research physician will monitor safety data throughout\
      \ the course of the study.</p>\n<p>Cardiovascular measures, including ECGs and\
      \ 24-hour Ambulatory ECGs (see Section 3.9.3.4.2) will be monitored on an ongoing\
      \ basis as follows:</p>\n<ul>\n<li><p>As noted in Section 3.9.3.4.2, all patients\
      \ will be screened by obtaining a 12-lead ECG, and will have repeat ECGs performed\
      \ at Visits 4, 5, 7, 8, 9, 10, 11, 12, 13, and early termination (ET) (see Schedule\
      \ of Events for Protocol H2Q-MC-LZZT(c), Attachment LZZT.1). ECG data will be\
      \ interpreted at the site and express mailed overnight to a central facility\
      \ which will produce a report within 48 hours. The report will be forwarded\
      \ to the investigator. At screening, the report of the central facility will\
      \ be used to exclude patients according to criteria specified in Section 3.4.2.2.\
      \ If, during the treatment phase of the study, review of ECG data (either at\
      \ the site or at the central facility) reveals left bundle branch block, bradycardia\
      \ \u226450 beats per minute, sinus pauses &gt;2 seconds, second degree heart\
      \ block, third degree heart block, Wolff-Parkinson-White syndrome, sustained\
      \ supraventricular tachyarrhythmia, or ventricular tachycardia at a rate of\
      \ \u2265120 beats per minute lasting \u226510 seconds, the investigator, the\
      \ Lilly research physician, the CRO research physician, and the cardiologist\
      \ chairing the DSMB will be notified immediately, and discontinuation of the\
      \ patient will be considered.</p></li>\n<li><p>As noted in Section 3.9.3.4.2,\
      \ all patients will undergo a 24-hour Ambulatory ECG at Visit 2 (prior to the\
      \ initiation of study medication).  Ambulatory ECG data from Visit 2 will be\
      \ express mailed overnight to a central facility which will produce a report\
      \ within 24 hours. The report will be forwarded to the investigator. If a report\
      \ documents sustained ventricular tachycardia with rate &gt;120 beats per minute,\
      \ third degree heart block, or sinus pauses of &gt;6.0 seconds, the investigator,\
      \ the Lilly research \nphysician, the CRO research physician, and the cardiologist\
      \ chairing the DSMB will be notified immediately, and the patient will be discontinued.\
      \ If any report documents sinus pauses of &gt;3.0 seconds or second degree heart\
      \ block, the CRO research physician, and Lilly research physician, and cardiologist\
      \ chairing the DSMB will be immediately notified and the record will be reviewed\
      \ within 24 hours of notification by the cardiologist chairing the DSMB.</p></li>\n\
      </ul>\n<p>In addition to ongoing monitoring of cardiac measures, a comprehensive,\
      \ periodic review of cardiovascular safety data will be conducted by the DSMB,\
      \ which will be chaired by an external cardiologist with expertise in arrhythmias,\
      \ their pharmacological bases, and their clinical implications. The membership\
      \ of the board will also include two other external cardiologists, a cardiologist\
      \ from Lilly, a statistician from Lilly, and the Lilly research physician. Only\
      \ the three external cardiologists will be voting members.</p>\n<p>After approximately\
      \ 75 patients have completed 1 month of treatment, the DSMB will meet to decide:</p>\n\
      <ul>\n<li><p>If discontinuation of the study or any treatment arm is appropriate</p></li>\n\
      <li><p>If additional cardiovascular monitoring is required</p></li>\n<li><p>If\
      \ further cardiovascular monitoring is unnecessary</p></li>\n<li><p>If adjustment\
      \ of dose within a treatment arm (or arms) is appropriate.</p></li>\n</ul>\n\
      <p>If necessary, this analysis will be repeated after 150 patients have completed\
      \ 1 month of treatment, after 225 patients have completed 1 month of treatment,\
      \ and after 300 patients have completed 1 month of treatment. Primary consideration\
      \ will be given to the frequency of pauses documented in Ambulatory ECG reports.\
      \ The number of pauses greater than or equal to 2, 3, 4, 5, and 6 seconds will\
      \ be tabulated. Primary analysis will focus on the number of pauses greater\
      \ than or equal to 3 seconds.</p>\n<p>In the event of a high incidence of patient\
      \ discontinuation due to syncope, the following guideline may be employed by\
      \ the DSMB in determining if discontinuation of any treatment arm is appropriate.\
      \ If the frequency of syncope in a xanomeline treatment arm relative to the\
      \ frequency of syncope in the placebo arm equals or exceeds the following numbers,\
      \ then consideration will be given to discontinuing that treatment arm. The\
      \ Type I error rate for this rule is approximately 0.032 if the incidence in\
      \ each group is 0.04. The power of this rule is 0.708 if the incidence is 0.04\
      \ for placebo and 0.16 for xanomeline TTS.</p>\n<table class=\"table table-bordered\"\
      >\n<tr><td><p>Placebo</p></td><td><p>Xanomeline</p></td><td></td><td>Placebo</td><td>Xanomeline</td></tr>\n\
      <tr><td><p>0</p></td><td><p>6</p></td><td></td><td>6</td><td>15</td></tr>\n\
      <tr><td><p>1</p></td><td><p>7</p></td><td></td><td>7</td><td>16</td></tr>\n\
      <tr><td><p>2</p></td><td><p>9</p></td><td></td><td>8</td><td>17</td></tr>\n\
      <tr><td><p>3</p></td><td><p>11</p></td><td></td><td>9</td><td>18</td></tr>\n\
      <tr><td><p>4</p></td><td><p>12</p></td><td></td><td>10</td><td>20</td></tr>\n\
      <tr><td><p>5</p></td><td><p>13</p></td><td></td><td>X</td><td>2X (2-fold)</td></tr>\n\
      </table>\n<p>This rule has been used in other studies for monitoring spontaneous\
      \ events with an incidence of less than 10%. This rule is constructed assuming\
      \ a 2-group comparison with each group having a final sample size of 100. Unblinding\
      \ which occurs during these analyses will be at the group level and will be\
      \ documented.</p>\n<p>The stopping rule based on Ambulatory ECG findings is\
      \ as follows:</p>\n<style type=\"text/css\">\n .indent { margin-left: 20px;\
      \ }\n</style>\n<p class=\"indent\">If the number of patients experiencing a\
      \ pause of \u22656 seconds in a xanomeline treatment arm relative to the number\
      \ of patients in the placebo arm equals or exceeds the numbers in the following\
      \ table, then that treatment arm will be discontinued. The Type I error rate\
      \ for this rule is approximately 0.044 if the incidence in each group is 0.01.\
      \ The power of this rule is 0.500 if the incidence is 0.01 for placebo and 0.04\
      \ for xanomeline TTS.</p>\n<table class=\"table table-bordered\">\n<tr><td><p>Placebo</p></td><td><p>Xanomeline</p></td></tr>\n\
      <tr><td><p>0</p></td><td><p>3</p></td></tr>\n<tr><td><p>1</p></td><td><p>5</p></td></tr>\n\
      <tr><td><p>2</p></td><td><p>6</p></td></tr>\n<tr><td><p>3</p></td><td><p>7</p></td></tr>\n\
      <tr><td><p>4</p></td><td><p>8</p></td></tr>\n<tr><td><p>x</p></td><td><p>2x</p></td></tr>\n\
      </table></div>"
- id: 1477
  properties:
    _type: NarrativeContent
    id: NarrativeContent_41
    instanceType: NarrativeContent
    label: NarrativeContent_41
    name: SECTION 3.9.5.
    sectionNumber: 3.9.5.
    sectionTitle: Appropriateness and Consistency of Measurements
    text: <div><p>The medications and efficacy measurements have been used in other
      studies in elderly subjects and patients.</p></div>
- id: 1478
  properties:
    _type: NarrativeContent
    id: NarrativeContent_42
    instanceType: NarrativeContent
    label: NarrativeContent_42
    name: SECTION 3.10.
    sectionNumber: 3.10.
    sectionTitle: Patient Disposition Criteria
    text: <div></div>
- id: 1479
  properties:
    _type: NarrativeContent
    id: NarrativeContent_43
    instanceType: NarrativeContent
    label: NarrativeContent_43
    name: SECTION 3.10.1.
    sectionNumber: 3.10.1.
    sectionTitle: Discontinuations
    text: "<div><p>Participation in the study shall be terminated for any patient\
      \ who is unable or unwilling to comply with the study protocol or who develops\
      \ a serious adverse event.</p>\n<p>In addition, patients may be discontinued\
      \ for any of the following reasons:</p>\n<ul>\n<li><p>In the opinion of the\
      \ investigator, a significant adverse event occurs or the \nsafety of the patient\
      \ is otherwise compromised.</p></li>\n<li><p>The patient requests to be withdrawn\
      \ from the study.</p></li>\n<li><p>The physician in charge of the study or Lilly,\
      \ for any reason stops the \npatient's participation in the study.</p></li>\n\
      </ul>\n<p>If a patient's participation terminates early, an early termination\
      \ visit should be scheduled. Upon decision to discontinue a patient from the\
      \ study, the patient's dose should be titrated down by instructing the patient\
      \ to immediately remove the 25-cm2 patch. Patients should be instructed to continue\
      \ to apply a 50-cm2 patch daily until the early termination visit, at which\
      \ time the drug will be discontinued. Physical exam, vital signs, temperature,\
      \ use of concomitant medications, chemistry/hematology/urinalysis labs, xanomeline\
      \ plasma sample, TTS acceptability survey, efficacy measures, adverse events,\
      \ and an ECG will be collected at the early termination visit.</p>\n<p>In the\
      \ event that a patient's participation or the study itself is terminated, the\
      \ patient shall return all study drug(s) to the investigator.</p></div>"
- id: 1480
  properties:
    _type: NarrativeContent
    id: NarrativeContent_44
    instanceType: NarrativeContent
    label: NarrativeContent_44
    name: SECTION 3.10.1.1.
    sectionNumber: 3.10.1.1.
    sectionTitle: Retrieval of Discontinuations
    text: <div><p>If possible, patients who have terminated early will be retrieved
      on the date which would have represented Visit 12 (Week 24). Vital signs, temperature,
      use of concomitant medications, adverse events, and efficacy measure assessment
      will be gathered at this visit. If the patient is not retrievable, this will
      be documented in the source record.</p></div>
- id: 1481
  properties:
    _type: NarrativeContent
    id: NarrativeContent_45
    instanceType: NarrativeContent
    label: NarrativeContent_45
    name: SECTION 3.10.2.
    sectionNumber: 3.10.2.
    sectionTitle: Qualifications for Analysis
    text: <div><p>All patients who are enrolled in the study will be included in the
      efficacy analysis and the safety analysis. Patients will not be excluded from
      the efficacy analysis for reasons such as non-compliance or ineligibility, except
      for the time period immediately preceding the efficacy assessment (see Section
      3.9.1.2).</p></div>
- id: 1482
  properties:
    _type: NarrativeContent
    id: NarrativeContent_46
    instanceType: NarrativeContent
    label: NarrativeContent_46
    name: SECTION 3.10.3.
    sectionNumber: 3.10.3.
    sectionTitle: Study Extensions
    text: <div><p>Patients who successfully complete the study will be eligible for
      participation in an openlabel extension phase, where every patient will be treated
      with active agent. The patients who elect to participate in the open-label extension
      phase will be titrated to their maximally titrated dose. This open-label extension
      phase will continue until the time the product becomes marketed and is available
      to the public or until the project is discontinued by the sponsor. Patients
      may terminate at any time at their request.</p></div>
- id: 1483
  properties:
    _type: NarrativeContent
    id: NarrativeContent_47
    instanceType: NarrativeContent
    label: NarrativeContent_47
    name: SECTION 3.10.3.1.
    sectionNumber: 3.10.3.1.
    sectionTitle: Compliance
    text: "<div><p>Because patients enrolled in this study will be outpatients, the\
      \ knowledge that patients have taken the medication as prescribed will be assured\
      \ in the following ways:</p>\n<ol type=\"a\">\n<li><p>Investigators will attempt\
      \ to select those patients and caregivers who \nhave been judged to be compliant.</p></li>\n\
      <li><p>Study medication including unused, partially used, and empty patch \n\
      containers will be returned at each clinical visit so that the remaining \n\
      medication can be counted by authorized investigator staff (nurse, \npharmacist,\
      \ or physician). The number of patches remaining will be \nrecorded on the CRF.</p></li>\n\
      <li><p>Following randomization at Visit 3, patients will be instructed to call\
      \ \nthe site if they have difficulty with application or wearing of patches.\
      \ If \ndaily doses are reduced, improperly administered, or if a patch becomes\
      \ \ndetached and requires application of a new patch on three or more days \n\
      in any 30-day period, the CRO research physician will be notified.</p></li>\n\
      </ol>\n<p>If the daily dose is reduced or improperly administered in the 24\
      \ hours prior to any scheduled clinic visit, the visit should be rescheduled\
      \ (except for early termination and retrieval visits).</p></div>"
- id: 1484
  properties:
    _type: NarrativeContent
    id: NarrativeContent_48
    instanceType: NarrativeContent
    label: NarrativeContent_48
    name: SECTION 3.11.
    sectionNumber: 3.11.
    sectionTitle: Quality Assurance
    text: "<div><p>To ensure both the safety of participants in the study, and the\
      \ collection of accurate, complete, and reliable data, Lilly or its representatives\
      \ will perform the following activities:</p>\n<ul>\n<li><p>Provide instructional\
      \ material to the study sites, as appropriate.</p></li>\n<li><p>Sponsor a start-up\
      \ training session to instruct the investigators and study \ncoordinators. This\
      \ session will give instruction on the protocol, the \ncompletion of the clinical\
      \ report forms, and study procedures.</p></li>\n<li><p>Make periodic visits\
      \ to the study site.</p></li>\n<li><p>Be available for consultation and stay\
      \ in contact with the study site \npersonnel by mail, telephone, and/or fax.</p></li>\n\
      <li><p>Review and evaluate clinical report form data and use standard computer\
      \ \nedits to detect errors in data collection.</p></li>\n</ul>\n<p>To ensure\
      \ the safety of participants in the study and to ensure accurate, complete,\
      \ and reliable data, the investigator will do the following:</p>\n<ul>\n<li><p>Keep\
      \ records of laboratory tests, clinical notes, and patient medical records in\
      \ the patient files as original source documents for the study.</p></li>\n</ul>\n\
      <p>Lilly or its representatives may periodically check a sample of the patient\
      \ data recorded against source documents at the study site. The study may be\
      \ audited by Lilly Medical Quality Assurance (MQA) and/or regulatory agencies\
      \ at any time. Investigators will be given notice before an MQA audit occurs.</p></div>"
- id: 1485
  properties:
    _type: NarrativeContent
    id: NarrativeContent_49
    instanceType: NarrativeContent
    label: NarrativeContent_49
    name: SECTION 4
    sectionNumber: '4'
    sectionTitle: Data Analysis Methods
    text: <div></div>
- id: 1486
  properties:
    _type: NarrativeContent
    id: NarrativeContent_50
    instanceType: NarrativeContent
    label: NarrativeContent_50
    name: SECTION 4.1.
    sectionNumber: 4.1.
    sectionTitle: General Considerations
    text: "<div><p>In general, all patients will be included in all analyses of efficacy\
      \ if they have a baseline measurement and at least one postrandomization measurement.\
      \ Refer to Section 3.9.1.2. for a discussion of which specific efficacy data\
      \ will be included in the primary analysis.</p>\n<p>In the event that the doses\
      \ of xanomeline TTS are changed after the study starts, the analysis will be\
      \ of three treatment groups (high dose, low dose, and placebo), even though\
      \ patients within the high dose treatment group, for example, may not all be\
      \ at exactly the same dose. Also, if the dose is changed midway through the\
      \ study, the mean dose within each group will be used in the dose response analysis\
      \ described in Section 4.3.3.</p>\n<p>All analyses described below will be conducted\
      \ using the most current production version of SAS\xAE available at the time\
      \ of analysis.</p></div>"
- id: 1487
  properties:
    _type: NarrativeContent
    id: NarrativeContent_51
    instanceType: NarrativeContent
    label: NarrativeContent_51
    name: SECTION 4.2.
    sectionNumber: 4.2.
    sectionTitle: "Demographics and Patient Characteristics Measured at \nBaseline"
    text: <div><p>All measures (for example, age, gender, origin) obtained at either
      Visits 1, 2, or 3, prior to randomization, will be summarized by treatment group
      and across all treatment groups. The groups will be compared by analysis of
      variance (ANOVA) for continuous variables and by Pearson's chi-square test for
      categorical variables. Note that because patients are randomized to 1 of the
      3 treatment groups, any statistically significant treatment group differences
      are by definition a Type I error; however, the resulting p-values will be used
      as another descriptive statistic to help focus possible additional analyses
      (for example, analysis of covariance, subset analyses) on those factors that
      are most imbalanced (that is, that have the smallest p-values).</p></div>
- id: 1488
  properties:
    _type: NarrativeContent
    id: NarrativeContent_52
    instanceType: NarrativeContent
    label: NarrativeContent_52
    name: SECTION 4.3.
    sectionNumber: 4.3.
    sectionTitle: Efficacy Analyses
    text: <div></div>
- id: 1489
  properties:
    _type: NarrativeContent
    id: NarrativeContent_53
    instanceType: NarrativeContent
    label: NarrativeContent_53
    name: SECTION 4.3.1.
    sectionNumber: 4.3.1.
    sectionTitle: Efficacy Variables to be Analyzed
    text: "<div><p>Efficacy measures are described in Section 3.9.1.1. As stated in\
      \ Section 3.9.1.2, the primary outcome measures are the ADAS-Cog (11) and CIBIC+\
      \ instruments. Because both of these variables must reach statistical significance,\
      \ an adjustment to the nominal p-values is necessary in order to maintain a\
      \ .05 Type I error rate for this study. This adjustment is described in detail\
      \ in Section 4.3.5.</p>\n<p>The DAD will be analyzed with respect to the total\
      \ score, as well as the subscores of \ninitiation, planning and organization,\
      \ and effective performance. This variable is \nconsidered a secondary variable\
      \ in the US, but is a third primary variable in Europe.</p>\n<p>The NPI-X is\
      \ a secondary variable. The primary assessment of this instrument will be for\
      \ the total score, not including the sleep, appetite, and euphoria domains.\
      \ This total score is computed by taking the product of the frequency and severity\
      \ scores and summing them up across the domains. Secondary variables derived\
      \ from the NPI-X include evaluating each domain/behavior separately. Also, caregiver\
      \ distress from the NPI-X will be analyzed.</p>\n<p>ADAS-Cog (14) and each of\
      \ the 14 individual components will also be analyzed. In addition, a subscore\
      \ of the ADAS-Cog will be computed and analyzed, based on results from a previous\
      \ large study of oral xanomeline. This subscore, referred to as ADAS-Cog (4),\
      \ will be the sum of constructional praxis, orientation, spoken language ability,\
      \ and word finding difficulty in spontaneous speech.</p>\n<p>Any computed total\
      \ score will be treated as missing if more than 30% of the items are missing\
      \ or scored \u201Cnot applicable\u201D. For example, when computing ADAS-Cog(11),\
      \ if 4 or more items are missing, then the total score will not be computed.\
      \ When one or more items are missing (but not more than 30%), the total score\
      \ will be adjusted in order to maintain the full range of the scale. For example,\
      \ ADAS-Cog(11) is a 0-70 scale. If the first item, Word Recall (ranges from\
      \ 0 to 10), is missing, then the remaining 10 items of the ADAS-Cog(11) will\
      \ be summed and multiplied by (70 / (70-10) ), or 7/6. This computation will\
      \ occur for all totals and subtotals of ADAS-Cog and NPI-X. DAD is a 40 item\
      \ questionnaire where each question is scored as either \u201C0\u201D or \u201C\
      1\u201D. The DAD total score and component scores are reported as percentage\
      \ of items that are scored \u201C1\u201D. So if items of the DAD are \u201C\
      not applicable\u201D or missing, the percentage will be computed for only those\
      \ items that are scored. As an example, if two items are missing (leaving 38\
      \ that are scored), and there are 12 items scored as \u201C1\u201D, the rest\
      \ as \u201C0\u201D, then the DAD score is 12/38=.316.</p></div>"
- id: 1490
  properties:
    _type: NarrativeContent
    id: NarrativeContent_54
    instanceType: NarrativeContent
    label: NarrativeContent_54
    name: SECTION 4.3.2.
    sectionNumber: 4.3.2.
    sectionTitle: Times of Analyses
    text: "<div><p>Baseline data will be collected at Visit 3.</p>\n<p>The primary\
      \ analysis of ADAS-Cog (11) and CIBIC+ will be the 24-week endpoint, which is\
      \ defined for each patient and variable as the last measurement obtained postrandomization\
      \ (prior to protocol defined reduction in dose).</p>\n<p>Similar analyses at\
      \ 24 weeks will be conducted for the secondary efficacy variables. Analysis\
      \ of patients who complete the 24-week study will also be conducted for all\
      \ efficacy variables; this is referred to as a \u201Ccompleter\u201D analysis.</p>\n\
      <p>Additionally, each of the efficacy variables will be analyzed at each time\
      \ point both as \u201Cactual cases,\u201D that is, analyzing the data collected\
      \ at the various time points, and also as a last-observation-carried-forward\
      \ (LOCF). Note that the LOCF analysis at 24 weeks is the same as the endpoint\
      \ analysis described previously.</p>\n<p>Several additional analyses of NPI-X\
      \ will be conducted. Data from this instrument will be collected every 2 weeks,\
      \ and represent not the condition of the patient at that moment in time, but\
      \ rather the worst condition of the patient in the time period since the most\
      \ recent NPI-X administration. For this reason, the primary analysis of the\
      \ NPI-X will be of the average of all postrandomization NPI-X subscores except\
      \ for the one obtained at Week 2. In the event of early discontinuations, those\
      \ scores that correspond to the interval between Weeks 2 to 24 will be averaged.\
      \ The reason for excluding Week 2 data from this analysis is that patients could\
      \ be confused about when a behavior actually stops after randomization; the\
      \ data obtained at Week 2 could be somewhat \u201Ctainted.\u201D Also, by requiring\
      \ 2 weeks of therapy prior to use of the NPI-X data, the treatment difference\
      \ should be maximized by giving the drug 2 weeks to work, thereby increasing\
      \ the statistical power. Secondary analyses of the NPI-X will include the average\
      \ of all postrandomization weeks, including measures obtained at Weeks 2 and\
      \ 26.</p></div>"
- id: 1491
  properties:
    _type: NarrativeContent
    id: NarrativeContent_55
    instanceType: NarrativeContent
    label: NarrativeContent_55
    name: SECTION 4.3.3.
    sectionNumber: 4.3.3.
    sectionTitle: Statistical Methodology
    text: "<div><p>The primary method to be used for the primary efficacy variables\
      \ described in Sections 4.3.1 and 4.3.2 will be analysis of covariance (ANCOVA),\
      \ except for CIBIC+ which is a score that reflects change from baseline, so\
      \ there is no corresponding baseline CIBIC+ score. Effects in the ANCOVA model\
      \ will be the corresponding baseline score, investigator, and treatment. CIBIC+\
      \ will be analyzed by analysis of variance (ANOVA), with effects in the model\
      \ being investigator and treatment. Investigator-by-treatment interaction will\
      \ be tested in a full model prior to conducting the primary ANCOVA or ANOVA\
      \ (see description below).</p>\n<p>Because 3 treatment groups are involved,\
      \ the primary analysis will be the test for linear dose response in the ANCOVA\
      \ and ANOVA models described in the preceding paragraph. The result is then\
      \ a single p-value for each of ADAS-Cog and CIBIC+.</p>\n<p>Analysis of the\
      \ secondary efficacy variables will also be ANCOVA. Pairwise treatment comparisons\
      \ of the adjusted means for all efficacy variables will be conducted using a\
      \ LSMEANS statement within the GLM procedure.</p>\n<p>Investigator-by-treatment\
      \ interaction will be tested in a full ANCOVA or ANOVA model, which takes the\
      \ models described above, and adds the interaction term to the model. Interaction\
      \ will be tested at \u03B1 = .10 level. When the interaction is significant\
      \ at this level, the data will be examined for each individual investigator\
      \ to attempt to identify the source of the significant interaction. When the\
      \ interaction is not significant, this term will be dropped from the model as\
      \ described above, to test for investigator and treatment main effects. By doing\
      \ so, all ANCOVA and ANOVA models will be able to validly test for treatment\
      \ differences without weighting each investigator equally, which is what occurs\
      \ when using Type III sums of squares (cell means model) with the interaction\
      \ term present in the model. This equal weighting of investigators can become\
      \ a serious problem when sample sizes are dramatically different between investigators.</p>\n\
      <p>For all ANOVA and ANCOVA models, data collected from investigators who enrolled\
      \ fewer than 3 patients in any one treatment group will be combined prior to\
      \ analysis. If this combination still results in a treatment group having fewer\
      \ than 3 patients in any one treatment group, then this group of patients will\
      \ be combined with the next fewestenrolling investigator. In the event that\
      \ there is a tie for fewest-enrolling investigator, one of these will be chosen\
      \ at random by a random-number generator.</p>\n<p>The inherent assumption of\
      \ normally distributed data will be evaluated by generating output for the residuals\
      \ from the full ANCOVA and ANOVA models, which include the interaction term,\
      \ and by testing for normality using the Shapiro-Wilk test from PROC UNIVARIATE.\
      \ In the event that the data are predominantly nonnormally distributed, analyses\
      \ will also be conducted on the ranked data. This rank transformation will be\
      \ applied by ranking all the data for a particular variable, across all investigators\
      \ and treatments, from lowest to highest. Integer ranks will be assigned starting\
      \ at 1; mean ranks will be assigned when ties occur.</p>\n<p>In addition, the\
      \ NPI-X will be analyzed in a manner similar to typical analyses of adverse\
      \ events. In this analysis, each behavior will be considered individually. This\
      \ analysis is referred to as \u201Ctreatment-emergent signs and symptoms\u201D\
      \ (TESS) analysis. For each behavior, the patients will be dichotomized into\
      \ 1 of 2 groups: those who experienced the behavior for the first time postrandomization,\
      \ or those who had the quotient between frequency and severity increase relative\
      \ to the baseline period defines one group. All other patients are in the second\
      \ group. Treatments will be compared for overall differences by Cochran-Mantel-Haentzel\
      \ (CMH) test referred to in SAS\xAE as \u201Crow mean scores differ,\u201D 2\
      \ degrees of freedom. The CMH correlation statistic (1 degree of freedom test),\
      \ will test for increasing efficacy with increasing dose (trend test).</p></div>"
- id: 1492
  properties:
    _type: NarrativeContent
    id: NarrativeContent_56
    instanceType: NarrativeContent
    label: NarrativeContent_56
    name: SECTION 4.3.4.
    sectionNumber: 4.3.4.
    sectionTitle: One-sided Justification
    text: "<div><p>All comparisons between xanomeline and placebo with respect to\
      \ efficacy variables should be one-sided. The justification for this follows.</p>\n\
      <p>The statistical hypothesis that is tested needs to be consistent with the\
      \ ultimate data-based decision that is reached. When conducting placebo-controlled\
      \ trials, it is imperative that the drug be demonstrated to be superior in efficacy\
      \ to placebo, since equivalent or worse efficacy than placebo will preclude\
      \ approvability. Consequently, a one-sided test for efficacy is required.</p>\n\
      <p>The null hypothesis is that the drug is equal or worse than placebo. The\
      \ alternative hypothesis is that the drug has greater efficacy than placebo.\
      \ A Type I error occurs only when it is concluded that a study drug is effective\
      \ when in fact it is not. This can occur in only one tail of the distribution\
      \ of the treatment difference. Further details of the arguments for one-sided\
      \ tests in placebo-controlled trials are available in statistical publications\
      \ (Fisher 1991; Koch 1991; Overall 1991; and Peace 1991).</p>\n<p>The argument\
      \ for one-sided tests does not necessarily transfer to safety measures, in general,\
      \ because one can accept a certain level of toxicity in the presence of strong\
      \ efficacy. That is, safety is evaluated as part of a benefit/risk ratio.</p>\n\
      <p>Note that this justification is similar to that used by regulatory agencies\
      \ worldwide that routinely require one-sided tests for toxicological oncogenicity\
      \ studies. In that case, the interest is not in whether a drug seems to lessen\
      \ the occurrence of cancer; the interest is in only one tail of the distribution,\
      \ namely whether the drug causes cancer to a greater extent than the control.</p>\n\
      <p>Different regulatory agencies require different type I error rates. Treatment\
      \ differences that are significant at the .025 \u03B1-level will be declared\
      \ to be \u201Cstatistically significant.\u201D When a computed p-value falls\
      \ between .025 and .05, the differences will be described as \u201Cmarginally\
      \ statistically significant.\u201D This approach satisfies regulatory agencies\
      \ who have accepted a one-sided test at the .05 level, and other regulatory\
      \ agencies who have requested a two-sided test at the .05 level, or equivalently,\
      \ a one-sided test at the .025 level. In order to facilitate the review of the\
      \ final study report, two-sided p-values will be presented in addition to the\
      \ one-sided p-values.</p></div>"
- id: 1493
  properties:
    _type: NarrativeContent
    id: NarrativeContent_57
    instanceType: NarrativeContent
    label: NarrativeContent_57
    name: SECTION 4.3.5.
    sectionNumber: 4.3.5.
    sectionTitle: Nominal P-value Adjustments
    text: "<div><p>When there are multiple outcomes, and the study drug is declared\
      \ to be effective when at least one of these outcomes achieves statistical significance\
      \ in comparison with a placebo control, a downward adjustment to the nominal\
      \ \u03B1-level is necessary. A well-known simple method is the Bonferroni method,\
      \ that divides the overall Type I error rate, usually .05, by the number of\
      \ multiple outcomes. So, for example, if there are two multiple outcomes, the\
      \ study drug is declared to be effective if at least one of the two outcomes\
      \ is significant at the .05/2 or .025 level.</p>\n<p>However, when one has the\
      \ situation that is present in this study, where there are 2 (or 3 for Europe)\
      \ outcome variables, each of which must be statistically significant, then the\
      \ adjustment of the nominal levels is in the opposite direction, that is upwards,\
      \ in order to maintain an overall Type 1 error rate of .05.</p>\n<p>In the case\
      \ of two outcomes, ADAS-Cog (11) and CIBIC+, if the two variables were completely\
      \ independent, then each variable should be tested at the nominal \u03B1-level\
      \ of .05 1/2 = .2236 level. So if both variables resulted in a nominal p-value\
      \ less than or equal to .2236, then we would declare the study drug to be effective\
      \ at the overall Type 1 error rate of .05.</p>\n<p>We expect these two outcome\
      \ measures to be correlated. From the first large-scale \nefficacy study of\
      \ oral xanomeline, Study MC-H2Q-LZZA, the correlation between \nCIBIC+ and the\
      \ change in ADAS-Cog(11) from baseline was .252. Consequently, we</p>\n<p>plan\
      \ to conduct a randomization test to combine these two dependent dose-response\
      \ p-values into a single test, which will then be at the .05 Type I error level.\
      \ Because there will be roughly 300!/(3 * 100!) possible permutations of the\
      \ data, random data permutations will be sampled (10,000 random permutations).</p>\n\
      <p>Designate the dose response p-values as p1 and p2 (computed as one-sided\
      \ p-values), for ADAS-Cog(11) and CIBIC+, respectively. The rejection region\
      \ is defined as</p>\n<p>[ {p1 \u2264 \u03B1 and p2 \u2264 \u03B1} ].</p>\n<p>The\
      \ critical value, \u03B1, will be determined from the 10,000 random permutations\
      \ by choosing the value of \u03B1 to be such that 2.5% of the 10,000 computed\
      \ pairs of dose response p-values fall in the rejection region. This will correspond\
      \ to a one-sided test at the .025 level, or equivalently a two-sided test at\
      \ the .05 level. In addition, by determining the percentage of permuted samples\
      \ that are more extreme than the observed data, a single p-value is obtained.</p></div>"
- id: 1494
  properties:
    _type: NarrativeContent
    id: NarrativeContent_58
    instanceType: NarrativeContent
    label: NarrativeContent_58
    name: SECTION 4.4.
    sectionNumber: 4.4.
    sectionTitle: Safety Analyses
    text: '<div><p>Although safety data is collected at the 24 week visit for retrieved
      dropouts, these data will not be included in the primary analysis of safety.</p>

      <p>Pearson''s chi-square test will be used to analyze 3 reasons for study discontinuation
      (protocol completed, lack of efficacy, and adverse event), the incidence of
      abnormal (high or low) laboratory measures during the postrandomization phase,
      and the incidence of treatment-emergent adverse events. The analysis of laboratory
      data is conducted by comparing the measures to the normal reference ranges (based
      on a large Lilly database), and counting patients in the numerator if they ever
      had a high (low) value during the postrandomization phase.</p>

      <p>Additionally, for the continuous laboratory tests, an analysis of change
      from baseline to endpoint will be conducted using the same ANOVA model described
      for the efficacy measures in Section 4.3. Because several laboratory analytes
      are known to be nonnormally distributed (skewed right), these ANOVAs will be
      conducted on the ranks.</p>

      <p>Several outcome measures will be extracted and analyzed from the Ambulatory
      ECG tapes, including number of pauses, QT interval, and AV block (first, second,
      or third degree). The primary consideration will be the frequency of pauses.
      The number of pauses greater than or equal to 2, 3, 4, 5 and 6 seconds will
      be tabulated. Primary analysis will focus on the number of pauses greater than
      or equal to 3 seconds. Due to possible outliers, these data will be analyzed
      as the laboratory data, by ANOVA on the ranks.</p>

      <p>Treatment-emergent adverse events (also referred to as treatment-emergent
      signs and symptoms, or TESS) are defined as any event reported during the postrandomization
      period (Weeks 0 - 26) that is worse in severity than during the baseline period,
      or one that occurs for the first time during the postrandomization period.</p></div>'
- id: 1495
  properties:
    _type: NarrativeContent
    id: NarrativeContent_59
    instanceType: NarrativeContent
    label: NarrativeContent_59
    name: SECTION 4.5.
    sectionNumber: 4.5.
    sectionTitle: Subgroup Analyses
    text: <div><p>The effect of age, gender, origin, baseline disease severity as
      measured by MMSE, Apo E, and patient education level upon efficacy will be evaluated
      if sample sizes are sufficient to warrant such analyses. For example, if all
      patients are Caucasian, then there is no need to evaluate the co-factor origin.
      The ANCOVA and ANOVA models described above will be supplemented with terms
      for the main effect and interaction with treatment. Each co-factor will be analyzed
      in separate models. The test for treatment-bysubgroup interaction will address
      whether the response to xanomeline, compared with placebo, is different or consistent
      between levels of the co-factor.</p></div>
- id: 1496
  properties:
    _type: NarrativeContent
    id: NarrativeContent_60
    instanceType: NarrativeContent
    label: NarrativeContent_60
    name: SECTION 4.6.
    sectionNumber: 4.6.
    sectionTitle: Interim Efficacy Analyses
    text: '<div><p>Two interim efficacy analyses are planned. The first interim analysis
      will occur when approximately 50% of the patients have completed 8 weeks; the
      second interim analysis is to be conducted when approximately 50% of the patients
      have completed 24 weeks of the study. The purpose of these interim analyses
      is to provide a rationale for the initiation of subsequent studies of xanomeline
      TTS, or if the outcome is negative to stop development of xanomeline TTS. The
      method developed by Enas and Offen (1993) will be used as a guideline as to
      whether or not to stop one treatment arm, or the study, to declare ineffectiveness.
      The outcome of the interim analyses will not affect in any way the conduct,
      results, or analysis of the current study, unless the results are so negative
      that they lead to a decision to terminate further development of xanomeline
      TTS in AD. Hence, adjustments to final computed p-values are not appropriate.</p>

      <p>Planned interim analyses, and any unplanned interim analyses, will be conducted
      under the auspices of the data monitoring board assigned to this study. Only
      the data monitoring board is authorized to review completely unblinded interim
      efficacy and safety analyses and, if necessary, to disseminate those results.
      The data monitoring board will disseminate interim results only if absolutely
      necessary. Any such dissemination will be documented and described in the final
      study report. Study sites will not receive information about interim results
      unless they need to know for the safety of their patients.</p></div>'
- id: 1497
  properties:
    _type: NarrativeContent
    id: NarrativeContent_61
    instanceType: NarrativeContent
    label: NarrativeContent_61
    name: SECTION 4.7.
    sectionNumber: 4.7.
    sectionTitle: Interim Safety Analyses
    text: <div><p>An analysis of the cardiovascular safety monitoring (see section
      3.9.4) will be performed when approximately 25 patients from each treatment
      arm have completed at least 2 weeks at the treatment arms' respective full dosage
      (Visit 5). If necessary, this analysis will be repeated every 25 patients per
      arm. This analysis will be conducted under the auspices of the DSMB. This board
      membership will be composed of 3 external cardiologists who will be the voting
      members of the board, a Lilly cardiologist, a Lilly statistician, and the Lilly
      research physician in charge of the study. Only the DSMB is authorized to review
      completely unblinded cardiovascular safety analyses and, if necessary, to disseminate
      those results. The outcome of the cardiovascular safety analyses will determine
      the need for further Ambulatory ECGs.</p></div>
- id: 1498
  properties:
    _type: NarrativeContent
    id: NarrativeContent_62
    instanceType: NarrativeContent
    label: NarrativeContent_62
    name: SECTION 4.8.
    sectionNumber: 4.8.
    sectionTitle: Pharmacokinetic/Pharmacodynamic Analyses
    text: <div><p>Plasma concentrations of xanomeline will be determined from samples
      obtained at selected visits (Section 3.9.2). The plasma concentration data for
      xanomeline, dosing information, and patient characteristics such as weight,
      gender and origin will be pooled and analyzed using a population pharmacokinetic
      analysis approach (for example, NONMEM). This approach preserves the individual
      pharmacokinetic differences through structural and statistical models. The population
      pharmacokinetic parameters through the structural model, and the interindividual
      and random residual variability through the components of the statistical models
      will be estimated. An attempt will also be made to correlate plasma concentrations
      with efficacy and safety data by means of population pharmacokinetic/pharmacodynamic
      modeling.</p></div>
- id: 1499
  properties:
    _type: NarrativeContent
    id: NarrativeContent_63
    instanceType: NarrativeContent
    label: NarrativeContent_63
    name: SECTION 5
    sectionNumber: '5'
    sectionTitle: "Informed Consent, Ethical Review, and Regulatory \nConsiderations"
    text: <div></div>
- id: 1500
  properties:
    _type: NarrativeContent
    id: NarrativeContent_64
    instanceType: NarrativeContent
    label: NarrativeContent_64
    name: SECTION 5.1.
    sectionNumber: 5.1.
    sectionTitle: Informed Consent
    text: "<div><p>In the United States and Canada, the investigator is responsible\
      \ for preparing the informed consent document. The investigator will use information\
      \ provided in the current [Clinical Investigator's Brochure or product information]\
      \ to prepare the informed consent document.</p>\n<p>The informed consent document\
      \ will be used to explain in simple terms, before the patient is entered into\
      \ the study, the risks and benefits to the patient. The informed consent document\
      \ must contain a statement that the consent is freely given, that the patient\
      \ is aware of the risks and benefits of entering the study, and that the patient\
      \ is free to withdraw from the study at any time.</p>\n<p>As used in this protocol,\
      \ the term \u201Cinformed consent\u201D includes all consent and/or assent given\
      \ by subjects, patients, or their legal representatives.</p>\n<p>In addition\
      \ to the elements required by all applicable laws, the 3 numbered paragraphs\
      \ below must be included in the informed consent document. The language may\
      \ be altered to match the style of the informed consent document, providing\
      \ the meaning is unchanged. In some circumstances, local law may require that\
      \ the text be altered in a way that changes the meaning. These changes can be\
      \ made only with specific Lilly approval. In these cases, the ethical review\
      \ board may request from the investigator documentation evidencing Lilly's approval\
      \ of the language in the informed consent document, which would be different\
      \ from the language contained in the protocol. Lilly shall, upon request, provide\
      \ the investigator with such documentation.</p>\n<ol>\n<li><p>\u201CI understand\
      \ that the doctors in charge of this study, or Lilly, may \nstop the study or\
      \ stop my participation in the study at any time, for any \nreason, without\
      \ my consent.\u201D</p></li>\n<li><p>\u201CI hereby give permission for the\
      \ doctors in charge of this study to \nrelease the information regarding, or\
      \ obtained as a result of, my \nparticipation in this study to Lilly, including\
      \ its agents and contractors; \nthe US Food and Drug Administration (FDA) and\
      \ other governmental \nagencies; and to allow them to inspect all my medical\
      \ records. I \nunderstand that medical records that reveal my identity will\
      \ remain \nconfidential, except that they will be provided as noted above or\
      \ as \nmay be required by law.\u201D</p></li>\n<li><p>\u201CIf I follow the\
      \ directions of the doctors in charge of this study and I \nam physically injured\
      \ because of any substance or procedure properly \ngiven me under the plan for\
      \ this study, Lilly will pay the medical \nexpenses for the treatment of that\
      \ injury which are not covered by my \nown insurance, by a government program,\
      \ or by any other third party. \nNo other compensation is available from Lilly\
      \ if any injury occurs.\u201D</p></li>\n</ol>\n<p>The investigator is responsible\
      \ for obtaining informed consent from each patient or legal representative and\
      \ for obtaining the appropriate signatures on the informed consent document\
      \ prior to the performance of any protocol procedures and prior to the administration\
      \ of study drug.</p></div>"
- id: 1501
  properties:
    _type: NarrativeContent
    id: NarrativeContent_65
    instanceType: NarrativeContent
    label: NarrativeContent_65
    name: SECTION 5.2.
    sectionNumber: 5.2.
    sectionTitle: Ethical Review
    text: "<div><p>The name and address of the ethical review board are listed on\
      \ the Investigator/Contacts cover pages provided with this protocol.</p>\n<p>The\
      \ investigator will provide Lilly with documentation of ethical review board\
      \ approval of the protocol and the informed consent document <i>before</i> the\
      \ study may begin at the site or sites concerned. The ethical review board(s)\
      \ will review the protocol as required.</p>\n<p>The investigator must provide\
      \ the following documentation:</p>\n<ul><li><p>The ethical review board's annual\
      \ reapproval of the protocol</p></li>\n<li><p>The ethical review board's approvals\
      \ of any revisions to the informed \nconsent document or amendments to the protocol.</p></li></ul></div>"
- id: 1502
  properties:
    _type: NarrativeContent
    id: NarrativeContent_66
    instanceType: NarrativeContent
    label: NarrativeContent_66
    name: SECTION 5.3.
    sectionNumber: 5.3.
    sectionTitle: Regulatory Considerations
    text: '<div><p>This study will be conducted in accordance with the ethical principles
      stated in the most recent version of the Declaration of Helsinki or the applicable
      guidelines on good clinical practice, whichever represents the greater protection
      of the individual.</p>

      <p>After reading the protocol, each investigator will sign 2 protocol signature
      pages and return 1 of the signed pages to a Lilly representative (see Attachment
      LZZT.10).</p></div>'
- id: 1503
  properties:
    _type: NarrativeContent
    id: NarrativeContent_67
    instanceType: NarrativeContent
    label: NarrativeContent_67
    name: SECTION 6
    sectionNumber: '6'
    sectionTitle: References
    text: "<div><div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-10\
      \ offset-md-1 text-left\">\n<p>Bierer LM, Haroutunian V, Gabriel S, Knott PJ,\
      \ Carlin LS, Purohit DP, et al. 1995.<br/>Neurochemical correlates of dementia\
      \ severity in AD: Relative importance of the cholinergic deficits. J of Neurochemistry\
      \ 64:749-760.</p>\n</div>\n</div>\n<div class=\"row\">\n<div class=\"col-md-10\
      \ offset-md-1 text-left\">\n<p>Cummings JL, Mega M, Gray K, Rosenberg-Thompson\
      \ S, et al. 1994. The Neuropsychiatric Inventory: Comprehensive assessment of\
      \ psychopathology in dementia. Neurology 44:2308-2314.</p>\n</div>\n</div>\n\
      <div class=\"row\">\n<div class=\"col-md-10 offset-md-1 text-left\">\n<p>Enas\
      \ GG, Offen WW. 1993. A simple stopping rule for declaring treatment ineffectiveness\
      \ in clinical trials. J Biop Stat 3(1):13-32.</p>\n</div>\n</div>\n<div class=\"\
      row\">\n<div class=\"col-md-10 offset-md-1 text-left\">\n<p>Fisher A, Barak\
      \ D. 1994. Promising therapeutic strategies in Alzheimer's disease based \n\
      on functionally selective M 1 muscarinic agonists. Progress and perspectives\
      \ in new \nmuscarinic agonists. DN&amp;P 7(8):453-464.</p>\n</div>\n</div>\n\
      <div class=\"row\">\n<div class=\"col-md-10 offset-md-1 text-left\">\n</div>\n\
      </div>\n<div class=\"row\">\n<div class=\"col-md-10 offset-md-1 text-left\"\
      >\n<p>GLUCAGON for Injection ITO [Package Insert]. Osaka, Japan: Kaigen Pharma\
      \ Co., Ltd; 2016.Available at:\n        http://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/130616_7229400D1088_\n\
      \        1_11.</p>\n</div>\n</div>\n<div class=\"row\">\n<div class=\"col-md-10\
      \ offset-md-1 text-left\">\n<p>Polonsky WH, Fisher L, Hessler D, Johnson N.\
      \ Emotional distress in the partners of type 1diabetes adults:\n        worries\
      \ about hypoglycemia and other key concerns. Diabetes Technol Ther. 2016;18:292-297.</p>\n\
      </div>\n</div>\n<div class=\"row\">\n<div class=\"col-md-10 offset-md-1 text-left\"\
      >\n<p>Fisher LD. 1991. The use of one-sided tests in drug trials: an FDA advisory\
      \ committee \nmember's perspective. J Biop Stat 1:151-6.</p>\n</div>\n</div>\n\
      <div class=\"row\">\n<div class=\"col-md-10 offset-md-1 text-left\">\n<p>Koch\
      \ GG. 1991. One-sided and two-sided tests and p-values. J Biop Stat 1:161-70.\
      \ </p>\n</div>\n</div>\n<div class=\"row\">\n<div class=\"col-md-10 offset-md-1\
      \ text-left\">\n<p>Overall JE. 1991. A comment concerning one-sided tests of\
      \ significance in new drug \napplications. J Biop Stat 1:157-60.</p>\n</div>\n\
      </div>\n<div class=\"row\">\n<div class=\"col-md-10 offset-md-1 text-left\"\
      >\n<p>Peace KE. 1991. Oneside or two-sided p-values: which most appropriately\
      \ address the \nquestion of drug efficacy? J Biop Stat 1:133-8.</p>\n</div>\n\
      </div>\n</div></div>"
- id: 1504
  properties:
    _type: NarrativeContent
    id: NarrativeContent_68
    instanceType: NarrativeContent
    label: NarrativeContent_68
    name: SECTION Appendix 1
    sectionNumber: Appendix 1
    sectionTitle: Protocol Attachment LZZT.1. Schedule of Events for Protocol H2Q-MC-LZZT(c)
    text: "<div>\n<div class=\"col-md-8 offset-md-2 text-center\">\n<p class=\"usdm-warning\"\
      >Note:</p>\n<p class=\"usdm-warning\">The following SoA timelines are auto generated\
      \ using the detailed study design held within the USDM.</p>\n</div>\n <div class=\"\
      page soa-page table-responsive\"><p><b>Timeline: Main Timeline, Potential subject\
      \ identified</b></p><table class=\"table table-bordered table-sm\" style=\"\
      width:100%\"><tr><td><p class=\"soa-activity-text\"></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"StudyEpoch_1\" klass=\"StudyEpoch\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"StudyEpoch_1\" klass=\"StudyEpoch\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"StudyEpoch_2\" klass=\"StudyEpoch\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"StudyEpoch_2\" klass=\"StudyEpoch\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"StudyEpoch_3\" klass=\"StudyEpoch\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"StudyEpoch_3\" klass=\"StudyEpoch\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"StudyEpoch_3\" klass=\"StudyEpoch\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"StudyEpoch_3\" klass=\"StudyEpoch\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"StudyEpoch_3\" klass=\"StudyEpoch\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"StudyEpoch_3\" klass=\"StudyEpoch\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"StudyEpoch_3\" klass=\"StudyEpoch\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"StudyEpoch_3\" klass=\"StudyEpoch\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"StudyEpoch_3\" klass=\"StudyEpoch\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"StudyEpoch_3\" klass=\"StudyEpoch\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"StudyEpoch_4\" klass=\"StudyEpoch\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"StudyEpoch_5\" klass=\"StudyEpoch\"></usdm:ref></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"label\" id=\"Encounter_1\" klass=\"Encounter\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"label\" id=\"Encounter_2\" klass=\"\
      Encounter\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"\
      label\" id=\"Encounter_3\" klass=\"Encounter\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Encounter_4\" klass=\"Encounter\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"Encounter_5\" klass=\"Encounter\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Encounter_6\" klass=\"Encounter\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"Encounter_7\" klass=\"Encounter\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Encounter_7\" klass=\"Encounter\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"Encounter_8\" klass=\"Encounter\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Encounter_8\" klass=\"Encounter\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"Encounter_9\" klass=\"Encounter\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Encounter_9\" klass=\"Encounter\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"Encounter_10\" klass=\"Encounter\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Encounter_10\" klass=\"Encounter\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"Encounter_11\" klass=\"Encounter\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Encounter_12\" klass=\"Encounter\"\
      ></usdm:ref></p></td></tr><tr><td><p class=\"soa-activity-text\"></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"label\" id=\"Timing_1\" klass=\"\
      Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"\
      label\" id=\"Timing_2\" klass=\"Timing\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Timing_3\" klass=\"Timing\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"Timing_4\" klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"\
      ><usdm:ref attribute=\"label\" id=\"Timing_5\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"label\" id=\"Timing_6\" klass=\"\
      Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"\
      label\" id=\"Timing_7\" klass=\"Timing\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Timing_8\" klass=\"Timing\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"Timing_9\" klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"\
      ><usdm:ref attribute=\"label\" id=\"Timing_10\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"label\" id=\"Timing_11\" klass=\"\
      Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"\
      label\" id=\"Timing_12\" klass=\"Timing\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Timing_13\" klass=\"Timing\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"Timing_14\" klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"\
      ><usdm:ref attribute=\"label\" id=\"Timing_15\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"label\" id=\"Timing_16\" klass=\"\
      Timing\"></usdm:ref></p></td></tr><tr><td><p class=\"soa-activity-text\"></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_1\"\
      \ klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"windowLabel\" id=\"Timing_2\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_3\"\
      \ klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"windowLabel\" id=\"Timing_4\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_5\"\
      \ klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"windowLabel\" id=\"Timing_6\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_7\"\
      \ klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"windowLabel\" id=\"Timing_8\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_9\"\
      \ klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"windowLabel\" id=\"Timing_10\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_11\"\
      \ klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"windowLabel\" id=\"Timing_12\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_13\"\
      \ klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"windowLabel\" id=\"Timing_14\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_15\"\
      \ klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"windowLabel\" id=\"Timing_16\" klass=\"Timing\"></usdm:ref></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_1\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_2\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_3\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_4\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_5\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_6\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_7\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_8\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_9\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_10\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_11\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_12\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_13\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_14\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_15\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_16\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_17\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_18\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_19\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_20\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_21\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_22\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_23\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_24\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X<sup>1</sup></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"\
      ></p></td></tr><tr><td><p class=\"soa-activity-text\"><usdm:ref attribute=\"\
      label\" id=\"Activity_25\" klass=\"Activity\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"\
      soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"\
      soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"\
      soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"\
      soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"\
      soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"\
      soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"\
      soa-body-text\">X</p></td><td><p class=\"soa-body-text\">X</p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_26\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_27\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X<sup>2</sup></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"\
      ></p></td></tr><tr><td><p class=\"soa-activity-text\"><usdm:ref attribute=\"\
      label\" id=\"Activity_28\" klass=\"Activity\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\">X<sup>3</sup></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_29\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\">X<sup>4</sup></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\">X</p></td><td><p\
      \ class=\"soa-body-text\"></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_30\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X<sup>5</sup></p></td><td><p class=\"soa-body-text\"\
      ></p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"\
      >X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"\
      >X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"\
      >X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"\
      >X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"\
      >X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"\
      >X</p></td><td><p class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"\
      >X</p></td></tr></table><table class=\"table table-borderless table-sm\"><tr><td><p\
      \ class=\"soa-footnote-text\"><sup>1</sup></p></td><td><p class=\"soa-footnote-text\"\
      >Performed if patient is an insulin-dependent diabetic</p></td></tr><tr><td><p\
      \ class=\"soa-footnote-text\"><sup>2</sup></p></td><td><p class=\"soa-footnote-text\"\
      >Practice only - It is recommended that a sampling of the CIBIC+, ADAS-Cog,\
      \ DAD, and NPI-X be administered at Visit 1. Data from this sampling would not\
      \ be considered as study data and would not be collected.</p></td></tr><tr><td><p\
      \ class=\"soa-footnote-text\"><sup>3</sup></p></td><td><p class=\"soa-footnote-text\"\
      >Practice only - It is recommended that a sampling of the CIBIC+, ADAS-Cog,\
      \ DAD, and NPI-X be administered at Visit 1. Data from this sampling would not\
      \ be considered as study data and would not be collected.</p></td></tr><tr><td><p\
      \ class=\"soa-footnote-text\"><sup>4</sup></p></td><td><p class=\"soa-footnote-text\"\
      >Practice only - It is recommended that a sampling of the CIBIC+, ADAS-Cog,\
      \ DAD, and NPI-X be administered at Visit 1. Data from this sampling would not\
      \ be considered as study data and would not be collected.</p></td></tr><tr><td><p\
      \ class=\"soa-footnote-text\"><sup>5</sup></p></td><td><p class=\"soa-footnote-text\"\
      >Practice only - It is recommended that a sampling of the CIBIC+, ADAS-Cog,\
      \ DAD, and NPI-X be administered at Visit 1. Data from this sampling would not\
      \ be considered as study data and would not be collected.</p></td></tr></table></div><div\
      \ class=\"page soa-page table-responsive\"><p><b>Timeline: Adverse Event Timeline,\
      \ Subject suffers an adverse event</b></p><table class=\"table table-bordered\
      \ table-sm\" style=\"width:100%\"><tr><td><p class=\"soa-activity-text\"></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"label\" id=\"Timing_17\" klass=\"\
      Timing\"></usdm:ref></p></td></tr><tr><td><p class=\"soa-activity-text\"></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_17\"\
      \ klass=\"Timing\"></usdm:ref></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_31\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr></table></div><div class=\"page soa-page\
      \ table-responsive\"><p><b>Timeline: Early Termination Timeline, Subject terminates\
      \ the study early</b></p><table class=\"table table-bordered table-sm\" style=\"\
      width:100%\"><tr><td><p class=\"soa-activity-text\"></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Timing_18\" klass=\"Timing\"\
      ></usdm:ref></p></td></tr><tr><td><p class=\"soa-activity-text\"></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_18\"\
      \ klass=\"Timing\"></usdm:ref></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_7\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_13\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_16\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_19\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_20\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_21\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_22\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_23\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_25\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_26\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_27\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_28\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_29\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_30\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_32\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr></table></div><div class=\"page soa-page\
      \ table-responsive\"><p><b>Timeline: Vital Sign Blood Pressure Timeline, Automatic\
      \ execution</b></p><table class=\"table table-bordered table-sm\" style=\"width:100%\"\
      ><tr><td><p class=\"soa-activity-text\"></p></td><td><p class=\"soa-body-text\"\
      ><usdm:ref attribute=\"label\" id=\"Timing_19\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"label\" id=\"Timing_20\" klass=\"\
      Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"\
      label\" id=\"Timing_21\" klass=\"Timing\"></usdm:ref></p></td><td><p class=\"\
      soa-body-text\"><usdm:ref attribute=\"label\" id=\"Timing_22\" klass=\"Timing\"\
      ></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref attribute=\"label\"\
      \ id=\"Timing_23\" klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"\
      ><usdm:ref attribute=\"label\" id=\"Timing_24\" klass=\"Timing\"></usdm:ref></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"windowLabel\" id=\"Timing_19\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_20\"\
      \ klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"windowLabel\" id=\"Timing_21\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_22\"\
      \ klass=\"Timing\"></usdm:ref></p></td><td><p class=\"soa-body-text\"><usdm:ref\
      \ attribute=\"windowLabel\" id=\"Timing_23\" klass=\"Timing\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"><usdm:ref attribute=\"windowLabel\" id=\"Timing_24\"\
      \ klass=\"Timing\"></usdm:ref></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_33\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_34\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td></tr><tr><td><p class=\"soa-activity-text\"\
      ><usdm:ref attribute=\"label\" id=\"Activity_35\" klass=\"Activity\"></usdm:ref></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td></tr><tr><td><p\
      \ class=\"soa-activity-text\"><usdm:ref attribute=\"label\" id=\"Activity_36\"\
      \ klass=\"Activity\"></usdm:ref></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\"></p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td><td><p class=\"soa-body-text\"></p></td><td><p\
      \ class=\"soa-body-text\">X</p></td></tr></table></div></div>"
- id: 1505
  properties:
    _type: NarrativeContent
    id: NarrativeContent_69
    instanceType: NarrativeContent
    label: NarrativeContent_69
    name: SECTION Appendix 2
    sectionNumber: Appendix 2
    sectionTitle: Protocol Attachment LZZT.2. Alzheimer's Disease Assessment Scale-Cognitive
      Subscale (ADAS-Cog) with Attention and Concentration Tasks
    text: '<div>

      <div class="col-md-8 offset-md-2 text-center">

      <p class="usdm-warning">Note:</p>

      <p class="usdm-warning">The attachment has not been included in this issue of
      the protocol. It may be included in future versions.</p>

      </div>

      </div>'
- id: 1506
  properties:
    _type: NarrativeContent
    id: NarrativeContent_70
    instanceType: NarrativeContent
    label: NarrativeContent_70
    name: SECTION Appendix 3
    sectionNumber: Appendix 3
    sectionTitle: Protocol Attachment LZZT.3. Video-referenced Clinician's Interview-Based
      Impression of Change (CIBIC+)
    text: '<div>

      <div class="col-md-8 offset-md-2 text-center">

      <p class="usdm-warning">Note:</p>

      <p class="usdm-warning">The attachment has not been included in this issue of
      the protocol. It may be included in future versions.</p>

      </div>

      </div>'
- id: 1507
  properties:
    _type: NarrativeContent
    id: NarrativeContent_71
    instanceType: NarrativeContent
    label: NarrativeContent_71
    name: SECTION Appendix 4
    sectionNumber: Appendix 4
    sectionTitle: Protocol Attachment LZZT.4. Revised Neuropsychiatric Inventory (NPI-X)
    text: '<div>

      <div class="col-md-8 offset-md-2 text-center">

      <p class="usdm-warning">Note:</p>

      <p class="usdm-warning">The attachment has not been included in this issue of
      the protocol. It may be included in future versions.</p>

      </div>

      </div>'
- id: 1508
  properties:
    _type: NarrativeContent
    id: NarrativeContent_72
    instanceType: NarrativeContent
    label: NarrativeContent_72
    name: SECTION Appendix 5
    sectionNumber: Appendix 5
    sectionTitle: Protocol Attachment LZZT.5. Disability Assessment for Dementia (DAD)
    text: '<div>

      <div class="col-md-8 offset-md-2 text-center">

      <p class="usdm-warning">Note:</p>

      <p class="usdm-warning">The attachment has not been included in this issue of
      the protocol. It may be included in future versions.</p>

      </div>

      </div>'
- id: 1509
  properties:
    _type: NarrativeContent
    id: NarrativeContent_73
    instanceType: NarrativeContent
    label: NarrativeContent_73
    name: SECTION Appendix 6
    sectionNumber: Appendix 6
    sectionTitle: Protocol Attachment LZZT.6. Mini-Mental State Examination (MMSE)
    text: '<div>

      <div class="col-md-8 offset-md-2 text-center">

      <p class="usdm-warning">Note:</p>

      <p class="usdm-warning">The attachment has not been included in this issue of
      the protocol. It may be included in future versions.</p>

      </div>

      </div>'
- id: 1510
  properties:
    _type: NarrativeContent
    id: NarrativeContent_74
    instanceType: NarrativeContent
    label: NarrativeContent_74
    name: SECTION Appendix 7
    sectionNumber: Appendix 7
    sectionTitle: Protocol Attachment LZZT.7. NINCDS/ADRDA Guidelines
    text: '<div>

      <div class="col-md-8 offset-md-2 text-center">

      <p class="usdm-warning">Note:</p>

      <p class="usdm-warning">The attachment has not been included in this issue of
      the protocol. It may be included in future versions.</p>

      </div>

      </div>'
- id: 1511
  properties:
    _type: NarrativeContent
    id: NarrativeContent_75
    instanceType: NarrativeContent
    label: NarrativeContent_75
    name: SECTION Appendix 8
    sectionNumber: Appendix 8
    sectionTitle: Protocol Attachment LZZT.8. Hachinski Ischemic Scale
    text: '<div>

      <div class="col-md-8 offset-md-2 text-center">

      <p class="usdm-warning">Note:</p>

      <p class="usdm-warning">The attachment has not been included in this issue of
      the protocol. It may be included in future versions.</p>

      </div>

      </div>'
- id: 1512
  properties:
    _type: NarrativeContent
    id: NarrativeContent_76
    instanceType: NarrativeContent
    label: NarrativeContent_76
    name: SECTION Appendix 9
    sectionNumber: Appendix 9
    sectionTitle: Protocol Attachment LZZT.9. TTS Acceptability Survey
    text: '<div>

      <div class="col-md-8 offset-md-2 text-center">

      <p class="usdm-warning">Note:</p>

      <p class="usdm-warning">The attachment has not been included in this issue of
      the protocol. It may be included in future versions.</p>

      </div>

      </div>'
- id: 1513
  properties:
    _type: NarrativeContent
    id: NarrativeContent_77
    instanceType: NarrativeContent
    label: NarrativeContent_77
    name: SECTION Appendix 10
    sectionNumber: Appendix 10
    sectionTitle: Protocol Attachment LZZT.10. Protocol Signatures
    text: '<div>

      <div class="col-md-8 offset-md-2 text-center">

      <p class="usdm-warning">Note:</p>

      <p class="usdm-warning">The attachment has not been included in this issue of
      the protocol. It may be included in future versions.</p>

      </div>

      </div>'
- id: 1429
  properties:
    _type: StudyProtocolDocumentVersion
    id: StudyProtocolDocumentVersion_1
    instanceType: StudyProtocolDocumentVersion
    label: StudyProtocolDocumentVersion_1
    protocolVersion: '2'
- id: 1428
  properties:
    _type: StudyProtocolDocument
    description: null
    id: StudyProtocolDocument_1
    instanceType: StudyProtocolDocument
    label: StudyProtocolDocument_1
    name: Protocol_Document_CDISC PILOT - LZZT
- id: 1
  properties:
    _type: Study
    description: null
    id: null
    instanceType: Study
    label: Study
    name: Study_CDISC PILOT - LZZT
